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3. Abbreviations 
 
+/+  wild-type 
-/-  knockout 
ADAM  a disintegrin and metalloproteinase 
AdMIDAS adjacent to metal ion dependent adhesion site 
ADP  adenosine diphosphate 
AE  anion exchanger 
AGM  aorta-gonad-mesonephros region 
Akt  RAC-alpha serine/threonine protein kinase 
Arp2/3  actin-related protein 2/3 complex 
ATP  adenosine triphosphate 
bp  base pare 
CAII  carbonic anhydrase II 
CD  cluster of differentiation 
C. elegans Caenorhabditis elegans 
ClC-7  chloride channel 7 
Cre  cyclization recombinase 
D  aspartate 
DAP12 DNAX-activating protein of 12 kDa 
DC  dentritic cell 
DOCK180 dedicator of cytokinesis 1 
E  glutamate 
EGF  epidermal growth factor 
EGFR  epidermal growth factor receptor 
ECM  extracellular matrix 
E.coli  Escherichia coli 
Epo  erythropoietin 
ERK  extracellular signal-regulated kinase 
ESAM  endothelial cell-selective adhesion molecule 
EX  embryonic day X 
F  phenylalanine 
F1-3  FERM subdomain 1-3 
FA  focal adhesion 
FAK  focal adhesion kinase 
FcR   fragment (crystallisable) receptor  
FERM  four-point-one/ezrin/radixin/moesin 
G  glycine 
GAP  GTPase-activating protein 
G-CSF  granulocyte colony stimulating factor 
GDI  guanine nucleotide dissociation inhibitor 
GDP  guanosine diphosphate 
GEF  guanine nucleotide exchange factors 
GFP  green fluorescent protein 
GIT  G-coupled receptor kinase-interacting protein 
GM-CSF granulocyte macrophage colony stimulating factor 
GP  glycoprotein 
GPCR  G-protein coupled receptor 
GPI  glycosylphosphatidyl inositol 
GTP  guanosine triphosphate 
GTPase guanosine triphosphatase 
H  histidine 
HGFR  hepatocyte growth factor receptor 
HSC  haematopoietic stem cell 
ICAM  intercellular adhesion molecule 
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Ig  immunoglobulin 
ILK  Integrin linked kinase 
IPP  ILK/pinch/parvin 
ITAM  immunoreceptor tyrosine-based activation motif 
JAM-A  junctional adhesion molecule A 
JNK  c-Jun N-terminal kinase 
K  lysine 
L  leucine 
LAD  leukocyte adhesion deficiency 
LAP  latency-associated peptide 
LDV  lysine/aspartate/valine 
LFA  lymphocyte finction associated protein 
LPS  lipopolysaccharide 
MadCAM mucosal vascular addressin cell adhesion molecule 
M-CSF macrophage colony stimulating factor 
MFGE8 milk fat globule-EGF factor 8 
MHC  major histocompatibility complex 
MIDAS metal ion dependent adhesion site 
Mig-2  mitogen inducible gene 2 
MLC  myosin light chain 
MMP  matrix metalloproteinase 
mRNA  messenger RNA 
N  asparagine 
neo  neomycin resistence gene 
NFATc1 nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1 
NF-   nuclear factor-  
NK  natural killer cells 
ODF  osteoclast differentiation factor 
OPG  osteoprotegerin 
OPGL  osteoprotegerin ligand 
P  proline 
p130Cas p130 Crk-associated substrate 
PAT  paralysed, arrested elongation at twofold stage 
PDGFR platelet-derived growth factor receptor 
PECAM-1 platelet/endothelial cell adhesion molecule 1 
PH  pleckstrin homology 
PI3K  phosphatidylinositol 3-kinase 
PINCH  particularly interesting new cysteine-histidine-rich protein 
PIP2  phosphotidylinositol-4,5-bisphosphate 
PIP3  phosphotidylinositol-3,4,5-trisphosphate 
PIPKI   phosphatidylinositol 4-phosphate 5-kinase  
PIX  PAK interactive exchange factor 
PLC  phospholipase C 
PGI2  prostacyclin 
PML/PMN polymorphonuclear leukocytes 
PSGL-1 P-selectin glycoprotein ligand 1 
PSI  plexin/semaphorin/integrin domain 
PTB  phosphotyrosine binding domain 
PtdIns   phosphatidylinositol 
PTEN  phosphatase and tensin homolog 
PTH  parathyroid hormone 
pY  phosphotyrosine 
Pyk2  proline-rich tyrosine kinase 2 
Q  glutamine 
R  arginine 
RANKL receptor activator of nuclear factor B ligand 
ABBREVIATIONS 
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RGD  arginine/glycine/aspartate 
RGDfV arginine/glycine/aspartate/D-phenylalanine/valine 
RIAM  Rap1-GTP–interacting adaptor molecule 
ROCK  Rho-associated protein kinase 
ROS  reactive oxygen species 
RTK  receptor tyrosine kinase 
S  serine 
SH2  Src homology 2 
SILAC  stable isotope labelling by amino acids in cell culture 
STAT  signal transducer and activator of transcription 
SyMBS synergistic metal ion binding site 
T  threonine 
TD   tail domain 
TGF   transforming growth factor  
TNF  tumour necrosis factor 
TRAF-6 tumour necrosis factor receptor-associated factor-6 
TRANCE tumour necrosis factor-related activation-induced cytokine 
TRAP  tartrate resistant acid phopsphatase 
Unc-112 uncoordinated protein 112 
URP  Unc-112 related protein 
VCAM  vascular cell adhesion molecule 
VE-cadherin vascular endothelial cadherin 
VLA  very late antigen 
VEGFR vascular endothelial growth factor receptor 
vWF  von Willebrand factor 
W  tryptophan 
WASp  Wiskott-Aldrich syndrome protein 
WIP  WASp interacting protein 
Y  tyrosine 
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4. Summary 
 
Integrins are ubiquitously expressed cell surface receptors consisting of an  and a  
subunit. They represent the major class of cell-extracellular matrix receptors and 
some of them also mediate cell-cell adhesion. A hallmark of integrins is their ability to 
shift between different conformational states. The shift from an inactive integrin with a 
low affinity for the ligand towards an active integrin with high ligand affinity is 
regulated by intracellular signals. Recently it has been shown that the final step in 
integrin activation is triggered by talin and kindlins, which are cytoplasmic proteins. 
The family of kindlin proteins consists of three members: kindlin-1, -2 and -3.  
Kindlin-1 is mainly expressed in epithelia, kindlin-2 is almost ubiquitously expressed 
and the expression of kindlin-3 is restricted to haematopoietic cells. Kindlins are 
characterized by a FERM (four-point-one/ezrin/radixin/moesin) domain with an 
inserted PH (pleckstrin homology) domain. These domains suggest that kindlins 
predominantly associate with cell membranes. All kindlins localize to integrin-
mediated adhesion sites by binding to the cytoplasmic domain of integrins. 
Kindlin-3 deficient mice die within one week after birth due to bleedings and severe 
anemia, caused by impaired platelet integrin activation and aggregation. It was 
already shown that kindlin-3 is essential for activation of 1 and 3 integrins on 
platelets but the role of kindlin-3 in other haematopoietic cells was not yet examined. 
In order to quantitatively analyse the proteome of various cell types and tissues, we 
applied the SILAC (stable isotope labelling by amino acids in cell culture) method to 
the whole mouse organism by using a diet, which contained a 13C6-substituted 
version of lysine. This technique was used to compare the proteomes of control and 
kindlin-3 deficient erythrocytes. In examinations of kindlin-3-/- erythrocytes we found 
a profound defect in the composition of structural proteins of the membrane skeleton 
leading to less stable erythrocytes. This partly contributes to the anemia of kindlin-3 
null mice (Paper I).  
In a further study we analysed the role of kindlin-3 in leukocytes (Paper II) and could 
show that kindlin-3 is also required for the activation of 2 integrins on leukocytes. In 
humans impaired activation of 1, 2 and 3 integrins on platelets and leukocytes 
leads to the rare autosomal recessive leukocyte adhesion deficiency syndrome type 
III (LAD-III), which is characterized by severe bleeding and impaired adhesion of 
leukocytes to the endothelium of inflamed tissues. Based on the analyses of kindlin-3 
null mice mutations in the human kindlin-3 gene were identified in LAD-III patients. 
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Since kindlin-3 deficient mice reveal the same symptoms as LAD-III patients, this 
mouse mutant can serve as a valuable model to characterize the molecular basis of 
this disease. 
A number of LAD-III patients additionally suffer from osteopetrosis. Kindlin-3 deficient 
mice also develop severe osteopetrosis, which is already apparent at birth. We 
examined the role of kindlin-3 in bone homeostasis (Paper III). Kindlin-3 deficient 
osteoclasts show a profound adhesion and spreading defect owing to impaired 
activation of 1, 2 and 3 integrins. However, integrin independent functions of 
kindlin-3 in osteoclasts can not be fully excluded. The defect of kindlin-3-/- 
osteoclasts was compared to osteoclasts lacking one, two or all three integrin 
classes. We found that loss of a single integrin class already affects osteoclast 
function and that the loss of all integrins indeed mimics kindlin-3 deficiency. 
Altogether our findings show that kindlin-3 is an essential regulator of blood cell 
integrins required for bidirectional integrin signaling. A number of open questions still 
remain. The mode of kindlin-3 regulation and its crosstalk with talin at the integrin 
cytoplasmic domain are two major issues that have to be addressed in near future. 
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5. Introduction 
 
5.1. Kindlins 
 
5.1.1. The family of kindlin proteins 
 
The kindlins are a new family of intracellular cell adhesion proteins consisting of three 
members in mice and humans, kindlin-1, -2 and -3. In C. elegans one kindlin 
orthologue exists, which is named Unc-112 (uncoordinated protein 112) and the 
Drosophila genome encodes for two kindlin-related proteins (fermitin-1 and -2). The 
kindlin family is named after the gene mutated in kindler syndrome, which is an 
autosomal recessive inherited genodermatosis in humans [1]. 
Kindlin-2, previously described as Mig-2 (mitogen inducible gene 2), was discovered 
in a cDNA screen for mitogen inducible genes [1]. Kindlin-1 and kindlin-3 were 
initially named Unc-112 related protein 1 (URP-1) and URP-2, respectively [2]. Siegel 
et al. [3] proposed to name the three different genes kindlin-1 (URP-1), kindlin-2 
(Mig-2) and kindlin-3 (URP-2). 
The kindlin proteins share an evolutionary conserved gene structure. Both human 
and murine kindlin genes consist of 15 exons. The ATG start codon is located in 
exon 2 of all three genes. Translation of the murine cDNAs gives rise to proteins with 
677 amino acids (kindlin-1), 680 amino acids (kindlin-2) and 655 amino acids (kindlin-
3). Sequence alignments revealed a high similarity of the kindlin proteins to each 
other. Kindlin-1 and kindlin-2 are most closely related with an identity of 60% and a 
similarity of 74%. Kindlin-3 has less homology to its relatives with 53% identity and 
69% similarity to kindlin-1 and 49% identity and 67% similarity to kindlin-2, 
respectively [4]. 
 
 
5.1.2. Domain structure of kindlin proteins 
 
All kindlin proteins exhibit the same and unique protein domain structure. Kindlins 
harbour a FERM domain (Band four-point-one/ezrin/radixin/moesin), which consists 
of three subdomains: F1-F3 (Figure 1). The subdomain F1 is folded in an ubiquitin-
like manner, subdomain F2 has an -helix bundle structure and subdomain F3 
reveals a phosphotyrosine binding (PTB) domain, which belongs to the pleckstrin 
homology (PH) domain folding superfamily [5-7]. A hallmark of kindlin proteins is a 
PH domain, which is inserted in the F2 subdomain [8]. 
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Figure 1: Common domain structure of kindlin proteins. F1-F3 represent the FERM 
subdomains. Subdomain F2 is inserted by a PH domain. 
 
More than 80 FERM domain containing proteins are known in mouse and man. The 
common feature of this heterogeneous group of proteins is their ability to link 
intracellular proteins to the cytoplasmic domains of transmembrane proteins. They 
furthermore can link filamentous actin within the cell cortex to cell surface proteins 
such as integrins, CD44, CD43, intercellular adhesion molecule-2 (ICAM-2) and 
ICAM-3 [9]. FERM domains consist of 200-300 amino acids. The conformation and 
activity of FERM proteins is regulated by a combination of phospholipid binding and 
phosphorylation [10]. 
Different members of the PH/PTB superfamily show only little sequence homology. 
PH/PTB domains consist of approximately 120 amino acids and are characterized by 
a common folding structure, in which two nearly orthogonal anti-parallel  sheets 
form a  sandwich flanked by an -helix that holds this structure together [7, 11; 12]. 
Approximately 50 proteins in mice and men contain a PTB domain. This domain was 
initially identified in the Src homology 2 domain adaptor protein Shc, where it 
mediates the binding of Shc to an NPXpY motif in activated receptor tyrosine kinases 
[13]. Interestingly, this recognition motif differs fundamentally from those of SH2 (Src 
homology 2) domains, which also bind to phosphorylated tyrosine residues. PTB 
domain containing proteins including talin [14] can also bind with the same or higher 
affinity to a non-phosphorylated NPxY motif. 
Proteins harbouring a PH domain fulfil a very broad range of tasks [11]. PH domains 
are found in approximately 250 human and murine proteins, such as protein kinases, 
guanine nucleotide exchange factors (GEFs), phospholipases and cytoskeletal 
proteins [15]. The main function of PH domains is to bind phosphatidylinositol lipids 
within cell membranes [16-18].  
Phosphatidylinositol (PtdIns) can be phosphorylated at three hydroxyl groups of the 
inositol, at the positions 3, 4 and 5. These phosphorylation sites are phosphorylated 
and dephosphorylated by different kinases such as phosphatidylinositol 3-kinase 
(PI3K) and lipid phosphatases like phosphatase and tensin homolog (PTEN) [12]. 
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This results in all kinds of combinations of mono-, bi- and triphosphorylated PtdIns. 
All PtdIns have a very distinct spatial and temporal distribution pattern within the 
various membranes of the cell. PtdIns(4,5)P2 (PtdIns 4,5-bisphosphate) for instance 
is predominantly found in the plasma membrane and the Golgi apparatus at steady 
state levels. PtdIns(3,4,5)P3 and PtdIns(3,4)P2 instead accumulate transiently at the 
plasma membrane only upon receptor stimulation. Different PH domains vary in their 
affinities to PtdIns depending on their phosphorylation status. Therefore, PH domains 
play an important role in targeting proteins to the membranes of various cellular 
compartments. 
Taken together, the kindlins are typical adaptor proteins containing two domains 
known to mediate membrane association. 
 
 
5.1.3. Role of Unc-112 in C. elegans 
 
First functional data on kindlin proteins were reported from Unc-112, the kindlin 
orthologue of C. elegans. Unc-112 was identified as a novel membrane-associated, 
cytoplasmic protein that colocalizes with integrins at cell-extracellular matrix (ECM) 
adhesion sites. Animals homozygous for the r367 allele of the unc-112 gene show a 
phenotype with a disorganized body wall muscle leading to paralysis in adult worms 
and uncoordinated movement [19]. Null mutants of the unc-112 gene show a much 
more severe phenotype. They display a paralyzed, arrested elongation at twofold 
stage (PAT) phenotype. 
PAT phenotypes occur after loss of proteins that are essential for the formation of 
functional embryonic body wall muscles [20]. Null mutants of unc-52, a homologue of 
perlecan, pat-2 (  integrin subunit) and pat-3 (  integrin subunit) reveal a PAT 
phenotype variant, which is very similar to the phenotype of Unc-112 null mutants 
[21]. In the body wall muscle cells of these mutants, myosin and actin are not 
organized into sarcomeres, and dense body and M-line components fail to assemble. 
Experiments with GFP-tagged Unc-112 showed that Unc-112 colocalizes with PAT-3 
at dense bodies and M-lines as well as at the basal plasma membrane of muscle 
cells where they contact neighbouring cells [20]. Upon loss of Unc-112 PAT-3 looses 
its specific targeting to dense bodies and M-lines. Unc-112 is not required for the 
initial polarized localisation of integrins in the muscle cells and their clustering into 
nascent adhesions, instead Unc-112 is necessary for the subsequent organization of 
these nascent adhesion sites into an ordered array within the muscle cell membrane. 
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Furthermore, PAT-4, the C. elegans orthologue of integrin linked kinase (ILK), 
recruits Unc-112 to the plasma membrane. But proper localisation of PAT-4 also 
depends on Unc-112. This process might be due to direct protein-protein interaction, 
since a direct interaction between Unc-112 and PAT-4 was suggested in a yeast two-
hybrid screen [22]. 
Depletion of Unc-112 in later, post-embryonic stages by RNAi results in sterility due 
to defective ovulation and impaired migration of the distal tip cells that form the 
gonads [23]. Failure in ovulation is a consequence of defective contraction and 
dilation of somatic gonad structures, as Unc-112 acts as an important regulator of 
actin mediated cell contractility. 
In summary, these data describe roles of Unc-112 in integrin mediated cell adhesion 
structures and in the linkage of integrins to the actin cytoskeleton. 
 
 
5.1.4. Role of fermitin 1 and 2 in Drosophila 
 
Little is known about the role of the kindlin orthologues fermitin 1 und 2 in Drosophila. 
fermitin 1 and fermitin 2 are both expressed in the musculature of the fly. In vitro 
studies on cultured cells and in vivo studies showed that fermitin 1 and 2 act in a 
partially redundant manner to maintain muscle integrity. siRNA knock-downs of 
fermitin 1 and fermitin 2 individually by injecting their corresponding dsRNAs into 
embryos result only in partial rounded-up muscle phenotypes caused by detachment 
of the muscles from the tendon cells. However, knock-down of both genes together 
leads to a complete rounded-up muscle phenotype, suggesting a partial redundancy 
in their function [24]. 
 
 
5.1.5. Kindlin-1 
 
Kindlin-1 mRNA is predominantly transcribed in epithelial cells. The highest mRNA 
levels can be found in bladder and colon, less transcription is detected in kidney, 
stomach, small intestine and skin. The expression level in the epidermis is much 
higher than in the dermis. Kindlin-1 is transcribed in two splice variants. The main 
isoform has a length of 4.6 kb. The other splice variant includes intron 7 into the 
coding sequence and results in a 5.2 kb transcript that encodes for a short 352 amino 
acid protein, which is expressed in kidney, colon and small intestine [3]. The larger 
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isoform exists in a non-phosphorylated and phosphorylated form with molecular 
masses of 74 kDa and 78 kDa, respectively [25]. 
Loss of function mutations within the human kindlin-1 gene cause Kindler syndrome. 
Mutations can occur within the entire gene and result in different truncated kindlin-1 
proteins [26]. Patients suffering from this disease show several skin pathologies. The 
severity of the symptoms varies among different patients [27]. The syndrome is 
characterized by skin atrophy and trauma induced skin blistering in very young 
patients. The blistering becomes less severe with age but photosensitivity and 
progressive poikiloderma arise. Additionally there are hints that Kindler syndrome 
patients are more prone to squamous cell carcinoma [28]. Some patients also 
develop ulcerative colitis [26; 29; 30], which together with Crohn’s disease belongs to 
idiopathic inflammatory bowel diseases. Kindlin-1 deficient mice also develop skin 
atrophy and an ulcerative colitis, which results in early postnatal lethality [31]. 
The Kindler syndrome is the first known skin blistering disease, which results from 
defective anchorage of the actin cytoskeleton to cell matrix adhesion sites [3; 32]. 
However, this cannot fully explain the phenotype and the mechanism how loss of 
kindlin-1 causes photosensitivity and poikiloderma still needs to be investigated. 
In vivo kindlin-1 shows a polar distribution within basal epidermal keratinocytes and is 
localized along the dermal-epidermal junction zone in areas between the 
hemidesmosomes. In kindlin-1-deficient skin, basal keratinocytes loose their polarity, 
their proliferation is strongly reduced and apoptotic cell death is increased [25; 31]. 
In vitro studies have shown that kindlin-1 plays an essential role in cell adhesion and 
spreading, as loss of kindlin-1 leads to reduced adhesion and delayed cell spreading 
in different cell lines. Kindlin-1 can interact with the cytoplasmic domains of the 
integrin subunits 1 and 3 [31]. In cultured cells it localizes to integrin-mediated cell 
adhesion sites, so called focal adhesions (FA). Kindlin-1 deficiency also impairs the 
motility of keratinocytes. These cells migrate slower and undirected due to a defect in 
integrin-mediated adhesion, loss of polarity and defects in organization of the actin 
cytoskeleton [8; 25; 31; 33]. 
 
 
5.1.6. Kindlin-2 
 
Kindlin-2 is the best characterized member of the kindlin protein family. Expression of 
kindlin-2 can be detected in all organs and cell types except for haematopoietic cells. 
The highest levels are found in striated and smooth muscle cells. Expression of 
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kindlin-2 can already be detected in embryonic stem cells [34]. Interestingly, kindlin-2 
is inversely expressed in the skin compared to kindlin-1, with higher expression in the 
dermis and lower levels in the epidermis [4]. This distinct expression pattern could 
provide an explanation for the fact that the presence of kindlin-2 cannot compensate 
for the loss of kindlin-1 in Kindler syndrome patients and kindlin-1 knockout mice. 
While kindlin-2, like kindlin-1, binds to the cytoplasmic tails of 1 and 3 integrins and 
localizes to focal adhesions in cultured keratinocytes, only kindlin-2 colocalizes with 
E-cadherin to cell-cell contacts in differentiated keratinocytes [4; 34; 35]. This 
differential subcellular localization could also explain why expression of kindlin-2 fails 
to rescue kindlin-1 deficiency in mice and men. In addition to the integrin-mediated 
adhesion sites, kindlin-2 localizes to actin stress fibers [4]. In cardiomyocytes, kindlin-
2 colocalizes with -actinin in Z-disks. 
Equivalent to loss of kindlin-1, kindlin-2 deficiency also leads to impaired cell 
spreading and defective adhesion [33]. Additionally to its binding to integrins, kindlin-
2 also interacts with migfilin and ILK, which both are involved in the linkage of 
integrins to the actin cytoskeleton [33; 34]. 
Kindlin-2 contains a nuclear localization sequence within its N-terminus, which is 
absent in both other kindlin family members. This nuclear localisation signal suggests 
additional, so far unknown functions. This is of particular interest as the kindlin-2 
interacting protein migfilin can localize to the nucleus as well. Nuclear localization of 
kindlin-2 has been reported in leiomyosarcomas and leiomyomas [36]. 
Deficiency of kindlin-2 in mice results in peri-implantation lethality caused by a severe 
detachment of the endoderm and epiblast from the basement membrane [34]. 
Altogether, kindlin-1 and kindlin-2 play a role in various cellular processes, including 
adhesion, polarization, proliferation and migration. They are involved in connecting 
the actin cytoskeleton to integrin-associated adhesion sites. 
 
 
5.1.7. Kindlin-3 
 
The expression of kindlin-3 is restricted to cells of the haematopoietic system [4]. It 
can be detected in macrophages, monocytes, dentritic cells, neutrophils, 
erythrocytes, B-cells, T-cells, platelets, bone marrow cells, osteoclasts and 
megakaryocytes (Figure 2). 
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Figure 2: Expression profile of kindlin-3. (A) Western blotting of different mouse tissues from 
adult C57Bl/6 mice probed with kindlin-3 antibody shows haematopoietic expression of kindlin-
3; tubulin serves as loading control. (B) Western blotting reveals expression of kindlin-3 in 
various cell types of haematopoietic origin; GAPDH is used as loading control [4]. 
 
Like kindlin-1 and -2, kindlin-3 also localizes to integrin-mediated adhesion structures 
and interacts with the cytoplasmic domain of  integrin subunits [4; 37]. But in 
contrast to fibroblasts or keratinocytes, haematopoietic cells do not form focal 
adhesions. Instead, they adhere via so called podosomes, which consist of a central 
actin core surrounded by a ring of plaque proteins such as talin, vinculin and paxillin 
[38; 39]. Kindlin-3 colocalizes with vinculin in the ring structure of podosomes (Figure 
3) [4]. 
 
 
Figure 3: EGFP-kindlin-3 (left) colocalizes (merge, yellow, right) with Vinculin (middle) in the 
ring structure of podosomes of a dentritic cell [4]. 
 
Mice lacking kindlin-3 (kindlin-3-/-; Figure 4) show a lethal phenotype [37]. They die 
within one week after birth due to a number of defects. Kindlin-3 heterozygous 
animals are normal and show no overt phenotype. Kindlin-3 knockout pubs are pale 
due to a pronounced anaemia (Figure 4A) and reveal severe haemorrhages in the 
gastrointestinal tract (Figure 4B), skin, brain and bladder. Severe bleedings can be 
already detected during development, mainly between embryonic days E13-17 
(Figure 4C). These severe bleedings are reminiscent of Glanzmann’s 
thrombasthenia, a disorder arising from defects in either integrin IIb or 3. 
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Figure 4: Kindlin-3-/- mice suffer from severe bleeding. (A) P2 wild-type (+/+) and kindlin-3 
knockout (-/-) pubs show severe bleedings, (B) especially in the gastrointestinal tract and 
bladder of a newborn kindlin-3-/- mouse. (C) E 14.5 wild-type (+/+) and kindlin-3 knockout (-/-) 
embryos. Modified from [37]. 
 
The severe bleeding of kindlin-3 deficient mice is due to impaired platelet function 
[37]. The mice suffer from a pronounced haemostatic defect. Platelet count is 
unchanged in these mice and platelet production seems to be unaffected. This was 
tested in fetal liver cell chimeras, which where produced by transferring kindlin-3-/- 
fetal liver cells into lethally irradiated wild-type recipient mice [37]. However, in vitro 
and in vivo assays revealed that kindlin-3 deficient platelets fail to aggregate and 
show a defect in platelet adhesion and spreading. 
In summary, all members of the kindlin gene family are important for adhesion and 
spreading of various cell types. They can interact with the cytoplasmic domain of  
integrin subunits and localize to integrin mediated cell adhesion structures. 
 
 
5.2. Integrins 
 
5.2.1. The integrin family 
 
Integrins are a family of heterodimeric cell adhesion receptors. They consist of two 
non-covalently associated glycoproteins, an  and a  chain. Integrins mediate both 
the attachment of cells to extracellular matrix and to other cells. 
The family of integrin receptors is highly conserved throughout evolution from 
sponges to mammals. The number of integrins expressed by an organism increases 
with its complexity. In C. elegans two different integrins can be found, which result 
from the combination of two  integrin subunits (PAT-2 and INA-1 [40]) with one  
integrin subunit (PAT-3). In Drosophila melanogaster the integrin family consists of 
five integrin heterodimers generated by five  subunits associated with one  subunit 
[41; 42]. 
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The genomes of mice and men encode for 18  and 8  subunits. Various 
combinations give rise to at least 24 different integrin heterodimers. Only certain 
subunits are able to form functional heterodimers with each other (Figure 5) [43]. 
Integrins can be grouped by their ligand binding abilities and by their  subunit. While 
some subunits appear exclusively in one heterodimer, others are part of several 
integrins. For example, integrin 1 can interact with twelve different  integrin 
subunits and five integrin heterodimers contain integrin V. Within the integrin family 
overlapping binding abilities can be observed. Certain extracellular matrix proteins 
can be bound by many different integrins and several integrin heterodimers are 
capable of recognizing more than one ECM molecule [44]. 
 
 
Figure 5: Family of integrin heterodimers sorted by their expression and their ability to bind 
certain extracellular matrix proteins. Shown are all known combinations of integrin subunits in 
mammals and their main ligands. Asterisks stand for alternatively spliced cytoplasmic 
domains [43]. 
 
The existence of different splice isoforms leads to a further diversity of the integrin 
family. Splice variants of the extracellular domain as well as of the cytoplasmic 
domain have been reported. Specific isoforms can be found in certain tissues and in 
some cases tissues can also switch between the expression of different isoforms 
during development. While for example the A isoform of the integrin 1 ( 1A) is 
expressed in all tissues except for muscle and heart, these tissues only express the 
isoform 1D [45]. 
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The integrins were named after their important role in the maintenance of the integrity 
of the cytoskeletal-ECM linkage [46; 47]. They provide a bidirectional connection 
between the interior of the cell and the extracellular environment across the cell 
membrane. The integrins link the extracellular matrix to the actin cytoskeleton, except 
for the integrin 6 4, which connects the ECM to intermediate filaments. 
Integrin ligand binding and integrin activation result in a large variety of signal 
transduction events within the cell that can influence different cell behaviours such as 
adhesion, proliferation, survival, apoptosis, cell shape, polarity, motility, gene 
expression and differentiation. The majority of these events depends on the 
modulation of the cell cytoskeleton [42]. 
 
 
5.2.2. Structure of integrins 
 
Integrin function is closely connected to its structure. Each integrin subunit is a type I 
transmembrane protein composed of an extracellular domain consisting of 
approximately 700-900 amino acids, a single transmembrane helix and a cytoplasmic 
domain with a length of 10-70 amino acids except for integrin 4 (1.072 amino acids) 
[48]. 
The cytoplasmic domains of  integrin subunits reveal a striking sequence homology 
among each other, while different  integrin subunits show highly divergent 
sequences except for a common K GFFKR sequence close to the plasma 
membrane with  standing for a conserved apolar amino acid [49; 50]. This 
sequence is essential for the association with the HDR(R/K)E motif in  integrin 
subunits via hydrophobic and electrostatic interactions. For some integrin 
heterodimers, the arginine residue in the  subunits and the aspartate residue in the 
 subunits are thought to form a salt bridge [51; 52]. 
Integrin cytoplasmic domains lack enzymatic activity and actin binding motifs. 
Therefore they depend on the binding of cytoskeletal and signaling proteins that 
mediate processes like signal transduction and coupling to the cytoskeleton. The 
cytoplasmic domains of most  integrin subunits reveal two recognition sites for PTB 
domains, a membrane proximal NPxY motif and a more distal NxxY motif. These 
motifs can be bound by FERM domain containing proteins like talin and kindlin, which 
play an important role in integrin activation [53]. 
The transmembrane domains of the integrins are merely characterized. Only the 
structures of the integrin subunits 3 and IIb are fully solved [54-56]. The 
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transmembrane domain of the integrin 3 consists of 30 amino acids arranged in a 
linear  helix. This helix is longer than a common lipid bilayer suggesting that the 
helix is tilted within the membrane. The IIb transmembrane domain forms an  helix 
of only 24 amino acids with an adjacent backbone reversal. This rare motif is 
conserved in all  integrin subunits pointing to a crucial role within the activation 
process. 
The extracellular domains of the two integrin subunits arrange as a head sitting on 
two legs (Figure 6), revealed by electron microscopy and biophysical data [57; 58]. 
The head domain represents the ligand binding part of the heterodimer with the 
extracellular domain of the  subunit determining the ligand specificity of the integrin. 
The extracellular domain of the  subunit shows a more complex domain structure 
than the one of the -subunit. It is composed of a A (also called I) domain, which is 
inserted into an immunoglobulin (Ig)-like “hybrid” domain, a N-terminal PSI (plexin, 
semaphorins, and integrins) domain, four tandem cysteine-rich epidermal growth 
factor (EGF)-like repeats and a -tail domain ( -TD) (Figure 6). A disulfide bond 
connects the PSI domain to the distal EGF domain [43; 48]. 
The extracellular domains of the  integrins contain an N-terminal seven-bladed -
propeller domain followed by an Ig-like (thigh) and two  sandwich domains (calf1 
and calf2) (Figure 6). The last three or four blades of the -propeller contain EF hand 
domains that bind Ca2+-ions and thereby allosterically affect ligand binding [49; 59]. 
The head region of the integrins is composed of the A and the “hybrid” domains of 
the  subunit together with the  propeller domain of the  subunit. The ligand 
binding pocket lies at the interface between the  propeller and the A domain. Tight 
interactions between integrins and their ligands are dependent on divalent cations. 
The A domain of the  integrin subunit contains three metal ion binding sites, which 
are essential for ligand binding. A central Mg2+ binding site called MIDAS (metal ion 
dependent adhesion site) is flanked by two Ca2+ binding sites, which are referred to 
as SyMBS (synergistic metal ion binding site) and AdMIDAS (adjacent to MIDAS), 
respectively [58].  
The collagen-binding and leukocyte-specific  integrin subunits contain an additional 
A domain, which is inserted into the large  propeller domain and which is 
analogous to the A domain of the  subunit. If present, its MIDAS motif is in most 
cases the ligand binding site [43; 60; 61]. 
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Figure 6: Schematic presentation of the integrin structure and integrin activation. The bent, 
inactive conformation (left) is characterized by certain contacts between the extracellular, the 
transmembrane and the cytoplasmic domains. Integrin activation leads to separation of the 
cytoplasmic and transmembrane domains and to an extended conformation (right). TD:  tail 
domain; EGF: epidermal growth factor domain; PSI: plexin/semaphorin/integrin domain [60]. 
 
Dependent on their activation state integrins exist in different conformations. They 
can be observed in a low, an intermediate and a high affinity state. Structural studies 
and electron microscopy gave insights into the different conformational states of 
integrins. It is believed that integrins in a low affinity, inactive state show a bent 
conformation, while the extracellular domains are extended in active, high-affinity 
integrins (Figure 6 and 7) [60]. 
 
 
Figure 7: Representative 2D projection averages of negatively stained v 3 integrin electron 
micrographs. (A) v 3 integrin in the presence of Ca
2+
 showing a bent inactive conformation 
(B) and (C) show extended v 3 integrins with an open headpiece purified in the presence of 
(B) Mn
2+
 or (C) Ca
2+
 and cyclo-RGDfV (arginine/glycine/aspartate/D-phenylalanine/valine). Size 
bar indicates 100 A°. Modified from [62]. 
 
The mechanism, by which the conformational changes occur, is not yet fully 
elucidated. Two major models have been proposed for this process. Both models 
suggest that the integrin head faces the membrane in its bent, inactive conformation. 
The switchblade model on one hand claims that integrins can only bind ligands in 
their extended conformation. The conformational changes within the inactive, bent 
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integrin start with the dissociation of the cytoplasmic and transmembrane domains. In 
those integrins that form a salt bridge between both cytoplasmic domains, this 
connection ruptures. Currently it is believed that the separation of the integrin tails is 
triggered by the binding of proteins, among which talin and kindlins seem to be the 
most important ones. While the transmembrane domains of an inactive integrin 
heterodimer interact with each other in a coiled-coil conformation via canonical 
GxxxG dimerization motifs in each transmembrane sequence, they separate during 
integrin activation [60]. These changes lead to dislocation of an EGF-like repeat in 
the  integrin stalk, outwards extension of the head region in a switchblade-like 
movement and the opening of the ligand binding pocket [48]. 
The deadbolt model on the other hand does not require an unbending process before 
ligand binding. This model states a conformational change within the head domain to 
unmask the ligand binding site upon a change in the tilt of the transmembrane 
domains. The extension occurs after ligand binding [48; 58; 63]. 
Crystal structure analyses of the integrin V 3 support the switchblade model. These 
experiments proved that the head region of an inactive integrin with low affinity to the 
ligand shows a bent conformation and that activated integrins show an extended 
conformation with a high affinity to ligands [42]. However, it has been shown that 
integrins in a bent conformation can also bind to ligands, especially in the case of 
small ligands indicating that bent integrins are not necessarily inactive [63]. 
 
 
5.2.3. Integrins and their ligands 
 
Integrins connect the ECM to the actin cytoskeleton providing the architectural 
framework to determine cell shape and to react to changes in the microenvironment 
[64; 65]. Integrins influence the type and the organization of the ECM surrounding the 
cell. The spatial distribution of the ECM affects directional cell migration. Integrin-
ligand interactions can also control the cell division axis during mitosis and therefore 
influence the arrangement of cells within multicellular tissues [66; 67]. 
According to their ligand-binding abilities, integrins can be divided into subclasses: 
the collagen-, the laminin- and the RGD (arginine/glycine/aspartate)-binding integrins 
[44]. The leukocyte-specific integrins represent the forth main class of integrins 
(Figure 5). They mediate cell-cell interactions with endothelial cells by binding to 
cellular counter-receptors such as ICAMs and vascular cell adhesion molecules 
(VCAMs) [68]. 
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The RGD sequence is the minimal integrin recognition site in various integrin ligands 
such as fibronectin, vitronectin, tenascin, osteopontin and fibrinogen. The family of 
RGD binding integrins is a very promiscuous group. This motif is recognized by all V 
integrins and by the integrins 5 1, 8 1 and IIb 3. Especially the 3 integrin family 
recognizes a large number of matrix proteins and soluble vascular ligands [44]. 
The LDV (lysine/aspartate/valine) sequence, recognized by the integrins 4 1, 4 7, 
9 1, the four members of the 2 subfamily and E 7, is functionally related to the 
RGD motif. The type III connecting segment region of fibronectin contains the 
prototype LDV ligand and integrin ligands such as VCAM-1 and MadCAM-1 reveal 
related sequences [44]. 
The combination of the integrin 1 and the A-domain containing integrins 1, 2, 
10 or 11 forms the group of collagen binding integrins. The integrins 3 1, 6 1 
and 7 1 and the integrin 6 4 interact selectively with laminins [44]. 
Additional integrin ligands are endostatin, endorepellin and tumstatin, which are 
derived by proteolysis from collagen XVIII, perlecan and collagen 3, respectively 
[69; 70]. Furthermore, M 2 and X 2 are able to interact with heparin as well as 
with negative charges in denatured proteins [44]. 
The family of integrin ligands includes further proteins, like milk fat globule-EGF 
factor 8 (MFGE8) and complement factor iC3b. The binding of integrins to 
complement factor is important for the phagocytosis of apoptotic cells as well as 
pathogens. Another ligand is the latency-associated peptide (LAP) of transforming 
growth factor  (TGF ), which regulates the activation of TGF . Some proteins of the 
ADAM family (a disintegrin and metalloproteinase) and the matrix metalloproteinase-
2 (MMP-2), which participate in ECM remodelling during cell adhesion and migration 
also belong to integrin ligands [53]. 
Furthermore, integrins can also bind to non-physiological ligands, such as snake 
toxins, several viruses and bacteria. Some of these ligands do not interact with the 
usual ligand-binding site if the integrin and reveal differences in their binding abilities 
compared to ECM molecules [59]. 
 
 
5.2.4. Integrins as bidirectional signaling molecules 
 
In contrast to most transmembrane proteins integrins have the ability to transmit 
signals bidirectionally: from the environment into the cell as well as from the interior 
of the cell to its surface. Ligand engagement results in the recruitment of cytoplasmic 
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proteins to the integrin cytoplasmic domains. These proteins either link the integrin 
with the actin cytoskeleton or signal via diverse signaling pathways. This process is 
known as integrin outside-in signaling and controls different cellular functions such as 
cell spreading, migration, proliferation and apoptosis. On the contrary the process of 
integrin activation is called integrin inside-out signaling. Here, intracellular signaling 
cascades induce changes in the integrin conformation resulting in an integrin with 
increased ligand binding affinity [43; 71; 72]. 
Integrins expressed on blood cells had been extensively studied. Their activation and 
signaling needs to be tightly controlled. Integrin activation is for instance necessary 
for platelet adhesion and aggregation, which are essential for sealing injured blood 
vessels in order to prevent blood loss. But it is crucial to prevent excessive, 
pathological platelet aggregation as it can initiate arterial thrombosis, causing heart 
attacks and stroke [73]. Similarly, leukocytes require integrin activation in case of 
inflammation in order to extravasate from blood vessels and migrate to inflamed 
tissue. Impaired integrin activation can result in leukocyte adhesion deficiency. 
Therefore regulation of integrin affinity is fundamental in these processes. 
 
5.2.4.1. Inside-out signaling 
 
Integrins on resting cells are usually found in an inactive conformation with low 
affinity to extracellular ligands until they get activated by intracellular signaling events 
in the process of integrin inside-out signaling. This is accompanied by binding of a 
number of cytoplasmic proteins to the cytoplasmic domain of the  integrin subunit, 
yet only talin and kindlins are known to regulate integrin affinity [71; 74]. 
The cytoskeletal protein talin, an antiparallel homodimer of two approximately  
270 kDa proteins, plays a crucial role during integrin activation. In mouse and man, 
talin exists in two isoforms, talin-1 and talin-2 [75]. The protein consists of a globular 
head at the N-terminus and a C-terminal rod domain. The rod domain consists of 
several helical bundles harbouring multiple vinculin binding sites. Both talin and 
vinculin can directly bind to actin filaments [75]. 
The FERM domain of the talin head binds to the cytoplasmic domain of the  integrin 
subunit via its PTB motif in the F3 subdomain. This event is essential for integrin 
activation. Talin binds at two distinct sites along the  integrin cytoplasmic domain. 
The talin head first interacts with the membrane proximal NPxY motif of  integrins 
and subsequently binds to its second, additional binding site, which is membrane 
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proximal where the integrin tails interact with each other. Binding of talin to both sites 
allows electrostatic interaction between a positively charged region in the F3 domain 
and the polar head groups of the plasma membrane (Figure 8, Figure 9A and B). 
Mutational studies of the  integrin tail showed that binding of talin to both regions is 
necessary to facilitate the separation of the integrin tails [51; 52; 76]. The amino 
acids R358 and W359 in the talin F3 domain are crucial for its function and mutations 
of these amino acids to alanine abolish the binding of talin to integrins and therefore 
its ability to mediate integrin activation [35]. 
 
 
Figure 8: Schematic overview of talin mediated integrin activation of 3 integrins. (A) The talin 
F3 domain (stained by charge) and the cytoplasmic domains of the integrin heterodimer 
connected by a salt bridge are shown. (B) The F3 domain binds to the membrane distal (MD) 
part of the  integrin tail (red) that includes the NPLY motif. This results in a higher order 
structure of the integrin tail but keeps the interaction between the subunits. (C) In the next step 
talin extends its interaction with the  integrin tail by binding to the membrane proximal (MP) 
part inducing the separation of the integrin subunits. Additionally a positively charged region 
in the F3 domain of talin forms electrostatic interactions with polar head groups of the plasma 
membrane. Together this leads to changes in the register of the transmembrane helices, which 
finally lead to integrin activation [76]. 
 
While binding of the talin head domain can increase integrin affinity, full-length talin is 
needed for connecting integrins with the cytoskeleton and for integrin clustering [77]. 
Talin reveals two binding sites for the  integrin subunit, one within the FERM domain 
and one in the rod domain. The presence of multiple integrin binding sites within a 
talin homodimer provides a possibility for integrin clustering [78]. 
Talin is necessary but not sufficient to activate integrins. A number of in vitro and in 
vivo studies have shown that in addition to talin the family of kindlin proteins is also 
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required for integrin activation [31; 34; 35; 37; 78]. Kindlins, like talin, also interact 
directly with the cytoplasmic tails of the  integrin subunits via their FERM domains 
[8; 35]. The FERM domains of kindlin proteins and talin reveal high similarities [8] but 
instead of the arginine 358 in the talin F3 domain, which is crucial for its interaction 
with the integrin tail, the kindlins reveal a glutamate [35]. 
All kindlins bind to the distal NxxY motif within the cytoplasmic domain of  integrins 
and have therefore a binding site, which is distinct from the talin binding site. 
Additionally, they interact with a serine/threonine motif, which is located between the 
two NxxY sequences (Figure 9A and 9C). Mutations within these sites abolish 
kindlin/integrin interaction. Furthermore, the integrin interaction site within the F3 
subdomain of the FERM domain has been mapped since mutations of certain 
glutamate and tryptophan residues into alanine prevent integrin binding and 
activation [35; 37]. 
 
 
Figure 9: Scheme of integrin tail binding by talin and kindlin. (A) The tryptophan (W) and the 
tyrosine (Y) from the membrane proximal NPxY motif of the cytoplasmic domain of the  
integrin subunit are bound by talin (B). The threonine/threonine (TT) or serine/threonine (ST) 
sequence and the tyrosine part of the membrane distal NxxY motif interact with kindlin (C). 
Modified from [60]. 
 
As integrin activation needs to be tightly regulated, the interaction of talin and 
probably also kindlin with the integrin underlies strict regulation. Non-activated talin 
exists in an autoinhibitory state, in which the C-terminal rod domain masks the 
integrin binding site of the FERM domain [80]. The mechanism, by which talin is 
activated, is not yet fully elucidated. Probably binding of the lipid second messenger 
phosphotidylinositol-4,5-bisphosphate (PIP2) is involved in this process by inducing a 
conformational change that weakens the autoinhibition [80; 81]. Talin interacts with 
phosphatidylinositol 4-phosphate 5-kinase  (PIPKI ) and directs it to focal adhesions 
[82; 83]. This may provide a feed-forward loop for the recruitment of talin to newly 
formed adhesion sites, as PIPKI  locally produces PIP2, which can be bound by 
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additional talin molecules. Calpain cleavage and phosphorylation may be further 
mechanisms controlling talin activity. 
In haematopoietic cells it could be shown that Rap1, a guanosine triphosphatase 
(GTPase) plays a role in talin recruitment to integrins [84; 85]. It associates with the 
Rap1 effector Rap1-GTP–interacting adaptor molecule (RIAM) and forms a ternary 
complex together with talin at the integrin cytoplasmic domain [86; 87]. A similar 
mechanism could take place in non-haematopoietic cells, in which the role of RIAM 
could be taken over by the RIAM-homolog lamellipodin [88]. 
A further possibility to regulate talin-integrin association is phosphorylation of the 
integrin’s cytoplasmic domain. The tyrosine residue in the NPxY motifs of the 
integrins 1 and 3 can be phosphorylated by the non-receptor tyrosine kinase Src 
[89]. This phosphorylation probably inhibits the interaction between talin and the 
integrin tail or it maintains an inhibitory complex between Dok1 and the cytoplasmic 
domain of the  integrin subunit that keeps the integrin in an inactive state [90]. 
Since both talin and kindlins are essential for integrin regulation it is very likely that 
kindlins are also tightly regulated, however the mechanism is still elusive. As kindlins 
contain a PH domain, they may also be regulated by certain phosphoinositides. A 
further possibility might be phosphorylation. In case of kindlin-1 phosphorylation 
could already be shown [25] but so far prove of a correlation between kindlin 
phosphorylation and activity is missing. 
Both talin and kindlins are crucial for integrin activation but neither of them is 
sufficient. They have to cooperate during the integrin activation process due to their 
distinct binding sites at the integrin tail [34; 91]. It was shown that overexpression of 
kindlins in cells with low talin levels has no or only little impact on integrin affinity [86], 
while coexpression of talin head together with kindlin results in an increase in integrin 
affinity. 
Many question on how exactly integrins are activated are still open. Involvement of 
further proteins that regulate integrin affinity can not yet be excluded and the precise 
mechanism of how talin und kindlins cooperate to control integrin activity remains to 
be elucidated. Several scenarios are conceivable. One model proposes a sequential 
binding of talin and kindlin to the cytoplasmic domain of the  integrin subunit, but so 
far it is completely unclear, which of the two proteins binds first. Another possibility 
could be a simultaneous binding of both proteins due to the distinct binding regions. 
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It also needs to be further investigated whether integrins on certain blood cells, which 
have to be activated very rapidly, and integrins expressed on cells of solid tissues or 
epithelia, where fast activation is less crucial, are activated via the same mechanism. 
 
5.2.4.2. Outside-in signaling 
 
Activation of integrins, binding to extracellular ligands and integrin clustering allow 
outside-in signaling. The transduction of a variety of signaling events influences a 
whole set of different cellular behaviours. The signaling downstream of integrins is 
not only dependent on the integrin heterodimer itself and the bound ECM molecule 
but is also influenced by the mechanical properties of the ECM. Integrins can 
transmit and modulate intracellular forces [92]. 
Integrin activation positively influences the affinity of a single integrin to ligands. To 
establish a very strong attachment site to the ECM, the binding avidity needs to be 
increased. This requires the organization of integrins into clusters, in which many 
weak integrin-ECM interactions together form a tight adhesion. Newly formed, small 
clusters are known as nascent adhesions [93]. Some of them mature into focal 
complexes, further into focal adhesions and finally into fibrillar adhesions [94]. A huge 
number of proteins are recruited to these adhesion sites. They are assembled in 
dynamic, multimolecular complexes with many functions: they organize the 
cytoskeleton, mechanically link the ECM to the actin cytoskeleton and serve as 
biochemical signaling hubs to concentrate various signaling processes. 
So far, more then 150 proteins are known that participate in integrin mediated 
adhesion sites as signaling, structural and adaptor proteins [95]. These proteins 
include enzymes, Rho family GTPases, protein and lipid kinases and phosphatases 
[96]. Proteins bound to the cytoplasmic domain of the integrin heavily influence the 
downstream effects and the formation of adhesion site itself as they bind additional 
proteins. Phosphorylation can provide further diversity. Modification of the integrin’s 
cytoplasmic domain, for instance phosphorylation of the NxxY motifs by Src, can also 
contribute to the determination, which proteins can bind [53]. 
Activation of various signaling pathways upon integrin ligand interactions is not only 
controlled by the assembly of the integrin-mediated adhesion complex but in addition 
through organization of the plasma membrane in lipid rafts and endocytosis [77]. 
The first, immediate consequences following integrin activation and ligand 
engagement are an increase in phosphorylation of certain proteins, e. g. Src, focal 
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adhesion kinase (FAK), p130Cas (p130 Crk-associated substrate) and paxillin, and 
elevated levels of lipid second messengers, such as PIP2 and PIP3 
(phosphotidylinositol-3,4,5-trisphosphate). Subsequently, cytoskeletal reorganization 
occurs and actin fibers get connected to integrins facilitating the cell to change shape 
or to start migration [77]. Adhesion to matrix over a longer period of time can lead to 
alterations in signaling pathways and finally to changes in gene expression. 
The immediate effects upon integrin ligation include the autophosphorylation of Src 
and FAK on tyrosine 418 and tyrosine 397, respectively, by which both proteins 
become activated. This enables FAK to interact with Src stabilizing its active form 
and increasing its catalytic activity. The formation of the Src/FAK complex, which 
further activates ERK (extracellular signal-regulated kinase) and JNK (c-Jun N-
terminal kinase), is central in the integrin signaling process [97]. Downstream of ERK 
cyclin D is activated and regulates cell cycle progression. Furthermore activated FAK 
recruits PI-3-kinase resulting in elevated PIP3 levels and activation of Akt (RAC-
alpha serine/threonine protein kinase). 
The Src/FAK complex can also act on RhoGTPases via Crk/Dock180 (dedicator of 
cytokinesis1) or the PIX/GIT (PAK interactive exchange factor/G-coupled receptor 
kinase-interacting protein) pathway (Figure 10 and 11A). RhoGTPases are important 
regulators of the downstream signals following integrin activation and regulate many 
aspects of actin dynamics. They are active in their GTP-bound form and inactive 
when harbouring GDP. They are controlled by GEFs, GTPase-activating proteins 
(GAPs) and guanine nucleotide dissociation inhibitors (GDIs). The major GTPases 
involved in integrin signaling are Rac, Cdc42 and RhoA [98]. Cdc42 and Rac1 
activate Arp2/3 via the Wiskott-Aldrich Syndrome protein (WASp) and the 
Scar/WAVE proteins, respectively. Activated Arp2/3 can initiate actin polymerisation 
and branching of actin filaments [99]. RhoA is important for the regulation of cell 
contractility. It activates formins and ROCK (Rho-associated protein kinase), which 
phosphorylates myosin light chain (MLC) thus inducing actin-myosin contraction 
(Figure 10A) [77]. 
Beside the activation of signaling pathways, the organization of the cytoskeleton is a 
consequence of integrin binding to ECM. The linkage of integrins to actin fibers is 
established by a number of proteins (Figure 10). The recruitment of talin plays a 
central role in this process. The binding of talin to the integrin tails is followed by the 
recruitment of vinculin, which is important for the maturation of focal adhesions. Talin 
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deficient cells and cells expressing the talin head domain lack focal adhesions [100], 
while vinculin deficient cells make few but small and unstable adhesion sites that do 
not maturate [101]. Talin can provide some direct connections to actin, enough for 
establishing nascent adhesions, but vinculin is required to strengthen the linkage 
[75]. The actin-binding protein -actinin can directly bind to  integrins and interacts 
with talin as well as vinculin (Figure 10A) [102]. Its most important function seems to 
be the strengthening of the integrin-actin connection. -actinin and also myosin-II are 
actin crosslinking proteins, important for FA growth and maturation [93]. 
Kindlins provide a link between adhesion sites and the cytoskeleton, too. Kindlin-1 
and -2 interact with migfilin, which in turn binds to filamin, and ILK. Both interactions 
provide indirect connections to the actin cytoskeleton (Figure 10B) [33; 103]. 
The adaptor protein ILK is another integrin tail binding protein. It associates with 
pinch (particularly interesting new cysteine-histidine-rich protein) and parvin in the 
ILK-pinch-parvin (IPP) complex (Figure 10B). It forms connections to the actin 
cytoskeleton via parvin and paxillin, which in turn can interact with parvin and vinculin 
[53]. ILK contributes to adhesion strengthening by providing integrin-actin 
connections and supporting integrin clustering [104]. In addition ILK crosslinks 
integrin and growth factor signaling as pinch can interact with Nck-2, which in turn 
binds to receptor tyrosine kinases (RTK) (Figure 10) [105]. 
 
 
Figure 10: Schemes of a focal adhesion showing proteins involved in signal transduction and 
integrin-actin connection. (A) Integrin-actin linkage includes talin, vinculin and -actinin. Other 
signaling adaptors like FAK and paxillin are also recruited. The adhesions generate signals like 
activated Rac and RhoA, leading to actin polymerisation and bundling. Modified from [106]. (B) 
ILK associates with Pinch and parvin in a ternary complex and binds to the cytoplasmic 
domain of the activated  integrin subunit. It can also interact with kindlin (Mig-2), providing a 
further linkage to the ECM via migfilin and filamin. ILK also links integrin signaling to receptor 
tyrosine kinase signaling via pinch and Nck-2. Modified from [107]. 
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5.2.5. Integrin crosstalk with growth factor and cytokine signaling 
 
The composition of proteins recruited to the cytoplasmic domains of the integrins is 
influenced by the integrin heterodimer, the ECM and the cell type. In addition, the 
growth factor environment plays an important role. Integrins and growth factor or 
cytokine receptors can cooperate to provide specificity in signaling processes. They 
can act independently of each other, but the ECM and soluble factors, such as 
growth factors, hormones or cytokines, can also simultaneously activate integrins 
and receptors, signal synergistically and lead to the regulation of complex events. 
Adhesion to matrix molecules can influence growth factor receptors and vice versa. A 
precise spatial and temporal organization of the signals is very important for the 
resulting downstream effects. The interaction between integrins and the ECM is 
rather stable and therefore the signals from the microenvironment are sustained over 
a period of time. In contrast the diffusible growth factors and cytokines signal in a 
more temporal manner [108]. 
Impaired crosstalk between integrin and growth factor signaling results in diseases, 
for instance cancer. Cancer is characterized by missregulation of growth factor 
signaling and tumour cells can be independent from integrins leading to increased 
proliferation and/or migration [109; 110]. Loss of integrin mediated adhesion is one 
step in the development of metastases. On the contrary, cells can also upregulate 
integrins during tumour progression to enhance downstream signals [111]. 
There are several ways, in which growth factors can influence integrin function. 
Growth factor signaling can for instance change the expression level of certain 
integrins or integrin-binding proteins. TGF 1 uses this mechanism to increase the 
expression of the integrins 1 and 5 in endothelial cells [112]. A further possibility 
how growth factor signaling interferes with integrin signaling is by influencing integrin 
conformation and by this the ligand affinity. They control the activation status of 
integrin associated signaling proteins like FAK, Src and PI3K and/or regulate 
downstream signaling effectors such as ERK, Akt, JNK and RhoGTPases (Figure 
11A). For example, ERK activation resulting from cooperative integrin and growth 
factor signaling is increased in intensity and duration [77]. 
Chemokine-activated G-protein coupled receptors (GPCR) signal via PI3-kinase and 
phospholipase C (PLC) to increase integrin affinity. This represents a form of integrin 
inside-out signaling and is especially important for immune cells. Activation of the T 
cell antigen receptor upon antigen binding increases integrin activation in a PLC 1- 
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and Rap1-dependent manner (Figure 11B) [113; 114]. Similar processes can activate 
integrins on platelets in the clotting cascade [115]. 
 
      
Figure 11: Signaling pathways resulting from crosstalk of integrins and growth factors. (A) 
Growth factor signaling influences integrin signaling in concert with the composition and the 
mechanical properties of the ECM [77]. (B) Signaling pathways leading to integrin activation in 
lymphocytes. Activation of a variety of receptors such as chemokine-activated G-protein 
coupled receptors or T cell receptors leads to recruitment of GTP-bound Rap1 and talin 
binding to the integrin tails, which results in activation of the integrins [114]. 
 
Conversely, integrins also have an impact on growth factor signaling. They can affect 
the cellular localization, posttranslational modification, expression of the receptors or 
the growth factors themselves. Integrins can also regulate receptor activation prior to 
ligand binding. Some integrins control for instance TGF  signaling via binding to 
latency-associated peptide [116]. Several receptor tyrosine kinases, such as PDGFR 
(platelet-derived growth factor receptor), EGFR (epidermal growth factor receptor), 
VEGFR (vascular endothelial growth factor receptor) and HGFR (hepatocyte growth 
factor receptor), can be activated simply by integrin mediated cell adhesion [117]. 
Most of these interactions are likely to be indirect. 
An example for the crosstalk between integrins and RTKs is the cooperation of 
integrin 1 and EGFR in several cell types. Both activate ERK and Akt pathways in 
order to regulate diverse cellular aspects, including cell cycle progression [118]. 
Integrins regulate proliferation via Src signaling and also in this process growth factor 
receptors contribute to the downstream effects. After ligand binding a fraction of 
EGFR is associated with integrin 1 in a complex with Src and p130Cas. This 
complex is required for phosphorylation and activation of the EGF receptor [119]. 
 
A 
 
B 
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Remarkably, this complex results in a distinct EGFR phosphorylation pattern, which 
is different from the phosphorylation pattern induced by EGF binding. This suggests 
additional functions of EGFR apart from the ones downstream of the growth factor. 
Integrin-mediated adhesion also controls interferon responses in a protein kinase C  
dependent manner. For instance, STAT1 (signal transducer and activator of 
transcription) signaling in response to interferon  is much stronger in adherent cells 
than in cells in suspension [120].  
Another example, in which integrins and growth factors collaborate, is the crosstalk 
between the integrin V 3 and the M-CSF (macrophage colony stimulating factor) 
receptor c-Fms in osteoclasts and their precursors. Signals from both receptors are 
required to regulate the osteoclast cytoskeleton, osteoclast differentiation as well as 
the proliferation of osteoclast precursors. Ligand binding by the integrin and M-CSF 
exposure simultaneously lead to a prolonged ERK signal [121]. The short-term effect 
of ERK activation is stimulation of precursor proliferation. Long duration of the signal 
induces for instance the expression of the transcription factor c-Fos and its nuclear 
translocation. This in turn promotes the expression of nuclear factors for activation of 
T cells (NFATs) that are central in osteoclast differentiation by upregulation of certain 
genes (Figure 12) [122]. The activation of c-Fms also leads to signaling through 
PI3K, which further activates Akt. Both proteins are also downstream targets of 
integrin signaling and therefore represent a further intersection of integrin-growth 
factor crosstalk [123]. Furthermore, integrin V 3 and c-Fms act via the non-receptor 
tyrosine kinase Syk. Activation of the V 3 heterodimer is followed by the activation 
of Src, probably by autophosphorylation. Src phosphorylates DAP12 (DNAX-
activating protein of 12 kDa) and FcR  (fragment (crystallisable) receptor ), which 
are adaptor molecules containing an immunoreceptor tyrosine-based activation motif 
(ITAM). The phosphorylation of ITAM provides a binding site for Syk and results in 
the recruitment of Syk to the cytoplasmic domain of the  integrin subunit. Syk 
subsequently interacts with Src and becomes activated. Downstream of Syk the Rac 
GEF Vav3 is activated. The GTP-bound form of Rac finally initiates cytoskeleton 
reorganization [123; 124]. Binding of M-CSF to its receptor on the other hand leads to 
autophosphorylation of the receptor generating a binding site for Src at tyrosine 559. 
This interaction also results in Src autophosphorylation and the phosphorylation of 
DAP12. The subsequent recruitment and activation of Syk again lead to cytoskeletal 
rearrangement via Vav3 and Rac (Figure 12) [123; 125]. 
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Figure 12: Scheme of the crosstalk between integrin V 3 and the M-CSF receptor c-Fms. ECM 
binding and M-CSF exposure together lead to the activation of a signaling pathway including 
ERK, which leads to differentiation via the nuclear proteins c-Fos and NFAT. Ligand bound 
integrin V 3 and activated c-Fms also result in activation of the RhoGTPase Rac via Src, Syk 
and Vav3 [123]. 
 
 
5.2.6. Integrins in mouse development 
 
The 24 different integrins show specific ligand binding properties and different 
expression patterns. All of them have distinct non redundant functions. This fact 
becomes apparent by the phenotypes of individual integrin mouse mutants. In most 
cases these mice show diverse and specific phenotypes that vary significantly 
between the different subunits. The most important integrin is the 1 subunit, which is 
ubiquitously expressed and which forms heterodimers with 12 different  subunits. 
None of these integrins is expressed in 1 integrin mouse mutants. Consequently, 
these mice die already during early mouse development at the peri-implantation 
stage [126; 127]. 
Loss of 4, 5 and V integrins in mice results in embryonic lethality, too. While 5 
deficient mice die at embryonic days 9.5 and 10 (E9.5/10) due to embryonic and 
extra embryonic vascular defects [128], integrin 4 knockout mice die later during 
embryonic development between E11 and E14 from defective choriallantois fusion 
and abnormal cardiac development [129]. In case of V deficiency, 80% of the mice 
die between E10 and E12 due to placental defects, while 20% survive embryonic 
development but die at birth because of a cleft palate and severe haemorrhages 
[130]. 
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Genetic deletions of 3 [131-133], 6 [134; 135], 8 [136; 137], 4 [138; 139] or 8 
[140] integrins cause perinatal lethality because of various defects. Integrin 3 
deficient mice reveal abnormalities in several organs. They suffer from skin blistering, 
kidney, lung and brain defects. 8 deficient mice have small or no kidneys and inner 
ear defects. 
Depending on their expression pattern deficiency of other integrin subunits has organ 
specific abnormalities but the knockout mice are viable and fertile. Absence of the 
integrins L, M, E and 7 lead to leukocyte malfunctions and other defects in the 
haematopoietic system [141-145]. Lack of 6 results in inflammations of skin and 
airways [146; 147]. 2 integrin deficiency causes leukocytosis, impaired inflammatory 
response, skin infections and T-cell defects [148]. 
3 and IIb knockout mice reveal defects in platelet function. They suffer from 
bleedings due to impaired platelet aggregation [149-151]. 3 deficient mice 
additionally suffer from osteopetrosis and defects in angiogenesis [152; 153]. 
The generation of tissue-specific integrin knockout mice is especially useful in cases 
of embryonic lethality and very severe phenotypes in multiple organs. In this way 
certain defects can be mapped to certain organs or cell types and less severe 
phenotypes and specific roles of integrins in later developmental stages become 
apparent in cases where a constitutive knockout is embryonic lethal. A skin specific 
knockout of integrin 1 for example leads to skin blistering, defects in basement 
membrane arrangement and abnormal hair follicle morphogenesis [154]. Mice 
lacking the 1 integrins in pericytes of blood vessels die perinatally because of blood 
vessel aneurysms and bleedings. This shows the essential role of integrin 1 in 
vessel wall integrity [155]. 
 
 
5.3. Integrins and cells of the haematopoietic system 
 
5.3.1. The haematopoietic system 
 
The haematopoietic system consists of all organs and tissues that contribute to the 
production of blood. In mouse and man, these are primarily bone marrow, spleen, 
thymus and lymph nodes. 
The process of blood cell formation is called haematopoiesis. All cellular components 
of the blood and the immune system are generated from haematopoietic stem cells 
(HSC), which are common pluripotent stem cells. The haematopoietic stem cells 
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reside in the bone marrow. These cells are not only multipotent, they also possess 
the ability to self-renew. Already a small number of HSCs can repopulate the 
haematopoietic system of an organism by proliferation, a phenomenon utilized in 
bone marrow transplantations [156]. 
Depending on the control of specific cytokines and granulocyte/monocyte stimulating 
factors haematopoietic stem cells give rise to myeloid and lymphoid precursor cells 
with progressively limited multipotency (Figure 13) [156]. Mature blood cells are 
divided into the two haematopoietic lineages: the myeloid lineage including 
neutrophils, monocytes, macrophages, erythrocytes, mast cells and megakaryocytes, 
and the lymphoid lineage made from B-cells, T-cells and natural killer (NK) cells 
[157]. Dentritic cells have a unique differentiation program, as they can derive from 
myeloid or lymphoid progenitors [158]. 
 
 
Figure 13: Diagram of the differentiation of the various mature blood cells from haematopoietic stem 
cells. LT-HSC: long term haematopoietic stem cells; ST-HSC: short term haematopoietic stem cells;  
MPP: multipotent progenitor; CMP: common myeloid progenitor; CLP: common lymphoid progenitor; 
CFU: colony forming unit; MEP: macrophage-erythrocyte progenitor; GMP: granulocyte-macrophage 
progenitor; BFU: burst forming unit. Modified from [159]. 
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HSCs express high levels of integrin 1. 1 deficient HSCs are unable to colonize 
fetal liver, bone marrow, spleen and thymus due to impaired adhesion and migration 
[160]. The integrin 4 1 is of special importance in this process by interacting with 
VCAM-1 [161; 162]. 4 1 is critical to HSCs homing, retention and lodgement. Lack 
of the integrin 4 subunit instead does not prevent bone marrow colonization, 
indicating that several heterodimers are responsible for proper HSC migration [163]. 
The integrins 5 1, 4 7 and 9 1 also contribute to HSC adhesion and migration 
by binding to fibronectin, MadCAM and osteopontin, respectively [164-167]. 
During embryonic development two different haematopoietic systems arise. The first, 
primitive haematopoietic system is built from aggregates of blood cells within the yolk 
sac called blood islands. They consist mainly of nucleated erythroid cells that deliver 
oxygen to the embryonic tissues [168]. With proceeding development and increasing 
size of the embryo this system is replaced by the definitive haematopoietic system. In 
the second wave of haematopoietic generation haematopoietic stem cells emerge 
from within the embryo in the aorta-gonad-mesonephros (AGM) region, which 
surrounds the dorsal aorta [169]. Subsequently, it is thought that some of these cells 
distribute via the circulation and/or interstitial migration to the fetal liver [170]. Blood 
cell formation then occurs mainly in the fetal liver, which is the most important 
haematopoietic organ, until the bone marrow develops and takes over the task of 
generating most of the blood cells for the whole organism. Under certain 
circumstances, liver, thymus and spleen can resume their ability to function as 
haematopoietic organs in a process called extramedullary haematopoiesis. This 
usually leads to an increase in the size of these organs. 
 
 
5.3.2. Erythrocytes 
 
Erythrocytes or red blood cells are the most abundant type of blood cells. They are 
the exclusive transporters of oxygen from the lung to the body tissues. In 
mammalians mature erythrocytes are non-nucleated. Erythroblasts, the precursors of 
erythrocytes, do not yet express haemoglobin and still reveal nuclei during early 
erythropoiesis. After several cell divisions and during maturation, haemoglobin 
appears in the cell and the nucleus becomes progressively smaller. The cells finally 
extrude their nucleus to provide more space for haemoglobin. They also lose most of 
their intracellular organs, such as the Golgi apparatus, the endoplasmatic reticulum 
and the mitochondria. Due to the lack of mitochondria erythrocytes do not consume 
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the oxygen they deliver. Instead they use fermentation of glucose to lactic acid to 
generate adenosine triphosphate (ATP) [171]. 
Erythrocyte generation occurs throughout life. The most important regulators of 
erythrocyte differentiation are the cytokine erythropoietin (Epo), produced in the 
kidneys, and its receptor, EpoR, expressed by erythroid progenitors. Furthermore the 
integrin 4 1 is essential for erythropoiesis and lack of the 4 subunit in mice leads 
to decreased numbers of differentiated erythroid cells [172; 173]. Erythropoiesis is a 
two step process: the early phase depends on Epo and is followed by Epo-
independent step that requires interaction of integrin 4 1 with fibronectin [174]. 
Mature erythrocytes are deficient of integrins. Integrin-associated protein, also known 
as CD47, mediates cell-cell interaction with splenic macrophages, interacts with 
soluble thrombospondin and participates in linking the red blood cell membrane with 
the cytoskeleton [174-176]. 
Mammalian erythrocytes show a characteristic shape of a biconcave disk, optimal for 
the flow in large blood vessels and small capillaries. The red blood cells obtain their 
mechanical properties through the membrane skeleton laminating the lipid bilayer, 
which is interspersed by numerous transmembrane proteins. The filamentous 
network of the skeleton has an essential role in control of the erythrocyte shape and 
its structural integrity. The erythrocyte skeletal proteins include the multifunctional 
proteins spectrin  and , which form dimers and tetramers. They build connections 
to actin and protein 4.1.  -spectrin is also linked to ankyrin, which in turn binds to the 
anion exchanger AE1, also called protein band 3, and is by this connected to 
transmembrane proteins. Additional important cytoskeletal proteins within the 
membrane skeleton are adducin and demantin. On the surface of the erythrocyte a 
number of proteins are presented, such as glycosylphosphatidyl inositol (GPI) 
anchored proteins [177; 178]. 
Lack of any of these important structural skeleton proteins or molecular defects lead 
to clinical manifestation due to loss of stability of the erythrocyte [177]. 
 
 
5.3.3. Platelets 
 
Platelets, also known as thrombocytes, are small cell fragments. They are formed 
within the bone marrow form megakaryocytes by fragmentation of cytoplasmic 
extensions. Like erythrocytes they lack a nucleus and are incapable of mitosis. Each 
megakaryocyte gives rise to 5.000 to 10.000 platelets. Megakaryocytes reveal 
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polyploidy achieved by endomitosis, which is necessary for the production of enough 
templates for the high protein requirements. Platelet production is regulated by the 
hormone thrombopoietin produced in liver and kidneys. It promotes megakaryocyte 
proliferation and differentiation [179]. 
A prerequisite for thrombopoiesis is the production of secretory granules, like - and 
dense granules. They are generated from the Golgi apparatus and contain for 
example ADP (adenosine diphosphate), ATP, PDGF, TGF 1, coagulation factors, 
fibrinogen, P-selectin, IIb 3 integrin, van Willebrand Factor (vWF) and 
granulophysin, which are essential for platelet function. The granules are filled by 
protein synthesis and endocytosis [180]. 
The main function of platelets is to maintain haemostasis. In case of blood vessel 
injury, platelets immediately attach to the wounded surface and to each other forming 
a thrombus. Platelets also contribute to the resistance of capillaries. They fill up weak 
spots in vessel walls. Lack of platelets leads to more fragile capillaries increasing the 
probability of spontaneous blood loss [181]. 
Platelet function underlies tight control as abnormalities can cause pathological 
thrombus formation leading to myocardial infarction or stroke. Endothelial cells, 
covering the inner surface of blood vessels, help to keep platelets in an inactive state 
by secreting nitric oxide, endothelial ADPase and prostacyclin (PGI2) [182]. The 
ADPase removes ADP, which is a platelet activator. Additionally, endothelial cells 
produce von Willebrand factor (vWF), which promotes their adhesion to the collagen 
of the basement membrane. In intact vessels collagen is not exposed to the 
bloodstream. In case of injury, collagen, vWF and further factors get accessible for 
platelets, which get activated by interaction of the platelet receptor glycoprotein GPIb 
and vWF (Figure 14A) [183]. Subsequently, GPVI, the main collagen adhesion 
molecule of platelets, binds to collagen in a low affinity interaction, initiating signaling 
pathways that activate integrins via inside-out signaling. This leads to the 
establishment of tight integrin-ligand interactions, required to mediate shear resistant 
attachment (Figure 14B). GPVI engagement also leads to the secretion of granule 
content, such as the secondary mediators ADP and thromboxane A2 (Figure 14C). 
These factors mediate together with thrombin the activation of G protein coupled 
receptors and therefore full platelet activation. Activated platelets undergo shape 
changes. While resting platelets are spherical, they spread upon activation, form 
pseudopods and adopt a stellate shape (Figure 14C) [184; 185]. 
INTRODUCTION 
31 
Platelet activation and adhesion is followed by aggregation. Integrin IIb 3, also 
known as GPIIa/IIIb is the most abundant platelet aggregation receptor. This 
heterodimer binds to the RGD motifs present in fibrinogen, its cleavage product fibrin, 
vWF and fibronectin [186; 187]. Fibrinogen is of special importance as this dimer 
provides two binding sites for IIb 3 integrin and can serve as a bridge between two 
platelets leading to crosslinking and finally to platelet aggregation (Figure 14D) [185; 
188]. Adhesion and aggregation cooperate to form a platelet plug. Reinforcing of this 
plug is achieved by actin-myosin contraction of the activated platelets. 
Beside IIb 3, platelets express at least four other integrin heterodimers but their 
roles are less well characterized. The three 1 integrins 2 1, also described as 
GPIa/IIb, 5 1 and 6 1 mediate platelet adhesion to collagen, fibronectin and 
laminin, respectively [185; 186]. Additionally little amounts of v 3 integrins are 
exposed on the platelet [183]. 
 
 
Figure 14: Scheme of platelet adhesion and aggregation under flow conditions. (A) Platelets 
adhere to collagen-bound von Willebrand factor (vWF) by glycoprotein Ib (GPIb). (B) Binding of 
GPVI to collagen leads to integrin activation and interaction of integrin 2 1 and IIb 3 with 
collagen and vWF, respectively. These contacts mediate firm adhesion. (C) Activated platelets 
spread and secret ADP, thromboxane A2 (TXA2) and other factors to activate additional 
platelets. (D) Aggregates form by crosslinking platelets via Fibrinogen (Fg) and vWF [189]. 
 
 
5.3.4. Neutrophils 
 
Neutrophils represent the biggest group of white blood cells with 50-80%. Together 
with eosinophiles and basophiles, which constitute only 3% of white blood cells, they 
belong to the class of granulocytes. Granulocytes, also called polymorphonuclear 
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leukocytes (PMN or PML), are characterized by their multilobed nucleus and a large 
number of cytoplasmic granules [190]. 
Neutrophils are important mediators of the inflammatory response. Circulating cells 
are recruited to sites of injury, infection and inflammation by chemotaxis. Resident 
macrophages in the affected tissue secrete cytokines, such as interleukin-1, TNF  
(tumour necrosis factor ) and attracting chemokines, upon recognition of and 
activation by pathogens. Further sources of cytokines are mast cells and activated 
endothelium [191]. Activated neutrophils release cytokines themselves, which in turn 
amplify inflammatory reactions by recruiting and activating several other cell types. 
Neutrophils play an important role in defending invading pathogens. They secrete 
soluble anti-microbials and belong to the group of phagocytes. They engulf bacteria 
and other microorganisms, which are digested and destroyed by enzymes and 
reactive oxygen species stored in the granules [192]. 
Neutrophil differentiation occurs within the bone marrow under the influence of  
G-CSF (granulocyte colony stimulating factor) and GM-CSF (granulocyte 
macrophage colony stimulating factor), beginning with the differentiation of a 
haematopoietic stem cell first into a myeloblast and then into a promyelocyte. The 
production of storage granules, which contain enzymes such as myeloperoxidase 
and elastase, starts already during the promyelocytic stage. Terminally differentiated 
neutrophils do not proliferate anymore. Once released into the blood stream, they 
have a half live of only a few hours and live slightly longer after migration into tissue. 
Most of the neutrophils never leave the bone marrow, which keeps a large number of 
them that can be released in case of inflammation or infection [193]. 
 
5.3.4.1. The leukocyte extravasation cascade 
 
Neutrophils and other leukocytes have to leave the blood stream and migrate through 
the blood vessel endothelium in order to reach inflamed tissue. This extravasation is 
a multistep process with a general concept (Figure 15) [68; 194]. In the first step, 
selectins, which are exposed on the blood vessel endothelium upon induction by 
interleukin-1 and TNF , interact with carbohydrate ligands on leukocytes. These 
transient contacts slow down the velocity of the leukocyte and lead to selectin-
mediated rolling. The rolling process can also be mediated by binding of the integrins 
4 1, also called VLA4 (very late antigen 4), and 4 7 to VCAM or MadCAM, 
respectively [195]. Reduction of speed allows the activation of G-protein coupled 
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chemokine receptors on leukocytes by chemokines presented on endothelial cells 
and released by macrophages. This induces integrin inside-out signaling and integrin 
activation via receptor crosstalk mechanisms. Activated integrins can firmly adhere to 
counter receptors on the endothelium, followed by arrest, reorganization of the 
cytoskeleton, cell spreading and transmigration [68]. 
Different leukocyte subtypes and tissues employ different selectins, chemoattractants 
and integrins in the process of extravasation. Lymphocytes for instance use 
predominantly the ICAM/ L 2 (LFA-1) interaction for arrest and 4 1 seems to 
facilitate rolling and adhesion [196]. For monocyte extravasation the integrin 4 1 is 
the most important integrin [197]. Neutrophils and monocytes additionally express 
integrin M 2 (Mac-1), which interacts with ICAM and fibrinogen. Neutrophil rolling 
and adhesion occurs via LFA-1, while Mac-1 allows the cell to crawl over the 
endothelium and search for the optimal spot for transmigration (Figure 15) [198; 199]. 
The cells protrude via podosomes into the endothelial cell layer to find a site to 
penetrate [200]. 
 
 
Figure 15: Scheme of the leukocyte extravasation cascade as a multistep process. Transient 
interactions initiate leukocyte capturing and start of rolling on the endothelium (step 1). In the 
second step, chemokine receptor signaling induces integrin activation and firm arrest (step 3). 
After adhesion strengthening and spreading the cells migrate on the vessel wall looking for an 
appropriate area for transmigration, which can occur paracellular or transcellular (step 4). The 
most important proteins involved in each step are shown in blue boxes. [68] 
 
Transendothelial migration of the leukocytes occurs either by paracellular or 
transcellular migration [200; 201]. Proteins such as PECAM-1 (platelet/endothelial 
cell adhesion molecule 1), CD99, JAM-A (junctional adhesion molecule A) and VE-
cadherin (vascular endothelial cadherin) are located in the junctions between 
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endothelial cells and collaborate in the opening of the endothelial junction. Integrin 
ligands such as ICAM and VCAM are expressed on the apical side of the 
endothelium and laterally in the junctions but the role of integrins in this process is 
unclear [202]. The laminin receptor 6 1 is important for overcoming the basement 
membrane, underlying the endothelium [203]. The leukocytes secrete proteases like 
matrix metalloproteinases to degrade the basement membrane and to form wholes in 
order to escape the blood vessel. The process of proteinase release and activation 
also depends on signals downstream of integrins [204; 205]. Within the interstitial 
fluid, the cells follow a chemotractic gradient. 
 
5.3.4.2. Leukocyte adhesion deficiency syndromes 
 
Defects in the process of leukocyte extravasation lead to leukocyte adhesion 
deficiency (LAD). LAD is a rare autosomal recessive disorder of neutrophil function, 
which is characterized by immunodeficiency leading to recurrent infections. A defect 
in neutrophil adhesion results in poor or no extravasation and impaired phagocytosis. 
LAD is currently divided into three subtypes, LAD-I, -II and –III. 
The most common type is LAD-I with an estimated prevalence of 1 in 100.000 births. 
It results from mutations in the 2 integrin subunit [206]. Leukocytes of these patients 
either lack the integrin heterodimers such as M 2 and L 2 or express only very 
low levels. Consequently, leukocyte extravasation is heavily impaired and the cells 
do not reach infected tissues. This leads to leukocytosis, meaning strongly elevated 
levels of neutrophils in the peripheral blood. Also phagocytosis and chemotaxis are 
affected, which are secondary effects due to abnormal cell adhesion [207]. LAD-I is 
treated by bone marrow transplantation. 
The course of disease is less severe in LAD-II, which is caused by a defect in the 
processing of glycans. Granulocytes and monocytes derived from LAD-II patients 
lack CD15, also named sialyl-LewisX, a ligand for selectins. Sialyl-LewisX is a fucose-
containing carbohydrate structure on cell surface glycoproteins and glycolipids [208]. 
The mutant cells bind minimally or not at all to E- and P-selectins but reveal normal 
P-selectin and 2 levels [209]. They show impaired rolling and decreased motility but 
normal phagocytosis. These cells adhere and migrate normally only in case of Mac-1 
activation [209]. Beside leukocytosis and leukocyte defects, LAD-II patients suffer 
from moderate to severe psychomotor retardation and mild dysmorphism, which are 
also due to primary defects in fucose metabolism [210]. Additionally, the patients 
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manifest the Bombay blood type. Their erythrocytes lack the H antigen, a fucose-
containing carbohydrate sequence and the precursor of the A, B and 0 blood types. 
The patients have deficiencies in many fucosylated carbohydrates [211]. This basic 
defect in fucose metabolism is due to low GDP-fucose import activity to the Golgi 
apparatus resulting from mutations in the GDP-L-fucose transporter [212; 213]. Some 
LAD-II patients can be treated be oral application of fucose, which induces 
expression of fucosylated selectin ligands [212]. 
The third subtype LAD-III is also known as LAD-I variant and is characterized by 
LAD-I like immunodeficiency and additional Glanzmann’s thrombasthenia like 
bleedings. In a number of patients also an osteopetrosis was found [214]. Mutations 
within the kindlin-3 gene are responsible for LAD-III [215; 216]. As kindlin-3 is 
expressed in all haematopoietic cells, lack of the protein affects leukocytes, platelets 
and lymphocytes [217]. Neutrophil activation, adhesion, motility and spreading are 
defective despite normal integrin expression and hemorrhages occur regardless of 
regular platelet counts [218]. The leukocyte defects as well as the bleeding 
phenotype result from impaired activation of 1, 2 and 3 integrins [219]. Like  
LAD-I, LAD-III can be cured by bone marrow transplantation. 
 
 
5.3.5. Monocytes and macrophages 
 
Monocytes and macrophages are critical for the non-specific innate immune 
response and help to initiate adaptive immunity. They are important for the regulation 
of inflammation, for example by producing inflammatory cytokines. They arrive at 
inflamed tissues later then granulocytes and are important in chronic infections. 
Monocytes and macrophages contain large numbers of small granules and, like 
granulocytes, belong to the phagocytes. They are able to ingest infectious agents as 
well as erythrocytes. Monocytes make up approximately 7% of the leukocytes. 
Monocytes differentiate from common myeloid progenitors under the influence of  
M-CSF, GM-CSF and other cytokines. They leave the bone marrow, circulate in the 
blood and differentiate into macrophages or inflammatory dentritic cells after entering 
the tissue [220]. Monocytes and macrophages belong to the antigen presenting cells. 
They internalize antigens by phagocytosis or receptor-mediated endocytosis and 
present fragments of the antigen bound to a class II MHC (major histocompatibility 
complex) molecule on the surface. This complex is then recognized by T-cells, 
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leading to their activation. Macrophages are also important for tissue homeostasis as 
they phagocytose apoptotic cells and secrete various growth factors [221]. 
Characteristic for macrophages are their very high expression level of Mac-1 and the 
presence of 3 1. Both are upregulated during differentiation of monocytes into 
macrophages. Macrophages can bind bacteria and LPS (lipopolysaccharide) by their 
2 integrins. The phagocytosis of complement-opsonized particles and the 
interaction of T-cells with antigen presenting MHCs are also mediated by integrins 
containing the 2 subunit [222; 223]. These integrins are activated by receptor 
crosstalk mechanisms and inside-out signaling under pro-inflammatory conditions, for 
example under the influence of tumour necrosis factors and platelet-activating factor, 
in presence of bacterial products and after T-cell receptor crosslinking [224]. 
Macrophage integrins also interact heavily with Fc receptors. Fc receptors bind the 
Fc region of antibodies, which are attached to infected cells or pathogens. Integrins 
and Fc receptors can modify each other’s response, achieved either by direct 
physical interactions within the cell membrane or by modifying the respective 
signaling pathways. Fc receptors modulate integrin adhesion by inside-out signaling. 
The integrin/Fc receptor crosstalk is bidirectional, as integrins also influence Fc 
receptor responses, such as adhesion to immune complexes and cell mediated 
antibody dependent cytotoxicity [225]. 
 
 
5.3.6. Osteoclasts 
 
Osteoclasts are the exclusive bone resorbing cells. Bone resorption is important for 
several processes, including bone growth, bone remodelling, tooth eruption and 
fracture healing but also for maintenance of blood calcium levels. 
Osteoclasts are huge acidophil cells with 25-30 nuclei and a size of up to 100 µm 
[226]. They are characterized by the expression of tartrate resistant acid 
phosphatase (TRAP) and cathepsin K [227]. 
Osteoclasts differentiate from monocyte/macrophage precursor cells by fusion into 
polykaryons [221]. Differentiation occurs under the influence of the cytokines M-CSF 
and RANKL (receptor activator of nuclear factor B ligand, also called tumour 
necrosis factor-related activation-induced cytokine (TRANCE), osteoprotegerin ligand 
(OPGL) and osteoclast differentiation factor (ODF) [228]), which are necessary and 
sufficient for osteoclastogenesis [229-232]. Both molecules are produced by 
mesenchymal cells of the bone marrow environment, predominantly by osteoblasts, 
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as soluble and membrane bound proteins (Figure 16A). These cells need to be in 
direct contact with osteoclast precursors, which is mediated by cadherin-6 [227; 233]. 
By binding to its receptor c-Fms, M-CSF is responsible for cell survival and 
proliferation of precursors but also contributes to osteoclast differentiation and 
induces cytoskeletal reorganization important for bone resorption. RANKL activates 
NF-  (nuclear factor- ) and NFATc1 via its receptor RANK [234]. Osteoclast 
differentiation can be inhibited by osteoprotegerin (OPG), which binds RANKL and 
therefore prevents its interaction with RANK [231]. 
Osteoclasts can be found in small cavities called Howship´s lacunae, which are 
formed by resorption of the underlying matrix. They undergo a resorptive cycle [235]. 
When they are not attached to bone, osteoclasts are non-polarized and contain 
diffusely distributed fibrillar actin. A prerequisite of matrix degradation is tight 
attachment of the osteoclast to the bone surface via integrins. This is achieved by the 
formation of sealing zones, which are ring-like structures that delineate the site of 
bone resorption (see below). Vesicles enriched with protons localize to the plasma 
membrane within sealing zones and eject their content. These processes generate 
the ruffled border, which is the functional organelle for resorption (Figure 16B). The 
now fully polarized osteoclast is capable of resorbing bone matrix. As the ruffled 
border and the underlying resorption lacunae are tightly isolated from the external 
space by the sealing zone, a microenvironment is provided that can further be 
acidified to a pH of approximately 4.5. This is achieved by secretion of hydrochloric 
acid through an electrogenic proton pump and a chloride channel [236]. The protons 
are produced by carbonic anhydrase II (CAII). At this acidic conditions the 
mineralized components of the bone matrix are dissolved into Ca2+, H3PO4, H2CO3 
and H2O and the organic parts consisting mainly of type I collagen are uncovered. 
The organic components are digested by proteases secreted by lysosomal vesicles 
that also contain additional protons. The most prominent protease is cathepsin K but 
MMPs, mainly MMP9, and other cathepsin family members support their function 
(Figure 16B) [228]. When a resorption depth of approximately 50 µm is reached, the 
cell detaches and migrates further to initiate another resorption cycle [237]. 
Osteoclasts undergo extensive vesicular trafficking. Beside the vesicles forming the 
ruffled border and delivering proteases and protons to the resorption lacunae, there 
are vesicles, which are transferred from the resorption lacunae through the ruffled 
border to the apical surface of the osteoclast, where they are unloaded (Figure 16B). 
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These vesicles contain cathepsin K, calcium- and phosphate-ions, as well as 
resorption products, which are further degraded by cathepsin K and reactive oxygen 
species (ROS) formed by TRAP (Figure 16B) [238]. 
 
       
Figure 16: Schematic views of the differentiation and the resorption process of mature 
osteoclasts. (A) Osteoclasts differentiate from monocyte/macrophage precursors under the 
influence of RANKL and MCSF [233]. (B) Bone resorbing osteoclasts adhere via sealing zones, 
which contain integrins. Carbonic anhydrase II (CAII) generates H
+
 and HCO3
-
. H
+
 and Cl
-
 are 
transported across the ruffled border into the resorption lacunae, a Cl
-
/HCO3
-
 ion exchanger 
allows ionic charge balance within the cell. Cathepsin K and other proteases are secreted into 
the resorption lacunae, resorption products are uptaken, transported through the cell in TRAP-
containing vesicles and exocytosed [239]. 
 
5.3.6.1. Adhesion structures of osteoclasts 
 
Depending on the substrate, upon which osteoclasts are spread, they adhere either 
via podosomes or via sealing zones. Cells cultured on ECM coated glass form 
podosomes, which are special integrin-mediated adhesion structures of cells from the 
monocytic lineage. Podosomes are highly dynamic, actin rich structures with a half-
life of 2-12 min [240]. They are also found in transformed fibroblasts, carcinoma cell 
lines and smooth muscle cells [39; 241]. Beside their function in adhesion, 
podosomes play a role in migration. They form at the leading edge and anchor the 
cell during translocation [242]. Furthermore, they are important for matrix remodelling 
and tissue invasion and accordingly, matrix metalloproteases such as MT1-MMP and 
MMP-9 localize to podosomes [39]. They have many molecular components in 
common with focal adhesions but differ from them in function and structure. They 
arrange already one hour after cell-substrate contact and are not dependent on de 
novo protein synthesis in contrast to focal adhesions [39]. 
  A  B 
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Podosomes have a diameter of approximately 0.5-1 µm. They are composed of a 
central actin core surrounded by a ring of plaque proteins (Figure 17). Podosomes 
contain cytoskeletal components and regulators, protein kinases and RhoGTPases. 
Podosome assembly is controlled by several RhoGTPases, among them Cdc42, 
controls. The podosome core consists primarily of F-actin and actin associated 
molecules, such as WASp, WASp interacting protein (WIP) and Arp2/3 complex. 
These proteins regulate actin assembly and reorganization within the core and are 
activated downstream of Cdc42. The cell surface receptor CD44 plays a major role in 
nucleating podosome cores by binding to WASp. CD44 is a widely expressed 
receptor for hyaluronic acid but it can also bind to osteopontin, collagen and laminin. 
Ligand bound CD44 triggers signaling pathways, which are sufficient to initiate 
podosome core formation [243]. Lack of functional CD44, WASp, WIP or Arp2/3 lead 
to impaired podosome formation [39; 244; 245]. Cytochalasin or latrunculin treatment 
leads to disassembly of podosomes, suggesting that the F-actin core is essential for 
their stability [240; 246]. The actin core is surrounded by a cloud of G-actin and actin 
oligomers, which is a source for actin turnover. While the actin core depends on 
CD44, the actin cloud is organized by integrins but both actin subdomains are 
interconnected by actin branching and crosslinking proteins such as cortactin and 
fimbrin [240; 243].  
Integrins, predominantly integrin V 3, and integrin associated proteins are mainly 
located in the ring structure. Integrin/ligand interactions lead to autophosphorylation 
of Pyk2 (proline-rich tyrosine kinase 2), necessary for complex formation with Src 
[247], and activation of Src and PI3K inducing the phosphorylation of p130Cas and 
Pyk2 at distinct sites by Src [248-250]. Also paxillin is phosphorylated upon integrin 
engagement. It binds to cytoplasmic domains of  integrin subunits and can provide a 
link to actin by interaction with vinculin, which in turn binds to talin and -actinin [39]. 
Dephosphorylation events are involved in podosome turnover. 
Podosomes are closely associated with microtubules and are influenced by them but 
the exact mechanism is still unclear [246]. Microtubules are not required for de novo 
assembly of podosomes, while reorganization, fission and fusion of podosomes are 
based on microtubule dynamics [251]. Podosomes also crosstalk with intermediate 
filaments and vimentin localizes to them. 
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Figure 17: Podosome model, cross section perpendicular to the substrate. The membrane is 
delineated by a black line. Membrane invaginations can provide space for matrix metallopro-
teinase secretion. The upper left panel shows the podosomal ring structure. Integrins mediate 
the connection to the ECM. A complex consisting of paxillin, Src, Pyk2, gelsolin, PI3K and 
p130Cas is recruited to the adhesion site, vinculin, talin and -actinin link the complex to actin. 
The upper right panel represents the podosomal core structure. WASp is activated by Cdc42 at 
the plasma membrane leading to the activation of the Arp2/3 complex. Cortactin and fimbrin 
crosslink the actin filaments [39]. 
 
Podosomes arrange into higher ordered structures. The actin cores of neighbouring 
podosomes are connected by radial actin filaments. In osteoclast precursors and 
immature osteoclasts, podosomes are usually organized in clusters that are 
embedded in an actin cloud composed of monomeric and polymerized actin [240]. 
The clusters can rearrange into short-lived rings. In fully differentiated osteoclasts 
these rings expand to a stable belt at the cell periphery by a treadmilling-like 
mechanism (Figure 18). Podosomes are newly formed at the periphery and 
disassembled in the centre. The centrifugal movement is reminiscent of Src activity 
waves [252]. Furthermore, this transition is dependent on microtubules, which are 
acetylated during the rearrangement process. Nocodazole treatment results in 
disorganisation of podosome belts and reappearance of clusters and rings [253]. 
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When mature osteoclasts adhere to mineralized matrix, calcium apatite crystals 
induce the formation of sealing zones in a microtubule dependent process (Figure 
18) [265]. Sealing zones consist of an actin ring with a width and height of 
approximately 4 µm and an inner and outer ring of vinculin and other plaque proteins. 
Sealing zones are composed of structural units that are closely related to individual 
podosomes but they are packed at very high density and are more heavily 
interconnected by a network of actin filaments than clustered podosomes [254]. 
 
 
Figure 18: Scheme of podosome organizations along osteoclast differentiation. Preosteoclasts arrange 
their podosomes in clusters that evolve into dynamic rings. These rings expand to a belt at the cell 
periphery in mature osteoclast stabilized by acetylated microtubules. Osteoclasts adherent on 
mineralized matrix form sealing zones [253]. 
 
5.3.6.2. Osteoclasts and integrins 
 
Integrin V 3 is the main osteoclast integrin. It recognizes the RGD motif, present in 
a number of non-collagenous bone-residing proteins, such as osteopontin and bone 
sialoprotein [123]. Osteoclast precursors express V 5, which also binds the RGD 
motif. V 5 is downregulated during osteoclast differentiation and genetic loss of 
V 5 results in enhanced osteoclast formation suggesting an inhibitory effect on 
differentiation [255]. 
Furthermore, 1 integrins are expressed on osteoclasts, such as 2 1, 5 1, 9 1 
and V 1 but the function of these integrins is not well characterized [256; 257]. 
Recognition of native collagen is mediated by integrin 2 1, whereas denatured 
collagen is predominantly bound by V 3 in a RGD-dependent manner. The RGD 
sites in native collagen are inaccessible to V 3 but are exposed in the denatured 
form [256]. Integrin 9 1 binds ADAM8, a disintegrin domain containing protein and 
MMP-like metalloproteinase. ADAM8 is an autocrine factor expressed on osteoclasts 
and 9 1/ADAM8 interaction is involved in osteoclast differentiation [258]. 
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5.4. Osteopetrosis 
 
5.4.1. Bone homeostasis and osteopetrosis 
 
Bone homeostasis is under the control of two cell types, osteoblasts and osteoclasts. 
Osteoblasts differentiate from mesenchymal stem cells and produce bone matrix. 
Osteoclasts are the exclusive bone resorbing cell type and derive from 
haematopoietic precursors by fusion into multinuclear cells. An intensive crosstalk 
between osteoblasts and osteoclasts exists in order to regulate bone mass. 
Osteoclast differentiation is dependent on the growth factors RANKL and M-CSF that 
are secreted by osteoblasts. RANKL and M-CSF production is triggered by 
parathyroid hormone (PTH) released from the parathyroid glands upon low serum 
calcium levels [259]. The balance between matrix production and matrix degradation 
needs to be maintained to achieve normal bone growth. This is essential to prevent 
both osteoporosis with a decreased amount of bone matrix and osteopetrosis, 
characterized by increased bone density. Osteopetrosis is a heterogeneous group of 
rare inheritable diseases, which is usually caused by a defect in bone resorption by 
osteoclasts [233; 260]. Defects in osteoclast function also affect shape and structure 
of bone due to impaired bone remodelling leading to brittle bone. In severe cases the 
medullary cavity is filled with endochondral bone. The consequence of an insufficient 
bone marrow cavity can be impaired haematopoiesis resulting in extramedullary 
haematopoiesis and hepatosplenomegaly. 
The abnormalities of osteoclasts leading to osteopetrosis are divided into defects that 
are either of intrinsic or extrinsic nature. This is of particular importance for the 
treatment of patients, as bone marrow transplantations are able to cure intrinsic 
osteoclast defects, while extrinsic malfunctions will not respond [233]. 
 
 
5.4.2. Mouse models 
 
A number of mouse models are available that reveal osteoclast abnormalities and 
therefore osteopetrosis. The defects can roughly be divided in early differentiation 
defects, defects caused by RANKL or related proteins, defects in acidification and 
functional defects. The osteopetrotic op/op mice have a mutation within the m-csf 
gene resulting in absence of circulating monocytes, macrophages and osteoclasts 
[230; 261]. This defect is extrinsic to the osteoclast, as stromal cells and osteoblasts 
are the main source of M-CSF. Osteopetrosis can also be caused by lack of the  
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M-CSF receptor c-Fms [262] or the transcription factor PU.1, which is functionally 
associated with the M-CSF pathway by binding to the promoter region of the M-CSF 
receptor gene and therefore regulates its synthesis [263]. 
Bone density is determined by the relative concentration of RANKL and OPG. OPG 
inhibits osteoclast differentiation by interacting with RANKL [232]. Overexpression of 
OPG results in osteopetrosis [264], while absence of OPG in mice leads to 
osteoporosis because of unregulated osteoclast differentiation and production [265]. 
Mice lacking RANK or RANKL develop osteopetrosis due to a lack of osteoclasts 
[266; 267]. Similarly, loss of proteins involved in RANK signaling, such as c-fos, 
NF B and TRAF-6 (tumour necrosis factor receptor-associated factor-6) also results 
in increased bone mass [268-270]. 
Osteopetrosis cannot only be caused by defective osteoclast differentiation, but can 
also result from dysfunctional osteoclasts. The generation of an acidic environment is 
crucial for dissolving mineralized matrix. Acidification of lysosomes and endosomes 
is achieved by proton pumps. Genetic ablation of Atp6i, which encodes for a subunit 
of an osteoclast specific ATP-dependent vacuolar proton pump results in 
osteopetrosis [271]. The same gene is mutated in naturally occurring osteosclerotic 
oc/oc mice [272]. Absence of the chloride channel ClC-7, which is necessary to 
achieve intracellular electroneutrality and is therefore charge coupled to the proton 
pump, also leads to osteopetrosis [273]. 
As tight adhesion is critical for osteoclast functionality, loss of the main osteoclast 
integrin V 3 results in osteopetrosis, which develops during adulthood, even if the 
osteoclast number in long bones from 3-/- mice is 3.5-times increased [152]. Their 
osteoclasts have a spreading defect and form abnormal ruffled borders, maybe due 
to loss of specific adhesive interactions between the resorption cavity and the ruffled 
border [121]. Actin organization is also affected leading to impaired podosome belt 
and sealing zone formation [152]. While retroviral expression of wild-type 3 rescues 
the defect of 3-deficient osteoclasts, the S752P mutant, which is incapable of 
kindlin-3 binding and is found in some patients with Glanzmann’s thrombasthenia, 
cannot restore osteoclast function [37; 274]. 
Beside integrin V 3, 1 integrins are also involved in osteoclast functionality. 
Blocking of the integrin subunits 1 or 2 by specific antibodies leads to reduced 
resorption [256], and lack of the subunit 9 in mice results in osteopetrosis due to 
impaired polarization, actin reorganization and mobility, too [275]. Furthermore, 
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osteoclast specific gene ablation of ILK, which is a component of the multiprotein 
complex that transduces signals downstream of integrins, results in increased bone 
volume despite increased osteoclastogenesis. ILK-/- osteoclasts are impaired in 
function and display decreased resorption activity [276]. 
Several transgenic mice lacking proteins that are involved in osteoclast integrin and 
M-CSF signaling are also osteopetrotic. For instance, mice deficient of Src, which is 
activated upon integrin ligation, also suffer from osteopetrosis despite slightly 
increased osteoclast numbers. Osteoclasts lacking Src show abnormal ruffled 
borders [277; 278] and the formation of podosomes and sealing zones is impaired 
[247; 279]. While kinase-dead Src can at least partially rescue the osteoclast defect 
by acting as an adaptor protein, Src’s kinase activity is additionally required for full 
rescue [280; 281]. As Pyk2 associates with Src in a complex upon integrin 
engagement during podosome assembly, it is not surprising that Pyk2-deficient mice 
also develop osteopetrosis. Pyk2 deficient osteoclasts are dysfunctional, as their 
sealing zone formation is impaired. Additionally they are unable to rearrange 
podosome clusters into belts due to altered microtubule stability and organization. 
Surprisingly, expression of activated Src cannot rescue the defect of Pyk2-/- 
osteoclasts, suggesting that Pyk2 mediates two separate signaling pathways, one 
regulating microtubule dependent podosome organization and one Src-dependent 
pathway involved in actin dynamics, adhesion and ruffled border formation [282]. 
Furthermore, Syk-deficient mice develop severe osteopetrosis and their osteoclasts 
are dysfunctional because they fail to properly organize their actin cytoskeleton [124]. 
As ITAM-containing adaptor proteins such as DAP12 and FcR  couple the 
downstream signals of integrins and c-Fms to Syk, DAP12 deficient mice develop 
osteopetrosis, which becomes even more severe in DAP12/FcR  double knockout 
mice [283; 284]. Furthermore, osteoclasts from these mice fail to form actin belts and 
sealing zones and osteoclasts deficient of DAP12 and FcR  are additionally impaired 
in differentiation due to lack of NFATc1 expression. As Syk has no impact on this 
transcription factor, this finding indicates that ITAM molecules additionally play a role 
in a Syk-independent, RANKL-mediated signaling pathway [285]. Since the RhoGEF 
Vav3 is a downstream target of Syk, loss of Vav3 also affects osteoclast cytoskeleton 
organization resulting in increased bone mass [286]. 
Moreover, deficiencies of cathepsin K or TRAP, which both are involved in bone 
matrix resorption, lead to osteopetrosis due to non-functional osteoclasts [287; 288]. 
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Understanding of the mechanisms involved in osteoclast differentiation and 
resorption provides opportunities to engineer new therapeutics to treat human bone 
diseases, predominantly osteoporosis. Orally active, non-peptide RGD mimetic V 3 
antagonists have been generated and for some of them it was shown that they can 
increase bone mineral density in women with postmenopausal osteoporosis [289-
292]. Also other proteins can serve as potential targets for an anti-osteoporotic 
therapy, such as the chloride channel ClC-7, Src and Vav3. 
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6. Aim of the thesis 
 
Kindlin-3 is restrictively expressed in haematopoietic cells and represents the solely 
kindlin expressed in blood cells. First in vitro studies on cultured cells showed that 
kindlins play an important role in integrin-mediated cell adhesion but in vivo functions 
were only partly examined. 
The general aim of this thesis was to analyse the consequences of kindlin-3 
deficiency on different haematopoietic cells. Genetic ablation of kindlin-3 in mice 
results in a lethal phenotype. These mice die within one week after birth and suffer 
from severe haemorrhages in the gastrointestinal tract, skin, brain and bladder, which 
are already apparent during development. Furthermore, kindlin-3 knockout mice 
develop anaemia, neutrophilia and a pronounced osteopetrosis. 
Within this thesis, the major goal was to examine the role of kindlin-3 in bone 
homeostasis and osteoclast biology and to elucidate the cause of the osteopetrotic 
phenotype of kindlin-3 deficient mice. Previous studies showed a progressive 
osteopetrosis in mice lacking integrin 3 expression and suggested an important role 
of integrin V 3 in osteoclast function. Due to the far less pronounced osteopetrosis 
in integrin 3-/- mice compared to kindlin-3-/- mice we hypothesized that also other 
integrin classes play a role in osteoclast-mediated bone resorption and are controlled 
by kindlin-3. In order to test this hypothesis we investigated osteoclasts lacking 1, 
2, 3 and/or V integrins and compared them with kindlin3-/- osteoclasts. 
Additional aims were to address also other phenotypes of the kindlin-3 deficient mice. 
It was already shown that kindlin-3 deficiency results in impaired platelet aggregation 
and therefore in bleedings and anaemia. To see if an erythrocyte defect contributes 
to the anaemia, we studied the effect of kindlin-3 loss on erythrocytes. In order to 
analyse the role of kindlin-3 in erythrocytes we used quantitative proteomics. 
Another phenotype we wanted to investigate was the pronounced neutrophilia. 
Based on the studies that kindlin-3 is essential for the activation of 1 and 3 
integrins on platelets, we wanted to analyse if the 1, 2 and 3 integrins expressed 
on neutrophils are also dependent on kindlin-3. Therefore we performed in vitro as 
well as in vivo experiments on kindlin-3-/- neutrophils. 
A further task was to answer the question how much kindlin-3 is needed to maintain 
its functions. For this purpose we used hypomorphic kindlin-3 mice and analysed 
their constitution as well as the effect of low kindlin-3 expression on various cell types 
with different kindlin-3 levels. 
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7. Brief summaries of the publications 
 
7.1. Paper I 
 
SILAC-mouse for quantitative proteomics uncovers Kindlin-3 as an essential 
factor for red blood cell function 
 
Krüger M.*, Moser M.*, Ussar S., Thievessen I., Luber C. A., Forner F., Schmidt S., 
Zanivan S., Fässler R., Mann M. 
*equal contribution 
 
This publication describes the application of the stable isotope labelling by amino 
acids in cell culture (SILAC) method to the whole mouse organism. Mice were fed 
with a special diet, in which the common 12C6-lysine, referred to as “light”, was 
replaced by “heavy” lysine labelled with 13C6 carbon. We were able to breed mice 
that were fully labelled with the heavy amino acid. This approach allows a 
quantitative analysis of whole proteomes by mass spectrometry. By applying this 
method to different genetically modified mice, it is possible to investigate the 
consequences of mutant genes on the proteome of distinct cell types within the 
whole mouse organism. By this method cell types can be analysed, which cannot be 
labelled in culture. 
First we show that wild-type and 1 integrin deficient platelets have comparable 
proteomes with the exception that the integrin 1 and its dimerizing  subunits 2 
and 6 are absent. Studies of hearts lacking -parvin expression elucidate that 
upregulation of -parvin expression compensates for the loss of -parvin. 
Furthermore, analyses of kindlin-3 deficient erythrocytes reveal severe structural 
membrane defects. The mutant erythrocytes have an altered composition of 
membrane and cytoskeletal proteins and we found an almost complete absence of 
the proteins ankyrin-1, band 4.1, adducin-2, and dematin in membrane fractions of 
erythrocytes. 
Altogether this publication describes how the whole mouse organism can be labelled 
with 13C6-lysine allowing the analyses of various cell types and organs by quantitative 
proteomics. We used this method to analyse kindlin-3 deficient erythrocytes and 
found that changes in protein composition of the erythrocyte membrane skeleton 
affect erythrocyte shape and stability, which contribute to the severe anaemia of 
kindlin-3 deficient mice. 
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7.2. Paper II 
 
Kindlin-3 is required for 2 integrin-mediated leukocyte adhesion to endothelial 
cells 
 
Moser M., Bauer M., Schmid S., Ruppert R., Schmidt S., Sixt M., Wang H., 
Sperandio M., Fässler R. 
 
Impaired activation of 1, 2 and 3 integrins on platelets and leukocytes is 
characteristic for LAD-III, a rare leukocyte adhesion deficiency syndrome in humans. 
The main symptoms of this disease are severe bleedings and impaired adhesion of 
leukocytes to inflamed endothelia. The main findings of this study are that kindlin-3 is 
not only required for activation of 1 and 3 integrins on platelets but also for 
activation of 2 integrins on leukocytes and that loss of kindlin-3 results in a LAD-III 
like phenotype in mice. 
We describe that kindlin-3 directly associates with the cytoplasmic domain of the 2 
integrin at the membrane distal NxxF motif and regulates binding of leukocytes to 2 
integrin ligands, such as ICAM and fibrinogen. Neutrophil adhesion is heavily 
impaired in the absence of kindlin-3. Kindlin-3 deficient neutrophils can slightly bind 
to immune complexes via their Fc receptors but spreading, which is dependent on Fc 
receptor triggered inside-out signaling of integrin M 2, is severely impaired. 
We also show defects of kindlin-3 lacking neutrophils in in vivo experiments. 
Therefore we generated fetal liver cell chimeras by transferring wild-type and  
kindlin-3-/- fetal liver cells into lethally irradiated wild-type recipient mice. Phorbol 
ester treatment of ears from kindlin3+/+ and kindlin3-/- chimeric mice reveal an 
inability of kindlin-3 deficient neutrophils to extravasate into the perivascular tissue. A 
pronounced extravasation defect can also be found in TNF- -stimulated cremaster 
muscle venules from kindlin3-/- chimeric mice. A more detailed investigation by 
intravital microscopy shows a strongly reduced adhesion of kindlin-3-/- neutrophils to 
the inflamed endothelium compared to control cells. Leukocyte rolling, which 
depends on P-selectin and E-selectin, is not affected in kindlin-3-/- chimeras. 
Furthermore, it is shown that chemokines fail to trigger neutrophil adhesion in  
kindlin-3-/- chimeras. 
In summary, we conclude from in vitro and in vivo experiments that loss of kindlin-3 
function is sufficient to cause a LAD-III–like phenotype in mice due to its essential 
role in activation of integrin 1, 2 and 3 classes. 
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7.3. Paper III 
 
Kindlin-3 mediated signaling from multiple integrin classes is required for 
osteoclast-mediated bone resorption 
 
Schmidt S., Nakchbandi I., Ruppert R., Kawelke N., Hess M. W., Pfaller K., Jurdic 
P., Fässler R., Moser M. 
 
The leukocyte adhesion deficiency syndrome LAD-III is caused by mutations in the 
KINDLIN-3 gene. Beside severe bleedings and immunodeficiency several patients 
suffering from this disease show osteopetrosis as an additional symptom. In this 
publication we describe that kindlin-3 deficient mice also develop an osteopetrotic 
phenotype due to a profound defect in osteoclast-mediated bone resorption. 
To test the influence of kindlin-3 on bone homeostasis, we analysed long bones of 
kindlin-3-/- mice and found a severe, early onset osteopetrosis. Surprisingly, the 
number of TRAP-positive, bone resorbing osteoclasts is even increased in kindlin-3 
null mice. Sera of mutant animals contain decreased Calcium and increased PTH 
and RANKL levels compared to control animals. As RANKL stimulates the formation 
of osteoclasts, this might explain the high number of osteoclasts in mutants. 
In vitro investigations show that lack of kindlin-3 has only a mild impact on osteoclast 
differentiation, which can be overcome by the treatment with high M-CSF 
concentrations. Kindlin-3 deficient osteoclasts reveal normal marker gene expression 
and protease activity. However, they are functionally impaired due to defective cell 
adhesion and spreading. They are not able to form proper podosomes and sealing 
zones, which are essential adhesion structures required for bone resorption. These 
defects are due to failure in the activation of 1, 2 and 3 integrins. Comparison of 
kindlin-3-/- osteoclasts with osteoclasts lacking integrin 1, 2, 3 or v or lacking 
combinations of 1, 2 and v integrins reveals that kindlin-3 loss mimics genetic 
ablation of 1, 2 and v integrins, but that deficiency of a single or two integrin 
classes already leads to defects in osteoclast function. 
Although we can not fully exclude integrin independent function of kindlin-3 in 
osteoclasts, our findings suggest that integrin v 3, which was considered to be the 
most important integrin heterodimer of osteoclasts, is only one integrin involved in 
osteoclast mediated bone resorption and that the whole integrin repertoire expressed 
on osteoclasts is required for proper osteoclast function. Kindlin-3 regulates all these 
integrin classes and is important for adhesion to the ECM, the formation and 
rearrangement of podosomes, and adhesion-mediated signaling in osteoclasts. 
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SUMMARY
Stable isotope labeling by amino acids in cell culture
(SILAC) has become a versatile tool for quantitative,
mass spectrometry (MS)-based proteomics. Here,
we completely label micewith a diet containing either
the natural or the 13C6-substituted version of lysine.
Mice were labeled over four generations with the
heavy diet, and development, growth, and behavior
were not affected. MS analysis of incorporation
levels allowed for the determination of incorporation
rates of proteins from blood cells and organs. The F2
generation was completely labeled in all organs
tested. SILAC analysis from various organs lacking
expression of b1 integrin, b-Parvin, or the integrin
tail-binding protein Kindlin-3 confirmed their ab-
sence and disclosed a structural defect of the red
blood cell membrane skeleton in Kindlin-3-deficient
erythrocytes. The SILAC-mouse approach is a versa-
tile tool by which to quantitatively compare pro-
teomes from knockout mice and thereby determine
protein functions under complex in vivo conditions.
INTRODUCTION
The administration of radioactive or stable isotope tracers to
animals is a well established technique by which to investigate
the rate of protein synthesis and protein degradation. (Wolfe
and Chinkes, 2005). This technology has been used for many
decades (Schoenheimer and Rittenberg, 1935). The infusion of
stable isotopes (13C or 15N) as tracers combined with measure-
ments of 13CO2 or
15N in urinary urea or ammonia is a broadly
used technique by which to explore the amino acid flux in meta-
bolic pathways (Bier, 1997; Dietz et al., 1982). Extensive incorpo-
ration of 13C or 15N stable isotopes does not result in discernable
health effects of the treated animals (Doherty and Beynon, 2006;
Gregg et al., 1973).
Mass spectrometry (MS) is not inherently quantitative, and rel-
ative protein expression changes are instead most accurately
measured by comparison of the natural form of a peptide with
its stable isotope analog (Ong and Mann, 2005). In recent years,
15N labeling has been applied to microorganisms such as yeast
(Oda et al., 1999; Pratt et al., 2002), Caenorhabditis elegans, and
Drosophila (Krijgsveld et al., 2003). Even a rat has been partially
(Wu et al., 2004) or completely 15N labeled (McClatchy et al.,
2007). In addition, nonsaturated labeling of a chicken, by using
the essential amino acid valine, allows for theMS-based analysis
of protein turnover rates in vivo (Doherty et al., 2005).
Our laboratory has previously described stable isotope label-
ing by amino acids in cell culture (SILAC) (Mann, 2006; Ong
et al., 2002), which has unique advantages for quantitative and
functional proteomics because of its inherent accuracy of quan-
titation and the ease of interpretation of MS results (Blagoev
et al., 2004; Kratchmarova et al., 2005). In a SILAC experiment,
two cell populations are generated: one in a medium that con-
tains the natural amino acid (i.e., 12C6-lysine), and the other in
a medium that contains the heavy isotope-substituted version
(i.e., 13C6-lysine). This allows for direct comparison of protein ex-
pression levels by mixing the nonlabeled ‘‘light’’ and the labeled
‘‘heavy’’ cell populations (Cox and Mann, 2007). Each peptide
appears as a pair in MS analysis with a difference in mass of
6 Da, and the relative peak intensities reflect the abundance
ratios. To date, SILAC labeling has been limited to cell culture
or microorganisms. To extend this powerful technique to higher
organisms, Oda and coworkers have SILAC labeled the Neuro
2A cell line to serve as an internal standard for quantitation of
a subset of peptides of the mouse brain proteome (Ishihama
et al., 2005).
In the present paper, we report the development of a mouse
SILAC diet that leads to complete labeling of the F2 generation.
We used in vivo SILAC quantitation to analyze newly synthesized
proteins from plasma and tissue samples in vivo. Furthermore,
we validated our in vivo quantitation system by comparing the
proteomes from platelets, heart, and erythrocytes from b1 integ-
rin-, b-Parvin-, and Kindlin-3-deficient mice, respectively.
Integrins are heterodimeric transmembrane proteins, consist
of a and b subunits, are ubiquitously expressed, and perform
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cell-cell and cell-matrix adhesion functions. Association of the
corresponding a and b subunits is required for their stability
and transport to the plasma membrane, as single subunits are
not stable and are rapidly degraded. Integrin-mediated cell
adhesion triggers intracellular signaling pathways (outside-in
signaling) that control migration, proliferation, survival, and dif-
ferentiation of cells. Prior to ligand binding, integrins require an
energy-dependent activation step, which is triggered within the
cell (inside-out signaling) and is characterized by a profound
conformational change in both integrin subunits. Although the
mechanism(s) underlying integrin activation are far from under-
stood, it is believed that the binding of the FERM-domain-con-
taining adaptor proteins talin and Kindlin to the integrin b cyto-
plasmic domains represents the last step in the activation
pathway (Calderwood, 2004; Moser et al., 2008).
Upon activation and ligand binding, integrins recruit and as-
semble a multiprotein complex at the site of cell adhesion that
fulfils two major tasks: it connects the extracellular matrix with
the actin cytoskeleton, and it alters the fluxes of many intracellu-
lar signaling pathways. A preformed complex consisting of the
three proteins, ILK, PINCH, and Parvin, represents an important
component of the integrin adhesion complex (Legate et al.,
2006). Parvins comprise a family of three proteins, a-, b- and
g-Parvin, that directly bind to ILK, F-actin, and other actin-asso-
ciated proteins, thereby linking the adhesion complex to the
actin cytoskeleton and controlling actin dynamics.
Kindlins have recently been identified within the integrin-medi-
ated cell adhesion complex and represent an additional family of
ILK-binding proteins (Montanez et al., 2007). They consist of
three members (Kindlin-1–3) and are named after the gene mu-
tated in Kindler syndrome, an autosomal recessive skin blister
disease in humans. Kindlin-3 expression is restricted to hemato-
poietic cells, and the highest levels are inmegakaryocytes (Ussar
et al., 2006). Inactivation of the Kindlin-3 gene in mice results in
severe anemia, which is thought to be due to a bleeding defect
caused by impaired activation of platelet integrins, defects in
platelet aggregation, and thrombus formation (Moser et al.,
2008).
To screen for potential defects in other cellular compartments
of the hematopoietic system in Kindlin-3-deficient mice, we
compared their proteome with those from control mice. During
the course of these studies, we discovered a deficit of structural
proteins in the plasma membrane of Kindlin-3-deficient erythro-
cytes, which contributes to the severe anemia seen in Kindlin-3-
deficient mice.
RESULTS
A Heavy SILAC Diet Has No Influence on Weight Gain
and Fertility
We prepared a SILAC diet by mixing 13C6-lysine or
12C6-lysine
into a customized lysine-free mouse diet to a final concentration
of 1% (Figure 1A) according to standard mouse nutritional
requirements (Benevenga et al., 1995). The amino acid content
was subsequently checked by hydrolysis and cation exchange
chromatography (Figure S1 available online). We first tested
whether the diet permits normal weight gain by feeding
mice with a regular diet or the SILAC diet (with 12C6-lysine or
13C6-lysine). During an observation period of 4 weeks, all animals
showed the same food consumption and a similar increase in
body weight of about 17% (Figures S2A and S2B), normal fertil-
ity, andmotor activity irrespective of the diet consumed. Further-
more, we SILAC labeled mice over four generations (see below),
indicating that the labeling is compatible with normal develop-
ment and physiology. Thus, we conclude that SILAC labeling
with a 13C6-substituted essential amino acid diet does not lead
to obvious discernable health effects in mice (Figure 1B).
SILAC Incorporation Rates Differ in Blood, Liver,
and Gut Epithelium
To track 13C6-lysine incorporation into the proteome over time,
we sampled blood each week for 4 weeks. Serum proteins
were separated on 1D gels in triplicate, in-gel digested, and
analyzed by high-resolution MS. The average relative standard
deviation of all quantified proteins was20% (Figure 1C), an ac-
curacy similar to what was seen in previous SILAC quantitation
experiments (Blagoev et al., 2004; Ong et al., 2003).
As an example of different incorporation levels, SILAC peptide
pairs of three serum proteins and one red blood cell protein are
shown in Figure 1C. For serum albumin, we observed a SILAC
ratio of 1:3.2, indicating that at least 74% of the protein had
been newly synthesized during the firstweek of feeding. Because
proteins can be synthesized from dietary amino acids as well as
from amino acids derived by protein catabolism, this value is
a lower limit for the true turnover (Beynon and Pratt, 2005). After
4 weeks, the three serum proteins were labeled to 90%. In
contrast, hemoglobin was only labeled to 57% after 4 weeks
(Figure 1C), due to the 60-day half-life of mouse erythrocytes
(Berlin et al., 1959). Additional profiles of blood proteins are listed
in Table S1.
Next, we measured the labeling efficiencies of a number of
organs after 4 weeks of feeding with the SILAC diet. Proteins
from heart showed an average protein ratio of 1:4.4 (Figure 2A;
Table S2), much lower than the serum proteins. Furthermore,
the distribution of SILAC ratios was relatively broad, reflecting
the different incorporation rates of individual cell types and the
‘‘contamination’’ of serum proteins in nonperfused samples.
For example, serum albumin has a similarly high incorporation
rate in blood (ratio 9) and heart (ratio 10) (Figures 1C and 2A).
In contrast to heart tissue, in which most cells are quiescent,
the intestinal epithelium regenerates within a few days (Radtke
and Clevers, 2005). Disaggregating the epithelium from the
digestive tube resulted in a more homogeneous cell pool con-
sisting of only a few cell types. As a consequence, we observed
a high SILAC ratio of 1:9.1 ± 2.1 reflecting a labeling efficiency of
more than 90% (Figure 2B), which is fully consistent with the high
proliferation rate of this tissue. For example, villin-1, a marker for
epithelial cells from the digestive system, showed a SILAC ratio
of 1:10.
Liver has a number of different physiological roles, including
carrying out metabolic functions and producing major blood
proteins. Accordingly, we observed a wide distribution of SILAC-
incorporation ratios among liver proteins. Hepatocytes are the
predominant liver cell type, and they are very rich in mitochon-
dria. To demonstrate that in vivo SILAC ratios can be measured
with subcellular resolution, we isolated mitochondria from liver
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cells (Forner et al., 2006) and compared their labeling ratios to
whole-cell lysates from the same sample (Figure 2C, black
bars). Interestingly, proteins frommitochondria showed an aver-
age SILAC ratio of 1:8.6 ± 2.4. This shows that the incorporation
rates of an organelle are more narrowly distributed and distin-
guishable from that of a whole tissue.
We next investigated several cell types of the hematopoietic
system. Platelets are cell fragments that are constantly released
bymegakaryocytes into the blood stream. They have a half-life of
7–9 days. We isolated platelets from a SILAC mouse after 4
weeks of labeling and measured incorporation levels of 86%
from 241 quantified proteins (Figure 2D). In contrast, serum albu-
min, which was also measured within the platelet sample due to
serum contamination, has a much higher incorporation level
compared to platelet proteins. Analysis of the red blood cell pro-
teome revealed a significantly lower 13C6-lysine incorporation of
75% (Figure 2E). Thus, consideration of SILAC-incorporation
rates could aid in the determination of the origin of the same
proteins from different cellular pools via their different dynamic
incorporation rates.
To combine SILAC-mouse analysis with cell sorting to obtain
an accurately defined cell population, we separated CD45R-
positive B lymphocytes from spleen by fluorescence-activated
cell sorting (FACS) (Figures 2F and S3). An in-solution protein
digest was performed from lysates of 13 106 spleen cells (Table
S2F). The distribution of measured ratios was 1:5.4 ± 1.3, dem-
onstrating that FACS-sorted populations of interest can readily
be investigated in the SILAC mouse.
Figure 1. SILAC Labeling and Incorporation Rates of Blood Proteins
(A) Mice are SILAC labeled by being fed a pelleted, lysine-free diet supplemented with normal or heavy lysine.
(B) Mice on a SILAC diet cannot be visually distinguished from mice with a normal, commercial diet.
(C) Mass spectra showing SILAC pairs of a representative peptide for four blood proteins. The right-hand side shows lysine-6 incorporation over the course of
4 weeks as an average measurement of triplicates.
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Taken together, our results indicate that feeding mice with
a SILAC diet is a suitable approach to label proteins in vivo
and to follow their metabolic incorporation in any organ.
Complete SILAC-Based Labeling of F2 Mice
Although the label efficiency was relatively high in many tissues,
we found that extending the labeling time did not lead to com-
plete labeling. This is likely due to the recycling of internal amino
acid sources (Doherty et al., 2005). Since labeling rates above
95% are required to perform comparative and quantitative pro-
teomics by MS, we started feeding our mice over several gener-
ations with the heavy diet. Importantly, the consumption of the
heavy diet did not affect litter size (Figure S2). The F1–F4 off-
spring developed normally, gained weight within the normal
weight-gain chart (Figure S2), and showed normalmating behav-
ior. Furthermore, newborn animals of the F1 generation were
almost completely labeled, reaching 93% in blood, brain, and
liver (Figures 3 and S4). To obtain fully labeled animals to serve
as internal standards and to investigate if SILAC labeling could
be performed for many generations, we bred F2, F3, and F4
mice. These mice contained virtually no unlabeled peptides
(Figures 3B, 3C, and 5A; Table S3).
Proteome of b1 Integrin-Deficient Platelets
For validation of our in vivo quantitative proteomics approach,we
analyzedandcomparedprotein lysates fromb1 integrin-deficient
Figure 2. SILAC Label Incorporation into Different Cell Types and Tissues after 4 Weeks
(A–F) The panels show the relative number of proteins with the specified ratios for each proteome investigated. (A) Heart tissue. (B) Gut epithelium. (C) Incorpo-
ration into whole liver (gray bars) is compared with incorporation into liver mitochondria (black bars). (D) Platelets. (E) Erythrocytes. (F) CD45R-positive B lympho-
cytes from spleen.
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and control platelets (Nieswandt et al., 2001). We generated
b1 integrin-deficient platelets by intercrossing b1 floxed mice
(b1fl/fl) with a transgenic mouse expressing an Mx1 promoter-
driven, interferon-inducible Cre (Mx1-Cre) (Brakebusch et al.,
2000; Kuhn et al., 1995). We treated b1fl/fl; Mx1-Cre mice with
synthetic double-stranded RNA (polyinosinic-polycytidylic acid,
pI-pC), which triggers endogenous interferon production and
subsequent Mx1-Cre activity. This leads to deletion of the b1 in-
tegrin gene in all hematopoietic cells, includingmegakaryocytes.
To monitor the knockout efficiency of b1 integrin, we compared
platelets from labeledwild-type animalswith platelet populations
from three groups of mice: (1) nonlabeled wild-type platelets; (2)
platelets from nonlabeled, non-pI-pC-induced b1fl/fl; Mx1-Cre
mice; and (3) platelets from nonlabeled, pI-pC-induced b1fl/fl;
Mx1-Cre mice (Figure 4). All mice were backcrossed on
a C57BL/6 background to reduce genetic variability.
We quantified 645 proteins in these platelets, and, as
expected, protein ratios of labeled and nonlabeled wild-type
platelets were tightly distributed, with an overall ratio of 1:1.
The quantitative MS analysis revealed complete loss of b1 integ-
rin in platelets from pI-pC-induced b1fl/fl; Mx1-Cre mice
(Figure 4F). The proteins with the next highest ratios were the di-
merization partners of the b1 integrin subunit, strikingly confirm-
ing the sensitivity and reliability of our SILAC-mouse labeling
system (Figure 4I). In a boxplot analysis, b1, a2, and a6 integrins
were all more than ten interquartile ranges away from themedian
(Figure S5A; Table S4).The complete loss of both a subunits can
be explained by the formation of a stable integrin heterodimer
during the synthesis and transport of the complexed integrin
subunits to the plasma membrane. Without the correct b integrin
subunit, the a subunit is rapidly degraded (Hynes, 2002). In con-
trast, the loss of b1 integrin has no impact on the expression of
other integrins, such as the major platelet integrin aIIbb3.
In addition, several other proteins in b1 integrin-deficient
platelets were outliers in the boxplot (Figure S5A; Table S4).
However, a second independent experiment did not verify these
proteins as being significantly downregulated. (Figure S5C). In
contrast, the b1 integrin dimerization partners a2 and a6 integ-
rins were again strongly reduced (Figure S5).
Interestingly, the analysis of platelets from noninduced b1fl/fl;
Mx1-Cre mice also revealed a slight downregulation of the b1,
a2, and a6 integrin levels compared to labeled wild-type plate-
lets (Figure 4J). This effect is due to the natural, endogenous
a/b interferon production in the bone marrow causing a low
Mx1 promoter activity (Kuhn et al., 1995). The detection of this
‘‘leak’’ impressively underscores the sensitivity of our quantita-
tive proteomics approach.
b-Parvin Deficiency in Heart Is Compensated
by a-Parvin Induction
We next wanted to confirm the applicability of our in vivo SILAC
approach to analyze the proteomes fromknockoutmice in a solid
organ. To this end, we compared the proteomes from hearts of
b-Parvin-deficient mice with those of control littermates. As
a heavy standard, we used heart lysates from 2-week-old mice
of the F4 generation, which showed an overall 97.7% incorpora-
tion of 13C-lysine (Figure 5A). To test our quantitation system, we
mixed ‘‘heavy’’ and ‘‘light’’ protein lysates from wild-type hearts
in ratios of 1:1, 1:2, and 1:4. As shown in (Figure 5B), mixing of
protein lysates from different heart samples gave rise to SILAC
ratios that accurately reflected the lysate mixture.
b-Parvin represents the dominant Parvin isoform of the heart,
since a-Parvin is only weakly present and g-Parvin is absent from
heart tissue. b-Parvin-deficient mice were generated by homol-
ogous recombination of a targeting vector in embryonic stem
(ES) cells, which lacks exons 2 and 3 of the b-Parvin gene (I.T.
and R.F., unpublished data). b-Parvin-deficient mice were viable
and fertile and did not show any overt phenotype, indicating that
b-Parvin is not essential for mouse development and organ for-
mation. Mass spectrometric measurements of whole protein ly-
sates from b-Parvin-deficient and control hearts of 2-week-old
animals showed a complete absence of b-Parvin in knockout an-
imals (Figures 5C and 5D). Out of 1205 proteins, only 4 proteins
showed a two-fold decrease in their abundance compared to
Figure 3. Complete Labeling of the F2 Generation
(A) Label efficiency of the liver of a 2-day-old mouse of the F1 generation.
(B and C) Histograms of liver proteins with the specified percent incorporation
at (B) P2 and at (C) P50 of the F2 generation. The averages of the SILAC ratios
and the corresponding percent of the SILAC labeling are displayed in the histo-
gram. The analysis encompasses 100 proteins.
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wild-type hearts (Table S5). Interestingly, lack of b-Parvin had no
dramatic consequence on the level of ILK and PINCH-1, which
are the two other components of the ILK/Pinch/Parvin complex.
The two-fold increase of a-Parvin in b-Parvin-deficient hearts
suggests that the absence of an obvious phenotype is due to
compensatory upregulation of a-Parvin (Figure 5C).
Kindlin-3 Deficiency Disrupts the Red Blood Cell
Membrane Skeleton
Kindlin-3-deficient mice die at birth and suffer from severe
bleeding, anemia, and pale skin color (Figures 7A and 7B; Moser
et al., 2008). To further validate the power of in vivo SILAC and to
obtain novel insights into Kindlin-3 function, we performed quan-
titative proteomics of platelets and erythrocytes fromKindlin-3ÿ/ÿ
mice. Platelet analysis identified Kindlin-3 as the protein with the
highest fold change of more than 1200 platelet proteins
(Figure S6A; Table S6). Interestingly, the levels of integrin aIIb
and b3 subunits were normal, suggesting that the reduced sur-
face levels found by FACS (Moser et al., 2008) were due to an im-
Figure 4. Analysis of b1 Integrin Knockout
Platelets
(A–J) (A, D, and G) Platelets from SILAC-labeled
wild-type mice were mixed with platelets from
a nonlabeled wild-type control mouse. Compari-
son of the wild-type SILAC mouse with (B, E, and
H) noninduced b1fl/fl; Mx1-Cre mice and with (C,
F, and I) pI-pC-induced b1fl/fl; Mx1-Cre mice. The
slight decrease of b1 integrin shown in (E) is due
to Cre activity induced by low endogenous inter-
feron expression. The arrows in (F) and (I) label
the reduced peak intensity of b1 and a2 integrin,
respectively. (J) Summary of quantified SILAC ra-
tios for b3, b1, a2, and a6 integrin subunits. White
bars represent the ratio between the labeled wild-
type WT(h) animal and the nonlabeled wild-type
animal, gray bars represent the SILAC ratio of
WT(h) and noninduced b1fl/fl, and black bars repre-
sent the SILAC ratio between WT(h) and induced
b1fl/fl; Mx1-Cre. The error bars show the variability
of the measured ratios.
paired integrin trafficking in the absence
of Kindlin-3 (Figure S6B).
We have previously reported that Kind-
lin-3 (also known as ‘‘unc-related protein
2’’) is present in red blood cells (Pasini
et al., 2006). This was confirmed by dif-
ferent SILAC-incorporation levels in
platelets (incorporation rate of 1:6.0) com-
pared to erythrocytes (incorporation rate
of 1:2.1), measured after the initial 4-week
labeling period (Figures 2, S7A, and
S7B). Furthermore, Kindlin-3 gene activity
in Ter119-positive Kindlin-3-heterozy-
gous erythroblasts was further corrobo-
rated by measuring Kindlin-3 promoter-
driven b-galactosidase reporter gene
activity with FACS (Figure S7C).
To investigate whether loss of Kindlin-3 affects erythroid cells,
we determined and quantitatively compared the proteomes from
wild-type, Kindlin-3+/ÿ, and Kindlin-3ÿ/ÿ erythrocytes (Figure 6;
Table S7). MS confirmed a 50% reduction of Kindlin-3 in hetero-
zygous and a complete absence of Kindlin-3 in Kindlin-3ÿ/ÿ
erythrocytes (Figure 6A).Out of 881 proteins identified in all 3 pro-
teomes, more than 50 were two-fold increased in Kindlin-3ÿ/ÿ
erythrocytes, andonlya few revealedamore than two-fold reduc-
tion. Interestingly, a large proportion of the upregulated proteins
was annotated to be nuclear (Table S7).
Blood smears from Kindlin-3ÿ/ÿ embryos and P3 animals
showed a strong reduction of cells when compared to wild-
type controls and, in concordance with this proteomic finding,
manymore nucleated erythroblasts (Figures 7B and 7C). In addi-
tion, the size and shape of Kindlin-3ÿ/ÿ erythrocytes were mark-
edly irregular.
Scanning electron microscopy showed abnormally shaped
erythrocytes with striking membrane invaginations and protu-
berances (Figure 7D). Red blood cell membrane abnormalities
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are often caused by mutations within membrane-skeleton pro-
teins, and the absence of key components can have drastic con-
sequences on the stability of the red cell membrane (Delaunay,
1995). To obtain an explanation for the structural defects, we
quantitatively compared the membrane-skeleton proteins from
total erythrocytes by using SILAC-based MS. The levels of the
most prominent skeleton proteins (e.g., a/b spectrin, ankyrin,
band 3, band 4.1, band 4.2, and actin) did not significantly differ
between wild-type and Kindlin-3ÿ/ÿ mice.
Next, we determined whether these proteins have formed
a stable meshwork that is connected with the erythrocyte mem-
brane. To address this question, we isolated the erythrocyte
membranes (so called red blood cell ‘‘ghosts’’) from wild-type
Figure 5. Analysis of Heart Tissue from
b-Parvin Knockout Mice
(A) 13C6-Lysine incorporation of heart tissue from
mice of the F4 generation shows a label efficiency
of 97.7%.
(B) Heart tissue from labeled and nonlabeled ani-
malswasmixed1:1, 1:2, and1:4. ThemeasuredSI-
LAC ratios after in-solution digestion were 0.93 ±
0.17 for the 1:1 mix, 0.58 ± 0.10 for the 1:2 mix,
and 0.26 ± 0.05 for the 1:4 mix. Approximately
300 SILAC protein ratios were used for the quanti-
fication.
(C) Heart tissue from SILAC-labeled wild-type
mice was mixed with nonlabeled b-Parvin (+/+)
and b-Parvin (ÿ/ÿ) hearts. The arrow indicates
the complete absence of b-Parvin.
(D) SILAC ratios of selected proteins.
and Kindlin-3ÿ/ÿ mice and compared
them to ghosts from SILAC-labeled con-
trol animals (Figure 7E). Quantitative
SILAC-based analysis revealed an almost
complete absence of ankyrin-1, band 4.1,
adducin-2, and dematin (Figure 7F, right
rows; Table S8), whereas other mem-
brane-skeleton proteins, like a/b spectrin
and band 3, were not changed.
Together, these findings show that
Kindlin-3 is required for the assembly of
a subset of proteins within the red blood
cell membrane skeleton. Furthermore,
the proteomic, morphological, and func-
tional data provide a clear explanation
for the anemia that leads to postnatal
lethality.
DISCUSSION
Thus far, quantitative gene expression
comparisons in higher organisms have
been restricted to RNA analyses by gene
chip approaches. These methods have
many advantages: for example, ready
accessibility and the fact that, in principle,
almost all genes can be analyzed on one
chip. However, because of posttranscriptional regulation as
well as regulated protein degradation, these data do not neces-
sarily predict changes in protein levels within cells or tissues.
Furthermore, there are specific cell populations, such as the
platelets and erythrocytes investigated here, that are devoid of
mRNA and are therefore out of reach for these techniques.
Here, we show that SILAC, a versatile and successful method
for quantitative proteomics in cell culture-based systems or mi-
croorganisms, can be extended to mammalian model systems.
Mice can be SILAC labeled without any obvious effect on
growth, behavior, or fertility. SILAC food preparation is straight-
forward and not particularly expensive when considering other
resources required for the generation and maintenance of
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knockout animals. We chose 13C6-lysine labeling, as lysine is not
converted into other amino acids. This makes endoprotease
Lys-C the preferred choice as the proteolytic enzyme. Another
interesting enzyme for SILAC mice is Lys-N, which has recently
been described as an efficient enzyme for proteomics and de
novo peptide sequencing (Taouatas et al., 2008). Organs derived
from SILAC mice can serve as standards for a large number of
subsequent experiments, in which wild-type and knockout
mice are compared. Importantly, cell types such as intestinal
epithelium that are difficult to study ex vivo can be analyzed by
the in vivo SILAC approach. Moreover, the SILAC mouse can
serve as a reference model at any biological scale, from the
whole organ through specific cell types down to intracellular
compartments or single proteins of interest. As an example,
we used SILAC mice to successfully study the mitochondrial
proteome, which can be extended to investigations in relevant
organs from metabolic or neurodegenerative disease models.
In studies in which a large number of mice are required—such
as in toxicology studies—labeled organ tissue could be stored
and used as an internal standard for each measurement. A la-
beled SILAC-mouse liver, for example, yields sufficient internal
standard for more than 1000 measurements. Although not
shown here, phosphopeptides can also be enriched from SILAC
mice and can serve as a standard for functional and time-
resolved phosphoproteomics (Olsen et al., 2006).
We analyzed the proteomes of cells from three independent
knockout mice. In all analyses, the complete absence of the tar-
geted genes was immediately revealed by the SILAC technique.
Furthermore, heterozygous Kindlin-3 animals present the ex-
pected two-fold reduction from wild-type levels, emphasizing
the quantitative nature of our proteomic technology. This may
be particularly useful in quantifying knockdown efficiencies in
Figure 6. Quantitative Proteomics of Erythrocytes
from Kindlin-3ÿ/ÿ Mice
(A) Mass spectra of a Kindlin-3 peptide SILAC pair in Kindlin-
3+/+, Kindlin-3+/ÿ, and Kindlin-3ÿ/ÿ erythrocytes.
(B) Histogram of SILAC ratios of wild-type (white bars) and
Kindlin-3ÿ/ÿ (gray bars) erythrocytes. The measured ratios
were grouped into ratio bins, and the y axis shows the relative
number of detected ratios per bin.
transgenic RNAi mice. The sensitivity of the
SILAC-based quantitation system became remark-
ably obvious by an observation from the b1 integrin
inactivation in platelets. Deletion of the b1 integrin
gene in hematopoietic cells is achieved by the
induction of the Mx1-Cre transgene through the
injection of pI-pC into b1 integrin floxed animals.
Even without induction of Cre, the low expression
levels of naturally expressed a/b interferon acti-
vated the Mx1 promoter and triggered b1 integrin
deletion in a few cells. Even this slight difference
in total b1 integrin expression proved sufficient for
detection by the SILAC method.
Our proteomic data on platelets of b1 integrin
mice showed that, although integrins control a num-
ber of different signaling pathways, the lack of the
b1 integrin has no consequences on the levels of other proteins
in platelets, apart from its dimerization partners a2 and a6 integ-
rins. This may be due to the fact that, in resting platelets, integ-
rins are inactive and signaling into the cell is only induced upon
stimulation via molecules like thrombin or collagen (Ruggeri,
2002). Further studies with the SILAC-mouse system could
focus on activation of signaling cascades during platelet aggre-
gation by using phosphoproteomics.
To test the SILAC-based analysis in a solid organ system, we
compared the proteomes from heart of b-Parvin-deficient mice
with control littermates. The complexity of a tissue, formedby dif-
ferent cell types, poses no limitation for the quantitative analysis
by MS. The interpretation of results, however, is more challeng-
ing because changes in protein levels may result from non-cell-
autonomous defects caused, for example, by altered cell-cell
communication rather than cell-autonomous defects.
To study the molecular cause of the anemia observed in Kind-
lin-3 mutants, we analyzed the consequences of this deletion on
the proteome of platelets and erythrocytes. Recently, we char-
acterized Kindlin-3 as an essential factor for the activation of
platelet integrins (Moser et al., 2008). Kindlin-3 directly binds to
the cytoplasmic tails of both b1 and b3 integrin subunits. Its ex-
pression is restricted to cells of the hematopoietic system (Ussar
et al., 2006). Our SILAC-based analysis of Kindlin-3-deficient
erythrocytes revealed an increased amount of nuclear proteins,
prompting us to investigate consequences of the knockout on
this cell type. Consistent with the proteomic results, we found
an increased number of nucleated erythroblasts in blood
smears. Furthermore, Kindlin-3-deficient erythrocytes are irreg-
ular in size and shape. The structural defects of the red blood
cell membrane skeleton suggested an additional function of
Kindlin-3. With the help of the SILAC method, we quantitatively
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compared the membrane-skeleton proteins of control and Kind-
lin-3-deficient erythrocytes and revealed a critical role of Kindlin-
3 in the formation or stabilization of this structure. The inner sur-
face of the red blood cell membrane is laminated by a protein
network that is linked to transmembrane proteins. In humans
and mice, mutations in genes encoding ankyrin, band 3, spec-
trin, and protein 4.1 or protein 4.2 cause hereditary spherocyto-
sis or poikilocytosis, often accompanied with hemolytic anemias
(Delaunay, 1995; Peters et al., 1998; Rybicki et al., 1995; Shi
et al., 1999; Southgate et al., 1996). The dramatic reduction of
ankyrin-1, protein 4.1, and dematin in membrane preparations
from Kindlin-3-deficient erythrocytes explains the severe
Figure 7. Kindlin-3-Deficient Erythrocytes Show Disrupted Membrane Skeletons
(A) Kindlin-3 knockout mice are anemic.
(B) Decreased hematocrit in Kindlin-3ÿ/ÿ mutants at embryonic day 15 and P3.
(C) Blood smears from E15 embryos and P3 wild-type and Kindlin-3ÿ/ÿ mice reveal fewer erythrocytes and an increased number of nucleated erythroblasts.
(D) Scanning electron microscopy of wild-type and Kindlin-3ÿ/ÿ erythrocytes. The scale bar represents 1 mm.
(E) ‘‘Ghost’’ lysates from wild-type, heterozygous, and Kindlin-3ÿ/ÿ mice were stained by Coomassie blue after SDS-PAGE. The arrows indicate the absence of
proteins within the membrane-skeleton fraction of Kindlin-3ÿ/ÿ erythrocytes.
(F) SILAC-ratio comparison of total erythrocytes (left rows) and the membrane fraction (right row).
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malformations. Thus, loss of Kindlin-3 affects erythropoiesis by
disrupting the assembly of structural components within the
red blood cell membrane skeleton.
In summary, a direct combination of the SILAC technology for
quantitative proteomics with the large number of powerful
mouse models generated by the community is now possible.
We have demonstrated here how proteomics can be combined
with several of the powerful technologies already used in this en-
deavor. We are confident that this technology will help to eluci-
date disease processes and guide novel intervention strategies.
Data Availability
Data used for quantitation accompany this article online.
EXPERIMENTAL PROCEDURES
Materials and Reagents
13C6-Lysine (98 atom %
13C) was purchased from Silantes, Martinsried, Ger-
many. Chemicals for the ‘‘in-solution’’ and ‘‘in-gel’’ digests were purchased
from Sigma-Aldrich, and LysC was obtained from WAKO. Wild-type mice
were obtained from an in-house C57Bl/6 colony.
Knockout Mice
Transgenic mice expressing the Cre recombinase under the control of theMx1
promotor (Kuhn et al., 1995) were mated with mice carrying a floxed b1 integrin
gene (Brakebusch et al., 2000). To ensure extensive downregulation of the b1
integrin on platelets, pI-pC (250 mg per mouse) (Amersham) was injected intra-
peritoneally three times in a 2-day interval.
Kindlin-3-deficient mice were generated as described byMoser et al. (2008).
A detailed description of the b-Parvin gene inactivation will be published else-
where (I.T. and R.F., unpublished data).
Food Preparation, Weight Gain, and Food Consumption
A customized lysine-free mouse diet (Harlan-Teklad, TD.99386) was com-
bined with the heavy L-13C6-lysine and the natural isotope L-lysine (Sigma) to
a final concentration of 1%. To obtain a homogenous distribution of the amino
acid, the powder was vigorously mixed with a blender for 5 min. For the prep-
aration of food pellets, 10 g of the mixture was filled into an in-house-manu-
factured cylinder with an inner diameter of 1.5 cm and a length of 10 cm. Food
was compressed with an exactly fitting pestle for 1 min. Pellets were taken out
and dried overnight at room temperature. After drying, the pellets were cut into
smaller pieces.
The lysine content was checked as described (Moore et al., 1958). Although
the hydrolysis with subsequent chromatography does not allow for the exact
determination of the amino acid contents, the supplemented lysine amount
was comparable to that in the customized diet containing the natural lysine
isotope.
For testing weight gain and food consumption, one group (n = 3 females)
was fed with a regular mouse diet, one group (n = 3 females) was fed with
the customized lysine-free diet supplemented with natural lysine (Sigma),
and one animal was fed with the diet containing the heavy isotope for lysine.
All animals were fed ad libitum and had access to water.
Food consumption was measured daily for 10 days during breeding and
weaning periods (Figure S2). The label percentage was calculated as the
mean of the heavy-labeled peptide signal divided by the sum of the light and
heavy signals.
Sample Preparation
Blood Samples
Mice were anesthetized with isofluran, and 20 ml blood was taken from the
retro-orbitral plexus. Blood samples were incubated with heparin (20 U/ml),
and, after centrifugation, the supernatant was frozen in liquid nitrogen and
stored at ÿ80C.
Tissue Harvest
After sacrificing animals by cervical dislocation, tissues were dissected,
washed in phosphate-buffered saline (PBS [pH 7.4]), and frozen in liquid nitro-
gen. For protein isolation, tissues were homogenized in a buffer containing 1%
NP-40, 0.1% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 50 mM Tris
(pH 7.5), and protease inhibitors (Complete tablets, Roche).The lysates were
centrifuged at 14,000 3 g to pellet cellular debris. A Bradford assay was per-
formed to determine protein concentrations of the supernatants.
Mitochondria Isolation
Liver tissue was quickly washed in water, then washed three times in 250 mM
sucrose, 10 mM Tris-HCl, 0.1 mM EGTA (pH 7.4) supplemented with protease
inhibitors (Roche). Crude mitochondria were isolated as described previously
(Forner et al., 2006) and were purified on a 30% Percoll density centrifugation
gradient.
Platelets were isolated by differential centrifugation steps as described by
Moebius et al. (2005).
Epithelial Cell Isolation from Gut
Small intestine was cut open and washed with PBS. The small intestine was
transferred to dissociation buffer (130 mMNaCl, 10 mM EDTA, 10 mMHEPES
[pH 7.4], 10% FCS, and 1 mM DTT) and was incubated for 45 min on a rotor at
37C. The rest of the intestine was removed, and the epithelial clumps were
collected by centrifugation at 800 rpm for 5 min and washed in PBS.
B Cell Isolation
For B cell isolation, spleen was cut into small fragments and digested with col-
lagenase and DNase, followed by the addition of EDTA. Subsequently, cells
were incubated with anti-CD45R, anti-CD3, and anti-CD49b (BD PharMingen).
B cells were selected as cells that stained positive for CD45R (B220) (Coffman,
1982) and negative for both anti-CD3 and anti-CD49b and were then sorted by
using a FACS Aria system (Becton Dickinson).
Mass Spectrometry
For protein separation, samples were loaded on a NuPAGE 4%–12% Bis-Tris
gel (Invitrogen). After staining of the gel with the Colloidal Blue Staining Kit
(Invitrogen), evenly sized gel pieces were excised from the gel and processed
for enhanced liquid chromatography-mass spectrometry (GeLC-MS).
For blood analysis, Coomassie-stained gel lanes were cut into eight pieces.
To determine incorporation ratios, we analyzed three gel pieces per lane from
heart, gut epithelia, liver, red blood cell, and platelet samples.
The gel pieces were subjected to in-gel reduction and alkylation, followed by
LysC digestion as previously described (Andersen et al., 2005; Shevchenko
et al., 1996). Finally, peptides were extracted twice by adding an equal volume
of 30% acetonitrile/0.3% trifluoraceticacid (TFA) in water to digest the mixture,
followed by a final extraction with 100% acetonitrile. Extracts were evaporated
in a speedvac to remove acetonitrile and were subsequently acidified with
0.5% TFA. Samples were desalted and concentrated with StageTips and
were resuspended in 5 ml of 0.5% acetic acid/1% TFA (Rappsilber et al.,
2003). In-solution digestion of proteins was performed as described by Ong
and Mann (2006).
Reverse-phase nano-LC-MS/MS was performed by using an Agilent 1100/
1200 nanoflow LC system (Agilent Technologies) with a cooled, thermostated
96-well autosampler. The LC system was coupled to a 7-Tesla LTQ-FT or LTQ
Orbitrap instrument (Thermo Fisher Scientific) equipped with a nanoeletros-
pray source (Proxeon). Chromatographic separation of peptides was per-
formed in a 10 cm long 8 mm tip opening/75 mm inner diameter capillary needle
(Proxeon). The column was custom made with methanol slurry of reverse-
phase ReproSil-Pur C18-AQ 3 mm resin (Dr. Maisch, GmbH). The LysC-di-
gested peptide mixtures were autosampled at a flow rate of 0.5 ml/min and
then eluted with a linear gradient at a flow rate of 0.25 ml/min. The mass spec-
trometers were operated in the data-dependent mode to automatically mea-
sure MS and MS/MS. LTQ-FT full scan MS spectra (from m/z 300 to m/z
1600) were acquired with a resolution of R = 100,000 at m/z 400 (after accumu-
lation to a target value of 3,000,000 in the linear ion trap). The five most intense
ions were sequentially isolated and fragmented in the linear ion trap by using
collisionally induced dissociation at a target value of 10,000 (Olsen et al., 2004).
Raw data files were converted to Mascot generic format files with in-
house software (Raw2MSM), and Mascot (version 2.0) was used for a
database search and protein identification. The following search
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parameters were used in all MASCOT searches: LysC digest; no missed
cleavage; carbamidomethylation of cysteine set as a fixed modification; and
oxidation of methionines and L-lysine-6 allowed as variable modifications.
The maximum allowed mass deviation for MS and MS/MS scans was 10
ppm and 0.5 Da, respectively. Only proteins that had at least two peptides
with ion scores >20 were considered for identification and quantitation.
MSQuant (Schulze andMann, 2004) was used to verify and quantify the result-
ing SILAC-peptide pairs. All proteomic results were deposited in the publicly
accessible MAPU database (Zhang et al., 2007). A target decoy database ap-
proachwas used to identify false-positive peptides and to set threshold criteria
such that <1% false positives were included in the peptide list (Tables S1 and
S2, statistics sheet). After mass recalibration withMSQuant, the average abso-
lute mass error of all peptides was better than 3 ppm.
Samples from all mouse mutants were analyzed by the in-house-developed
software MaxQuant (Cox and Mann, 2007; Graumann et al., 2008). Briefly,
MaxQuant performs a peak list, SILAC- and XIC-based quantitation, false-
positive rates (Gingras et al., 2007), and peptide identification based on Mas-
cot search results.
All data were searched against the International Protein Index sequence da-
tabase (mouse IPI, version 3.24) (Kersey et al., 2004). Fold-change for ghost
proteins was determined from the gel slice corresponding to the expected
migration of the full-length protein.
Blood Cell Analyses
Hematocrit was measured from peripheral blood with a hematology analyzer
(Nihon Kohden).
For ‘‘ghost’’ preparation,erythrocyteswerewashed twice in0.9%NaCl, 10mM
sodium phosphate buffer (pH 7.0) before hypotonic lysis were performed in
0.25% NaCl, 10 mM sodium phosphate buffer (pH 7.0). Lysis was performed
in several rounds in hypotonic buffer until the pellet became white.
Flow Cytometry
Flow cytometric lacZ staining of hematopoietic cells was performed on
Ter119-positive bone marrow cells that have been incubated with the fluores-
cent b-galactosidase substrate FDG (fluorescein di-b-D-galactopyranoside)
(Sigma) as described (Montanez et al., 2007). Flow cytometry was carried
out on a Becton Dickinson FACSCalibur.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and eight tables for protein identifi-
cation and quantification and are available with this article online at http://
www.cell.com/cgi/content/full/134/2/353/DC1/.
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Kindlin-3 is required for b2 integrin–mediated leukocyte
adhesion to endothelial cells
Markus Moser1, Martina Bauer1, Stephan Schmid2, Raphael Ruppert1, Sarah Schmidt1, Michael Sixt1,
Hao-Ven Wang1, Markus Sperandio2 & Reinhard Fässler1
Integrin activation is essential for the function of all blood cells,
including platelets and leukocytes1. The blood cell–specific
FERM domain protein Kindlin-3 is required for the activation of
the b1 and b3 integrins on platelets
2. Impaired activation of b1,
b2 and b3 integrins on platelets and leukocytes is the hallmark
of a rare autosomal recessive leukocyte adhesion deficiency
syndrome in humans called LAD-III, characterized by severe
bleeding and impaired adhesion of leukocytes to inflamed
endothelia3. Here we show that Kindlin-3 also binds the b2
integrin cytoplasmic domain and is essential for neutrophil
binding and spreading on b2 integrin-dependent ligands such
as intercellular adhesion molecule-1 and the complement C3
activation product iC3b. Moreover, loss of Kindlin-3 expression
abolished firm adhesion and arrest of neutrophils on activated
endothelial cells in vitro and in vivo, whereas selectin-mediated
rolling was unaffected. Thus, Kindlin-3 is essential to activate
the b1, b2 and b3 integrin classes, and loss of Kindlin-3
function is sufficient to cause a LAD-III–like phenotype
in mice.
Leukocyte adhesion to vessel walls and subsequent transmigration into
tissues is mediated through a sequential adhesion cascade, which
allows blood cells to overcome the high shear forces within blood
vessels. The cascade is initiated by transient selectin-carbohydrate
interactions, which trigger leukocyte rolling on the surface of activated
endothelial cells. Rolling leukocytes sense immobilized chemokines,
and chemokine receptor signaling induces activation of b2 integrins.
Activated b2 integrins mediate firm binding to counter-receptors on
the endothelial cell followed by transmigration of leukocytes through
the endothelial layer4. The central role of integrins and selectins in this
multistep process is impressively highlighted by leukocyte adhesion
deficiency (LAD) syndromes in man, which can be caused either by
mutations in the gene encoding b2 integrin (LAD-I)
5 or by impaired
glycosylation of selectin ligands (LAD-II)6–8.
In recent years, several groups have identified individuals suffering
from a novel form of LAD syndrome that has been termed LAD-III or
LAD-I variant. LAD-III is inherited in an autosomal recessive manner
and is characterized by a complete inability to induce activation of b1,
b2 and b3 integrins in hematopoietic cells, resulting in severe bleeding
due to impaired platelet aggregation and recurrent infections due to
abrogated leukocyte adhesion to activated endothelial cells3. Activa-
tion of leukocyte integrins can be triggered by various receptor
signaling pathways, including chemokine receptors. These signals
have been proposed to induce the binding of talin to integrin b1, b2
and b3 cytoplasmic domains, resulting in a shift of integrins from a
low-affinity to a high-affinity state for ligands (integrin activation)9.
As talin is ubiquitously expressed, and talin ablation leads to early
embryonic lethality in mice10, it is highly unlikely that mutations in
the gene encoding talin cause LAD-III. One group of researchers
found a mutation in a splice acceptor site of the CALDAGGEF1
(official symbol RASGRP2) gene and loss of CALDAGGEF1messenger
RNA in two subjects with LAD-III (ref. 11). Notably, mice lacking
CALDAG-GEF1 also suffer from defects in platelet and leukocyte
integrin function12. Moreover, CALDAG-GEF1 functions as a guanine
exchange factor for the small GTPase Rap1, which, in turn, activates
leukocyte and platelet integrins downstream of multiple receptors
including receptors for chemokines11. However, other individuals with
LAD-III lack mutations in the CALDAGGEF1 gene (see Svensson
et al.13 and Malinin et al.14 in this issue) and show normal Rap1
activity in platelets and leukocytes15,16, suggesting that mutations in
another gene cause this disease.
We recently showed that the FERM domain–containing, integrin b
tail–binding protein Kindlin-3 (encoded by the Fermt3 gene, called
Kindlin3 here) is required to activate b1 and b3 integrins in platelets
2.
Kindlin-3 belongs to a unique family (Kindlin-1, Kindlin-2 and
Kindlin-3) of focal adhesion proteins. Kindlin-1 is expressed in
epithelial cells, and mutations in the gene encoding Kindlin-1 cause
a skin-blistering disease in man called Kindler syndrome17. Kindlin-2
is widely expressed, and gene ablation in mice results in peri-
implantion lethality due to severely compromised function of b1
and b3 integrins
18. Kindlin-3 is exclusively expressed in hematopoietic
cells19, and mice lacking Kindlin3 (Kindlin3–/– mice) suffer from fatal
anemia, which is caused by severe bleeding and erythrocytopenia2,20.
Kindlin3–/– mice also show markedly reduced size and cellularity of
spleen and thymus and lack detectable mesenteric lymph nodes
(Supplementary Fig. 1 online).
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To test whether Kindlin-3 deficiency leads to defective leukocyte
adhesion and function, we generated fetal liver cell chimeras from
wild-type (Kindlin3+/+) and Kindlin3–/– embryos to circumvent post-
natal lethality of Kindlin3–/– mice2 and analyzed their polymorpho-
nuclear granulocytes (PMNs) in vitro and in vivo. Peripheral blood
smears 5 weeks after the fetal liver cell transfer indicated that
the number of PMNs was markedly increased in Kindlin3–/– chimeras
(Fig. 1a). This was confirmed by determining the absolute counts of
PMNs in peripheral blood, which reached 3,500 ± 1,000 cells
per ml (mean ± s.d.; n ¼ 9) in Kindlin3+/+ and 31,200 ± 27,000 cells
per ml (n ¼ 9) in Kindlin3–/– fetal liver cell chimeras (counts of other
blood cell types are shown in Supplementary Table 1 online). Despite
the severe granulocytosis, the size and nuclear morphology of PMNs
from peripheral blood or bone marrow as well as the expression
of surface markers such as Gr-1 were similar in Kindlin3+/+ and
Kindlin3–/– chimeras (Fig. 1a,b). Western blot analysis confirmed loss
of Kindlin-3 expression in bone marrow–derived Kindlin3–/– PMNs,
whereas talin amounts were normal (Fig. 1c). Pull-down experiments
with recombinant b1, b2 and b3 integrin cytoplasmic tails incubated
with platelet lysates showed a clear Kindlin-3 interaction with the b2
integrin cytoplasmic tail, although this binding was weaker compared
with binding of Kindlin-3 to b1 or b3 integrin cytoplasmic domains
(Fig. 1d). The cytoplasmic domain of b1 and b3 integrins contains two
NXXY (where X is any amino acid) motifs, whereas the b2 integrin tail
contains two NXXF motifs (Supplementary Fig. 2 online). To test
whether Kindlin-3 shares a similar spatial binding property on the
integrin b2 tail as on b1 and b3 integrin tails, we substituted each
phenylalanine residue in these motifs individually with an alanine
(F755A or F767A) and performed pull-down experiments. Kindlin-3
still bound to the F755A b2 integrin tail mutant but was unable to
interact with the F767A b2 integrin tail mutant (Fig. 1e), indicating
that the binding occurs at the distal NXXF motif and is spatially
conserved among all integrin tails tested so far. FACS analysis revealed
normal amounts of aL and slightly increased amounts of aM and b2
integrin subunits on Kindlin3–/– PMNs (Fig. 1f). Furthermore, the
expression of other surface receptors such as CD43, CD44 and
P-selectin glycoprotein ligand-1 was also not altered in the absence
of Kindlin-3 expression (Supplementary Fig. 3 online). Together
these data indicate that the absence of Kindlin-3 expression permits
the formation and maturation of PMNs. Similar to the granulocytosis
observed in individuals with LAD-I, LAD-II and LAD-III as well as in
b2 integrin–deficient mice
21, there is granulocytosis in Kindlin3–/–
chimeric mice, presumably due to a compensatory response to
impaired granulocyte number or function in tissues or both.
Next we tested whether b2 integrins can be activated in the absence
of Kindlin-3 by seeding Kindlin3–/– PMNs on glass surfaces coated
with intercellular adhesion molecule-1 (ICAM-1), the endothelial
counter-receptor for the leukocyte integrins aLb2 and aMb2 that are
crucial for tight adhesion and arrest of rolling PMNs on activated
endothelium. Untreated PMNs did not show substantial adhesion and
spreading (Fig. 2a), indicating that they were not activated during
their isolation. In the presence of phorbol-12-myristate-13-acetate
(PMA), a diacylglycerol analog triggering intracellular signaling events
leading to activation of integrins (‘inside-out’ signaling), PMNs from
Kindlin3+/+ chimeras rapidly adhered and spread on ICAM-1. In
contrast, adhesion and spreading of Kindlin3–/– PMNs on ICAM-1
was completely absent (Fig. 2a). To test whether the defect in b2
integrin activation in Kindlin3–/– PMNs is due specifically to a defect in
‘inside-out’ signaling, we used MnCl2 to induce b2 integrin activation.
We incubated PMNs in suspension with fluorescently labeled fibrino-
gen, a ligand for the aMb2 and avb3 integrins, and measured the extent
of fibrinogen binding by FACS. Notably, Kindlin3+/+ and Kindlin3–/–
PMNs bound comparable amounts of fibrinogen (Fig. 2b). Together,
these findings indicate that Kindlin-3 is a key player in the intracellular
signaling cascade leading to b2 integrin activation.
To corroborate the dependence of b2 integrin activation on
Kindlin-3, we measured PMN adhesion and spreading on immobi-
lized immune complexes, which is triggered by Fcg receptor–mediated
inside-out activation of aMb2 integrin and binding to the activated
complement component iC3b22. Whereas control PMNs adhered
strongly to immune complexes and approximately half of the adherent
PMNs spread, Kindlin-3–deficient PMNs adhered weakly to immune
complexes and did not spread (Fig. 2c,d). The adhesion of mutant
PMNs to immune complexes occurred in an Fcg receptor–dependent
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Figure 1 Characterization of PMNs in Kindlin3–/– chimeric mice.
(a) Peripheral blood smears from control and Kindlin3–/– chimeras. Scale
bar, 20 mm. (b) FACS profile of bone marrow–derived cells from control
and Kindlin3–/– chimeras stained for Gr-1–FITC and CD45.2 (Ly5.2)–
allophycocyanin. PMNs from the boxed area were sorted and used for all
in vitro experiments. (c) Western blot analysis of sorted PMNs from
Kindlin3+/+ and Kindlin3–/– chimeras showing talin and Kindlin-3
expression. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used
as a loading control. (d,e) GST fusions to b1, b2 and b3 (d) and b2, F755A
b2 and F767A b2 (e) integrin cytoplasmic domains were incubated with
platelet cell lysates and used in pulldown assays to assess the binding of
these integrin domains to talin and Kindlin-3. (f) Surface expression of aL,
aM and b2 integrins on PMNs from control and Kindlin3
–/– chimeras (black
lines show isotype controls; blue lines show Kindlin3+/+; green lines
show Kindlin3–/–).
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manner, as Fcg receptor blockage abolished Kindlin3–/– PMN cell
adhesion (Fig. 2c). Quantification of cell morphology after plating
revealed that around 60% of Kindlin3+/+ PMNs became flattened on
immobilized immune complexes, whereas no significant spreading
was observed with Kindlin3–/– PMNs (Fig. 2d). For closer inspection,
we followed PMNs contacting the immune complex–coated surfaces
with time-lapse video microscopy using differential interference con-
trast optics. Upon surface contact, Kindlin3+/+ PMNs spread within a
time frame of less than 1 min and subsequently remained flattened
and stationary with a ruffling periphery (Fig. 2e and Supplementary
Video 1 online). In sharp contrast, Kindlin3–/– PMNs showed severely
impaired spreading, despite active surface dynamics with peripheral
ruffling and occasional small lamellae that extended onto the surface
(Fig. 2e and Supplementary Video 1). To characterize spreading
behavior, we quantified the plasma membrane extension rates of
spreading PMNs by kymography. Spreading control PMNs rapidly
increased their diameters within 60 s after contacting the surface,
whereas the diameter of Kindlin3–/– PMNs remained unchanged
(Fig. 2f).
The spreading of preactivated PMNs on adhesive surfaces triggers a
b2 integrin–dependent degranulation and a respiratory burst that can
be measured as free reactive oxygen intermediates (ROIs). Therefore,
we seeded PMNs pretreated with tumor necrosis factor-a (TNF-a) on
immune complexes and quantified the kinetics of ROI release. In line
with findings from PMNs derived from b2 integrin–deficient mice
23
and subjects with LAD-I (ref. 24), Kindlin3–/– PMNs were completely
unresponsive, whereas Kindlin3+/+ cells showed a burst of ROI
(Fig. 2g). PMA treatment partially bypasses the adhesion dependency
of the reaction24. Accordingly, under PMA stimulation Kindlin3–/–
PMNs showed a considerable rescue of ROI production, indicating a
constitutive capability to undergo respiratory burst and confirming
the normal differentiation state of these cells (Fig. 2g).
To explore the consequences of abolished b2 integrin activation in
Kindlin3–/– chimeras, we studied leukocyte extravasation into the
perivascular tissue in vivo. Initially, we applied phorbol esters (croton
oil) to the ears of the mice and examined infiltration of PMNs into
perivascular tissue 4 h later by determining PMN distribution in
relation to the vascular basement membrane. In Kindlin3+/+ chimeric
mice, many Gr-1–positive cells transmigrated into the interstitium,
where they became evenly distributed (Fig. 3a). In contrast, in
Kindlin3–/– chimeric mice, Gr-1–positive cells were abolished com-
pletely absent from the perivascular tissue, but were visible within the
vasculature (Fig. 3a). We next investigated rolling, adhesion and
extravasation of PMNs from nonchimeric Kindlin3+/ÿ mice (as a
control) and from Kindlin3+/+ and Kindlin3–/– chimeric mice in
TNF-a–stimulated cremaster muscle venules. In line with the croton
oil experiment, Giemsa staining of treated cremaster tissues revealed a
strong and widespread influx of Kindlin3+/ÿ or Kindlin3+/+ PMNs into
the interstitium 3 hours after TNF-a application, whereas extravasa-
tion of Kindlin3–/– PMNs was markedly reduced (Fig. 3b). Together
these findings indicate that Kindlin3–/– chimeric mice suffer from a
considerable PMN extravasation deficiency as in individuals with
LAD-I, LAD-II or LAD-III.
To determine which step in the extravasation cascade is affected by
the absence of Kindlin-3, we analyzed leukocyte rolling and adhesion
in TNF-a–stimulated cremaster muscle venules of nonchimeric
Kindlin3+/ÿ mice and Kindlin3+/+ and Kindlin3–/– chimeric mice by
intravital microscopy. Microvascular parameters such as vessel dia-
meter, blood flow velocity and wall shear rate were similar among all
three types of mice (Supplementary Table 2 online), despite a
significant elevation of PMN counts in the peripheral blood of
Kindlin3–/– chimeric mice (P o 0.05). In line with previous observa-
tions25 and as shown here, TNF-a treatment markedly lowered
systemic leukocyte counts in Kindlin3+/ÿ mice and in Kindlin3+/+
chimeric mice (Supplementary Table 2). TNF-a–treatment in
Kindlin3–/– chimeric mice also decreased systemic leukocyte counts,
but these counts were significantly higher than in Kindlin3+/ÿ mice or
Kindlin3+/+ chimeric mice (Supplementary Table 2, P o 0.05).
In TNF-a–stimulated cremaster muscle venules of Kindlin3–/–
chimeric mice, the number of adherent leukocytes was significantly
reduced (220 ± 100 cells per mm2) when compared to Kindlin3+/ÿ
mice or Kindlin3+/+ chimeric mice (980 ± 90 cells per mm2 and
Figure 2 Functional properties of Kindlin3–/–
PMNs. (a) Adhesion of neutrophils to coated
ICAM-1. Control and Kindlin3–/– PMNs were
treated with or without PMA (n ¼ 4, each assay
was performed in triplicate). FOV, field of view.
(b) Fibrinogen binding of control and Kindlin3–/–
PMNs, as analyzed by flow cytometry. Cells were
incubated with either EDTA as a negative control
or with MnCl2. (c) Adhesion of PMNs on immune
complexes. Kindlin3+/+ and Kindlin3–/– PMNs
were plated on immune complexes (IC) in the
absence or presence of antibody to Fcg receptor
(Fc block) (n ¼ 3, each assay was performed in
triplicate). (d) Spreading of PMNs on immune
complexes. Kindlin3+/+ and Kindlin3–/– PMNs
were stimulated with TNF-a before plating.
Spreading was analyzed 10, 20 and 30 min after
plating (n ¼ 4). In a and d, graphs show means
± s.d.; Student’s t test was used for comparing
different datasets. (*, P o 0.05; **, P o 0.01;
***, P o 0.001). (e) Differential interference
contrast microscopy of Kindlin3+/+ and
Kindlin3–/– PMNs 20 min after plating on
immune complexes. Scale bar, 25 mm.
(f) Kymographs of a Kindlin3+/+ or a Kindlin3–/– PMN plated on immune complexes and imaged with differential interference contrast microscopy. Scale bar,
10 mm. (g) Oxidative burst after b2 integrin–mediated activation of PMNs. Sorted PMNs from Kindlin3
+/+ and Kindlin3–/– chimeras were stimulated with
either TNF-a or PMA and then the production of free ROIs was measured. Data are means ± s.d. of three independent experiments, each conducted in
triplicate. a.u., arbitrary units.
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1,220 ± 80 cells per mm2, respectively, P o 0.05 versus Kindlin3–/–
chimeric mice), indicating that Kindlin-3 is crucial for leukocyte
adhesion in vivo (Fig. 3c). Because leukocyte adhesion is greatly
influenced by the number of available circulating leukocytes, we also
calculated leukocyte adhesion efficiency, which is defined by the ratio
of adherent leukocytes to circulating leukocytes. Owing to the high
systemic leukocyte count in Kindlin3–/– chimeras, the adhesion
efficiency was dramatically reduced in Kindlin3–/– chimeric mice
(0.02 ± 0.01) when compared to Kindlin3+/ÿ mice or Kindlin3+/+
chimeric mice (0.25 ± 0.033 and 0.35 ± 0.03, respectively, P o 0.05
versus Kindlin3–/– chimeric mice; Fig. 3d).
Next, we analyzed leukocyte rolling in TNF-a–stimulated cremaster
muscle venules, which depends on P-selectin and E-selectin in this
model25. We observed a significant increase in the number of rolling
leukocytes in Kindlin3–/– chimeric mice (60 ± 16 cells per min) as
compared to Kindlin3+/ÿ mice or Kindlin3+/+ chimeric mice (12 ± 4
cells per min and 18 ± 3 cells per min, respectively, P o 0.05 versus
Kindlin3–/– mice; Fig. 3e and Supplementary Videos 2 and 3 online).
However, after correcting leukocyte rolling for differences in the total
number of systemic leukocytes (rolling flux fraction), we did not
observe any significant difference in rolling between Kindlin3+/+ and
Kindlin3–/– chimeric mice (Fig. 3f). We also analyzed mean leukocyte
Figure 3 Abrogated leukocyte adhesion
and extravasation in Kindlin3–/– chimeras.
(a) Sections of phorbol ester–treated ears from
Kindlin3+/+ and Kindlin3–/– chimeric mice,
stained with a pan-laminin antibody (green) to
visualize endothelial basement membranes and
Gr-1 (red) to visualize neutrophils. Arrowheads
indicate Gr-1–positive cells within blood vessels
of Kindlin3–/– chimeras. Scale bar, 200 mm.
(b) Quantification of perivascular leukocytes
in whole-mount Giemsa staining of TNF-a–
stimulated cremaster muscles from non-chimeric
Kindlin3+/– mice (15 venules in four mice),
Kindlin3+/+ (15 venules in four mice) and
Kindlin3–/– (21 venules in four mice) chimeras
3 h after cytokine application. Data are
means ± s.e.m. (c) Leukocyte adhesion in
TNF-a–stimulated cremaster muscle venules
assessed in 13 cremaster muscle venules of four
Kindlin3+/ÿ mice, 19 venules of six Kindlin3+/+
chimeric mice and 13 cremaster muscle venules
of four Kindlin3–/– chimeric mice. (d) Leukocyte
adhesion efficiency, given as the number of
adherent leukocytes per mm2 vascular surface area divided by the systemic leukocyte count. (e) Quantification of rolling leukocytes passing an imaginary
perpendicular line over the vessel in 1 min. (f) Leukocyte rolling flux fractions, calculated to account for differences in systemic leukocyte counts between
Kindlin3+/+ mice and Kindlin3–/– mice. All values are given as means ± s.e.m. Significant differences (P o 0.05) between groups are indicated by an asterisk.
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Figure 4 Leukocyte rolling and adhesion under
in vivo and in vitro conditions. (a,b) Mean
leukocyte rolling velocity (a) and the cumulative
frequency distribution (b) of leukocyte rolling
velocities from analysis of TNF-a–stimulated
postcapillary venules of cremaster muscles from
Kindlin3+/+ (n ¼ 54 venules from four mice) and
Kindlin3–/– (n ¼ 111 venules from four mice)
chimeric mice. (c) Top, quantification of
leukocyte rolling in an ex vivo flow chamber
system (P-selectin–coated microglass capillaries)
perfused with whole blood from Kindlin3+/+
(n ¼ 5 chambers from four mice) and Kindlin3–/–
(n ¼ 3 chambers from four mice) chimeric mice.
Bottom, the number of rolling leukocytes was
corrected for differences in systemic leukocyte
counts between Kindlin3+/+ and Kindlin3–/–
chimeric mice. WBC, white blood cell.
(d,e) Assessment of leukocyte adhesion (d) and
leukocyte rolling (e) in unstimulated cremaster
muscle venules of Kindlin3+/+ (n ¼ 4) and
Kindlin3–/– (n ¼ 3) chimeric mice before and
2 min after injection of the arrest chemokine
CXCL1. (f) b1 integrin–dependent adhesion
of leukocytes from Kindlin3+/+ (n ¼ 3) and
Kindlin3–/– chimeric mice (n ¼ 3) ex vivo. Flow chambers were coated with P-selectin only or a mixture of P-selectin, VCAM-1 and CCL2, connected to the
carotid artery, perfused with whole blood for 10 min, and the number of adhered PMNs and mononuclear cells was counted. For each condition, chambers in
at least three mice were used. All data are shown as means ± s.e.m.; significant differences (P o 0.05) are indicated by asterisk.
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rolling velocities and cumulative frequency distribution of leukocyte
rolling velocities and found that they were similar in Kindlin3+/+ and
Kindlin3–/– chimeric mice, suggesting that selectin-mediated rolling is
not disturbed in the absence of Kindlin-3 (Fig. 4a,b). This was further
confirmed in an ex vivo flow chamber assay26, where leukocyte rolling
on immobilized recombinant mouse (rm) P-selectin was indistin-
guishable between leukocytes from Kindlin3+/+ and Kindlin3–/– chi-
meric mice after correction for differences in systemic leukocyte
counts (Fig. 4c). To further confirm the in vivo leukocyte adhesion
defect of Kindlin3–/– chimeric mice, we blocked leukocyte rolling in
TNF-a–stimulated cremaster muscle venules by systemic injection of
blocking antibodies against P- and E-selectin during intravital micro-
scopic observation. The blocking antibodies abruptly abolished leu-
kocyte rolling in Kindlin3+/ÿ mice and in Kindlin3+/+ and Kindlin3–/–
chimeric mice as previously described for wild-type mice27. Five
minutes after antibody injection, a substantial number of adherent
leukocytes were still present in Kindlin3+/ÿ mice and in Kindlin3+/+
chimeric mice (940 ± 80 cells per mm2 and 1,070 ± 90 cells per mm2,
respectively, data not shown), whereas only a few adherent leukocytes
were observed in Kindlin3–/– chimeric mice (230 ± 50 cells per mm2,
data not shown; Supplementary Videos 4 and 5 online). Taken
together, these data indicate that Kindlin-3 is not required for leukocyte
rolling on inflamed endothelium but is essential for their firm adhesion.
To investigate whether Kindlin-3 is also required for chemokine-
induced leukocyte arrest in vivo, we systemically injected the
neutrophil arrest–inducing chemokine CXCL1 (also known as kerati-
nocyte-derived chemokine, KC)25 into Kindlin3+/+ and Kindlin3–/–
chimeric mice and observed leukocyte adhesion and rolling. CXCL1
injection into Kindlin3+/+ mice triggered a significant increase in the
number of adherent leukocytes in postcapillary venules of the exteriori-
zed cremaster muscle, which was accompanied by a marked drop in the
number of rolling leukocytes (Fig. 4d,e and Supplementary Video 6
online). In contrast, injection of CXCL1 into Kindlin3–/– chimeric
mice did not change leukocyte adhesion and rolling (Fig. 4d,e and
Supplementary Video 7 online), showing that chemokine-triggered
leukocyte arrest is also almost completely absent in Kindlin3–/– mice.
Finally, we addressed the role of Kindlin-3 in b1 integrin–mediated
leukocyte adhesion with an autoperfused flow chamber assay26.
Chambers were coated with a mixture of rmP-selectin, rm vascular
cell adhesion molecule-1 (VCAM-1) and rmCCL2 or with rmP-
selectin only and connected to the carotid artery of Kindlin3+/+ or
Kindlin3–/– chimeric mice. Leukocyte adhesion was assessed 10 min
after the start of perfusion with whole blood. In Kindlin3+/+ chimeric
mice, mononuclear cells adhered preferably to the surface coated
with all three proteins compared to the surface coated with rmP-
selectin only, for which adhered cells were almost completely absent
(Fig. 4f). In contrast, in Kindlin3–/– chimeric mice, leukocytes failed to
adhere to the surface coated with all three proteins (Fig. 4f), suggest-
ing that Kindlin-3 is crucial for b1 integrin– and b2 integrin–
dependent adhesion.
Our study demonstrates that Kindlin-3 is essential for the activation
of b2 integrins in PMNs. Consequently, lack of Kindlin-3 expression
prevents adhesion and spreading of PMNs on b2 integrin ligands such
as ICAM-1 and iC3b and results in a severe leukocyte adhesion
deficiency in vivo. The mechanism underlying Kindlin-3–mediated
activation b2 integrin is similar to that underlying its activation of the
b1 and b3 integrins, as Kindlin-3 is capable of binding the distal NXXF
motif of the b2 integrin cytoplasmic domain, albeit with a lower
efficiency than its binding to this motif in the b1 and b3 integrins.
The defects seen in Kindlin3–/– mice—a severe leukocyte adhesion
deficiency and fatal bleeding—bear a striking similarity to the
symptoms observed in individuals with LAD-III. Furthermore, the
gene defect causing LAD-III has been mapped to chromosome 11 in
humans, where the Kindlin3 gene is located. Kindlin3 is thus a prime
candidate to be mutated in LAD-III. However, a recent study identified
a mutation in the CALDAGGEF1 gene, which encodes a RAP-1
guanine exchange factor, to cause LAD-III (ref. 11). Notably, Svensson
et al.13 report in this issue that subjects with LAD-III who have
mutations in CALDAGGEF1 also carry nonsense mutations in their
Kindlin3 gene. Furthermore, reexpression of a Kindlin3 cDNA fully
rescued the adhesion and spreading defect in leukocytes from these
subjects. In contrast, reexpression of CALDAGGEF1 did not rescue
these defects. It will be useful now to clarify whether mutations in
different genes such as CALDAGGEF1 and Kindlin3 can indeed give
rise to the same LAD-III syndrome and how and where they function
in the signaling pathway that leads to b2 integrin activation. Studies
with mouse mutants suggest that deficiencies of either protein can lead
to a LAD-like phenotype2,12, although CALDAG-GEF1-deficient mice
seem to have slightly milder defects than those lacking Kindlin-3. The
reason for this difference could be that Kindlin-3 controls both inside-
out and ‘outside-in’ signaling of integrins2, whereas CALDAG-GEF1
has a role only in Rap-mediated inside-out integrin activation11.
METHODS
Generation of fetal liver cell chimeras. We recently generated Kindlin3-
deficient mice2. We obtained fetal liver cells from embryonic day 15
Kindlin3+/+ or Kindlin3–/– embryos by pushing liver tissue through a cell
strainer (Falcon). We injected 4  106 cells into the tail vein of lethally
irradiated (10 Gy) recipient C57BL/6 mice (Charles River Laboratories). Four
to five weeks after transfer, we either isolated PMNs from the bone marrow or
used the mice for intravital microscopy. All mouse experiments were performed
with approval by the District Government of Upper Bavaria.
Intravital microscopy.We injected rmTNF-a (R&D Systems) intrascrotally at a
dose of 500 ng per mouse in a volume of 0.3 ml sterile saline. Two hours later,
we anesthetized the mice as previously described25 and placed them onto a
heating pad to maintain body temperature at 37 1C. After intubation and
carotid artery cannulation for blood sampling and application of antibodies
and chemokines, we surgically prepared the cremaster muscle for intravital
microscopy as previously described28. Briefly, after opening the scrotum, we
exteriorized the cremaster muscle and spread it over a cover glass. We gently
moved the epididymis and testis aside to get microscopic access to the
cremaster muscle microcirculation and its postcapillary venules. We performed
intravital microscopy on an upright microscope (Olympus BX51) with a saline
immersion objective (40 and 0.8 numerical aperture). We recorded experi-
ments via CCD camera (model CF8/1, Kappa) on a Panasonic S-VHS recorder.
We also made recordings with a digital camera (LaVision Biotech) and stored
them on a computer with Imspector software package (LaVision Biotech). We
then used the digital recordings offline to generate movie clips with ImageJ
software (US National Institutes of Health). During the experiment, we
obtained systemic blood samples (10 ml into 90 ml Türck’s solution, Merck)
to assess systemic white blood cell counts. In some experiments, we stimulated
the postcapillary venules of the exteriorized cremaster muscle by systemic
injection of keratinocyte-derived chemokine (CXCL1, 600 ng per mouse,
Natutec) and assessed leukocyte rolling and adhesion before and 2 min after
injection of CXCL1 as previously described25.
Data analysis of intravital experiments. We measured vessel diameter and
vessel segment length of postcapillary venules with a digital image processing
system29. We obtained centerline red blood cell velocities in microvessels of the
cremaster muscle by a dual photodiode and a digital on-line cross-correlation
program (Circusoft Instrumentation), and we converted them offline to mean
blood flow velocities as previously described28. We assessed wall shear rates as
previously reported30. We defined rolling flux as the number of rolling cells per
min. We defined rolling PMN flux fraction as the percentage of rolling PMNs in
all PMNs passing the same vessel in 1 min28. We considered PMNs that did not
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move for more than 30 s to be adherent. We assessed the number of adherent
leukocytes as the number of adherent cells per mm2 vessel surface area25.
Whole-mount histology. To assess extravasated leukocytes in TNF-a–
stimulated cremaster muscles, we prepared whole mounts of cremaster muscles
as previously described25. Briefly, while the cremaster muscle was still mounted
on the stage for intravital microscopy, we fixed the tissue with 4% parafor-
maldehyde in 0.1 M phosphate buffer (pH 7.4). We removed the cremaster
muscle and mounted it flat on a superfrost glass slide (Menzel), air-dried it for
5ÿ10 min and fixed it in 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4) for 24 h at 4 1C. After fixation, we washed the tissue three times in
0.1 M phosphate buffer with 5% ethanol, stained it with Giemsa (Sigma) at
20 1C for 5 min and developed it in 0.01% acetic acid for contrast. We washed
the developed slides in water, 75% ethanol, 95% ethanol, 100% ethanol and
fresh xylene and then mounted them in mounting medium (AGAR Scientific).
We assessed the number of extravasated leukocytes in Giemsa-stained cremaster
muscles with a Zeiss upright microscope and a 100 and 1.3 numerical
aperture oil immersion objective (Zeiss).
Ex vivo flow chamber assay. We used an autoperfused flow chamber assay as
previously described26. Briefly, we used rectangular microglass capillaries
(VitroCom) as flow chambers. We coated the flow chambers with rmP-selectin
(20 mg mlÿ1, R&D Systems), rmCCL2 (3 mg mlÿ1, Natutec) and rmVCAM-1
(15 mg mlÿ1, R&D Systems). We blocked nonspecific binding by incubating the
flow chambers with 10% casein (Sigma) for 2 h at 20 1C. After blocking, we
rinsed the flow chambers with normal saline and connected them to the mouse
carotid artery via polyethylene tubing. We fixed the flow chamber itself under
an upright fluorescence microscope (BX51 WI, Olympus) with a saline
immersion objective (20 and 0.95 numerical aperture, Olympus). We
observed rolling of leukocytes within the flow chamber for 10 min and
recorded their rolling via a charge-coupled device camera system (CF8HS;
Kappa) on a Panasonic S-VHS recorder. We assessed leukocyte adhesion after a
10-min perfusion by counting adherent mononuclear cells and neutrophils in a
10-mm flow chamber segment; the adherent cells were stained by gentle
flushing of the chamber with Türck’s stain (Merck).
Statistical analyses. We performed statistical analyses was with the GraphPad
Prism software (version 5.00, GraphPad). Data are presented as means ± s.d. or
means ± s.e.m. We used unpaired Student’s t tests or one-way analysis of
variance followed by a multiple pairwise comparison test (Dunn’s test) as
appropriate to compare datasets. Asterisks indicate significant differences
(*, P o 0.05, **, P o 0.01 and ***, P o 0.005).
Additional methods. Detailed methodology is described in the Supplementary
Methods online.
Note: Supplementary information is available on the Nature Medicine website.
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Supplementary Video 1 
 
Cell spreading on immobilized immune complexes. Spreading of Kindlin3+/+ and 
Kindlin3-/- PMNs was observed by differential interference contrast microscopy. 
 
Supplementary Video 2 
 
Leukocyte rolling and adhesion in control fetal liver cell chimeras. Intravital 
transillumination microscopy was used to visualize leukocyte rolling and adhesion in 
TNF- -stimulated cremaster muscle venules of Kindlin3+/+ chimeric mice. Note the 
abundance of leukocytes firmly adherent on the inflamed endothelium and the rather 
low number of rolling leukocytes.
 
Supplementary Video 3 
 
Leukocyte rolling and adhesion in Kindlin3-/- fetal liver cell chimeras. Leukocyte 
rolling and adhesion in TNF- -stimulated cremaster muscle venules of Kindlin3-/- mice 
was observed by intravital microscopy. Due to the severe adhesion defect in  
Kindlin3-/- mice, leukocyte adhesion is rare while many rolling leukocytes are seen. 
 
Supplementary Video 4 
 
Leukocyte adhesion in Kindlin3+/+ fetal liver cell chimeras after blocking 
leukocyte rolling. Leukocyte adhesion was recorded in TNF- -stimulated cremaster 
muscle venules of Kindlin3+/+ chimeric mice five minutes after injection of  
anti-E-selectin blocking mAb 9A9 and anti-P-selectin blocking mAb RB40.34. 
Leukocyte rolling is completely absent, while a significant number of leukocytes is still 
firmly adherent on the inflamed endothelium. 
 
Supplementary Video 5 
 
Leukocyte adhesion in Kindlin3-/- fetal liver cell chimeras after blocking 
leukocyte rolling. Five minutes after systemic injection of anti-E-selectin blocking 
mAb 9A9 and anti-P-selectin blocking mAb RB40.34 into Kindlin3-/- chimeric mice, 
leukocyte rolling was completely blocked in TNF- -stimulated cremaster muscle 
venules. In contrast to Kindlin3+/+ chimeric mice, leukocyte adhesion is almost 
completely absent in Kindlin3-/- chimeras illustrating the crucial role of Kindlin-3 for 
firm leukocyte adhesion. 
 
Supplementary Video 6 
 
Chemokine-induced leukocyte arrest in Kindlin3+/+ fetal liver cell chimeras 
following systemic injection of CXCL1. Leukocyte adhesion and rolling was 
recorded before, during, and after injection of 600 ng CXCL1. Application of CXCL1 
(indicated by the appearance of a white square) into Kindlin3+/+ mice led to a 
significant increase in leukocyte adhesion accompanied by a dramatic drop in 
leukocyte rolling. 
 
Supplementary Video 7 
 
Chemokine-induced leukocyte arrest in Kindlin3-/- fetal liver cell chimeras 
following systemic injection of CXCL1. In contrast to Kindlin3+/+ mice, leukocyte 
adhesion and rolling in Kindlin3-/- mice were similar before, during (indicated by the 
white square), and after injection of 600 ng CXCL1 demonstrating that Kindlin-3 is 
essential in mediating chemokine-triggered firm leukocyte arrest in vivo. 
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Introduction
Integrins are /  heterodimeric cell surface receptors that bind 
extracellular matrix proteins and cell counter receptors. A hall-
mark of integrins is their ability to reversibly shift between dif-
ferent af"nity states for their ligands. The shift from an inactive 
to an active conformation is triggered by the direct binding of 
talin and kindlin to the cytoplasmic domains of 1, 2, and 
3 integrins, and is called integrin inside-out signaling (Moser 
et al., 2009b). Active integrins recruit and assemble large 
multimolecular complexes at their short cytoplasmic domains 
controlling several cellular processes such as organization of 
the cytoskeleton, migration, proliferation, differentiation, and 
apoptosis (integrin outside-in signaling; Legate et al., 2009).
Kindlins are a family of evolutionary conserved, intra-
cellular FERM (4.1, ezrin, radixin, moesin) domain–containing 
proteins that are recruited to integrin adhesion sites (Moser 
et al., 2009b). Mammals have three members, called kindlin-1, 
-2, and -3. In contrast to the widely expressed kindlin-1 and 
-2, kindlin-3 expression is restricted to hematopoietic cells 
(Weinstein et al., 2003; Ussar et al., 2006). The importance 
of kindlin-3 for integrin activation in vivo was "rst described 
in kindlin-3–de"cient mice, which suffer from bleeding and 
leukocyte adhesion defects (Moser et al., 2008, 2009a). Fur-
ther cellular and molecular analyses of mouse and human 
blood cells revealed that kindlin-3 is required for activation 
of IIb 3 on platelets and 2 integrins on leukocytes (Moser 
et al., 2009b). Based on these "ndings, several groups identi-
"ed mutations in the human kindlin-3 gene in patients with 
leukocyte adhesion de"ciency (LAD) type III syndrome, which 
T
he blood cell–specific kindlin-3 protein is required 
to activate leukocyte and platelet integrins. In line 
with this function, mutations in the KINDLIN-3 gene 
in man cause immunodeficiency and severe bleeding. 
Some patients also suffer from osteopetrosis, but the under-
lying mechanism leading to abnormal bone turnover 
is unknown. Here we show that kindlin-3–deficient mice 
develop severe osteopetrosis because of profound adhe-
sion and spreading defects in bone-resorbing osteoclasts. 
Mechanistically, loss of kindlin-3 impairs the activation of 
1, 2, and 3 integrin classes expressed on osteoclasts, 
which in turn abrogates the formation of podosomes and 
sealing zones required for bone resorption. In agreement 
with these findings, genetic ablation of all integrin classes 
abolishes the development of podosomes, mimicking 
kindlin-3 deficiency. Although loss of single integrin 
classes gives rise to podosomes, their resorptive activity is 
impaired. These findings show that osteoclasts require 
their entire integrin repertoire to be regulated by kindlin-3 
to orchestrate bone homeostasis.
Kindlin-3–mediated signaling from multiple  
integrin classes is required for osteoclast-mediated 
bone resorption
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Results
Kindlin-3–deficient mice develop  
severe osteopetrosis
Kindlin-3–de"cient (kindlin-3 / ) mice die a few days after 
birth because of a severe anemia caused by massive bleeding 
and erythrocyte defects (Krüger et al., 2008; Moser et al., 2008). 
To analyze whether kindlin-3 affects bone development, we 
performed histology and peripheral quantitative computer to-
mography (pQCT) on long bones from kindlin-3 /  mice. At 
postnatal day 4 (P4), kindlin-3 /  bones showed a signi"cant 
increase in trabecular bone accompanied by a marked decrease 
in bone marrow (Fig. 1 A). Van Kossa staining showed increased 
calci"ed bone (Fig. 1 B). pQCT analysis con"rmed a signi"cant 
increase in bone mineral density (BMD; Fig. 1 C). Bone surface 
as determined by static histomorphometry was markedly increased 
in the absence of kindlin-3 (Fig. 1 D).
To de"ne the onset of the osteopetrosis, we compared 
the histology of control and mutant long bones from different 
developmental stages. At embryonic day 14 (E14), long bones 
from kindlin-3 /  embryos showed normal primary ossi"ca-
tion centers surrounded by a normal coat of membranous bone 
(Fig. S1 A). At E16, kindlin-3 /  bones displayed increased 
ossi"cation, and at birth, the bone mass further increased at the 
expense of the bone marrow cavity (Fig. S1 A). Alkaline phos-
phatase (AP) staining of osteoblasts and tartrate-resistant acid 
phosphatase (TRAP)-positive osteoclasts did not signi"cantly 
differ between control and mutant bones at E14, E16, and P1 
(Fig. S1, A and B).
Loss of kindlin-3 leads to severe  
osteoclast dysfunction
It has been proposed that a dysfunction of osteoblasts is respon-
sible for increased bone density in LAD-III patients (Malinin 
et al., 2009). To test whether this is also the case in kindlin-3 /   
mice, we performed histomorphometric analysis, which showed 
normal osteoblast numbers per unit of bone surface in kindlin-3 /  
bones (Fig. S2 A). Calvaria-derived osteoblasts isolated from 
wild-type and kindlin-3 /  pups revealed comparable levels of 
gene expression for osteoblastic markers such as AP, osteocalcin, 
and collagen I as well as normal AP activity (Fig. S2, B, D, and E). 
Furthermore, the generation of mineralized bone nodules in vitro 
was similar in osteoblasts from both genotypes. (Fig. S2, F–H). Fi-
nally, and in line with the normal biological activity of kindlin-3 /  
osteoblasts, wild-type osteoblasts expressed kindlin-2 but neither 
kindlin-3 nor kindlin-1 (Fig. S2 C).
To determine whether osteoclasts are defective, we per-
formed TRAP staining and histomorphometric measurements 
of P4 kindlin-3 /  bones, which revealed that the number of 
TRAP-positive osteoclasts per bone surface was signi"cantly 
increased by more than threefold (Fig. 1, E and F). Despite the 
elevated number of osteoclasts, the surface covered by osteo-
clasts was signi"cantly decreased in kindlin-3 /  bones (Fig. 1 G). 
Consistent with the failure to erode bone, Ca2+ levels in the serum 
of kindlin-3 /  mice were signi"cantly decreased (Fig. 1 H), 
and parathyroid hormone (PTH) levels were increased (Fig. 1 I). 
Indeed, cultured osteoclasts differentiated from wild-type blood 
is characterized by recurrent bacterial and fungal infections 
and severe bleeding (Kuijpers et al., 2009; Malinin et al., 2009; 
Moser et al., 2009a; Svensson et al., 2009). In addition to 
the severe platelet and leukocyte dysfunction, increased bone 
mass was observed in several LAD-III patients (Kilic and 
Etzioni, 2009; McDowall et al., 2010; Sabnis et al., 2010). It 
was recently proposed that the osteopetrosis is caused by in-
creased osteogenic potential of mesenchymal stem cells (Malinin 
et al., 2009).
Bone remodeling depends on a tight interplay of osteo-
blasts that form bone and osteoclasts that resorb bone. 
Osteoblasts are derived from mesenchymal stem cells and 
cluster their integrins in adhesion sites termed focal adhe-
sions (FAs). Osteoclasts are large, multinucleated cells that 
derive from the monocyte lineage and arrange their integrins 
in adhesion structures called podosomes. Podosomes con-
tain a dotlike core of actin "laments, which is perpendicu-
larly oriented to the plasma membrane and surrounded by 
a ringlike arrangement of adhesion, adaptor, and signaling 
molecules such as integrins, paxillin, vinculin, talin, protein 
kinases, and actin-associated molecules (Linder and Kopp, 
2005). Podosomes are found in all cells of the monocytic 
cell lineage (macrophages, dendritic cells, etc.), smooth mus-
cle cells, endothelial cells, src-transformed "broblasts, and 
certain epithelial cells (Linder and Aepfelbacher, 2003). Bone-
resorbing osteoclasts arrange their podosomes by interconnect-
ing the actin cytoskeleton into densely packed rings called 
sealing zones. They delineate the active sites of bone re-
sorption and form a pocket, into which protons and bone-
resorbing proteases are secreted (Luxenburg et al., 2007). 
Sealing zones are attached to the bone matrix via v 3 inte-
grin. Although mature osteoclasts express integrins of the 1, 2, 
and v families, it is believed that v 3 integrins are the major 
adhesion proteins in osteoclast biology. This observation is 
largely based on the matrix degradation defects observed in 
Glanzmann patients or mice carrying null mutations in the 3 
integrin gene. The reduced resorptive activity was thought to 
be caused by loss of v 3-mediated signaling that regulates 
cell polarity and cytoskeletal reorganization (McHugh et al., 
2000; Faccio et al., 2003a). It cannot be excluded, however, 
that 1 and/or 2 integrins also play a role in osteoclast-
mediated bone resorption in vivo (Helfrich et al., 1996; Rao 
et al., 2006).
Increased bone mineralization has been proposed to be 
the cause for the osteopetrosis in LAD-III patients (Malinin 
et al., 2009). It remains unclear, however, whether loss of 
kindlin-3 is indeed responsible for the increased bone mass and 
whether this bone abnormality is caused by an osteoblast and/or 
osteoclast dysfunction. In this paper, we "nd that kindlin-3– 
de"cient mice develop a severe osteopetrotic phenotype 
caused by osteoclast dysfunctions. We show that kindlin-3–
de"cient osteoclasts fail to activate all their integrin classes, 
which in turn leads to their inability to spread and reorganize 
the actin cytoskeleton, as well as a failure to form podosomes 
and sealing zones and to degrade bone matrix. Our results 
indicate that all integrin classes are required for osteoclast- 
mediated bone resorption.
885Kindlin-3 controls osteoclast integrins • Schmidt et al.
osteoprotegerin (OPG), an inhibitor of RANKL, were similar be-
tween wild-type and kindlin-3 /  mice. Treatment of kindlin-3 /  
osteoclasts with RANKL in vitro induced a strong and sustained 
p38 and JNK phosphorylation that was comparable to wild-type 
osteoclasts (Fig. S3). The high levels of RANKL in the serum and 
the normal response to RANKL by kindlin-3 /  osteoclasts pro-
vides a plausible explanation for the increased osteoclastogenesis 
in kindlin-3 /  bones.
M-CSF and RANKL treatment induced the expression of 
osteoclastogenic markers such as cathepsin K, MMP9, and cal-
citonin receptor in wild-type and kindlin-3 /  fetal liver cells 
(Fig. 2 B). Even though induction of marker gene expression 
was slightly delayed in kindlin-3 /  cells, they nevertheless 
reached wild-type levels 6 d after cytokine treatment (Fig. 2 B). 
It should be noted that the expression of kindlin-3 remained 
stable throughout the differentiation period, and that kindlin-1 
and -2 were expressed in neither wild-type nor kindlin-3 /  cells 
upon cytokine treatment (Fig. 2 C).
Finally, we determined the number of nuclei in the osteo-
clasts as a marker for pre-osteoclast fusion and differentiation. 
Notably, in vitro generated kindlin-3 /  osteoclasts showed a 
lower tendency to form larger (>20 nuclei) polykaryons (Fig. 2 D), 
presumably because of decreased adhesion and cell spread-
ing; however, a signi"cant shift toward more multinucleated 
osteoclasts was detected in bone sections from kindlin-3 /  
mice (Fig. 2 E). This discrepancy can be explained by the in-
creased number of osteoclast precursors triggered by the ele-
vated RANKL levels in kindlin-3 /  mice.
precursors expressed high levels of kindlin-3 but neither 
kindlin-1 nor -2 (Fig. 2 B and Fig. S2 C).
These data suggest that kindlin-3 /  osteoclasts are func-
tionally impaired. To address this "nding, we tested the resorp-
tive activity of kindlin-3 /  osteoclasts by seeding them on an 
arti"cial calci"ed matrix (osteologic slides) as well as dentin 
discs. Although wild-type osteoclasts resorbed large areas of 
mineralized matrix, kindlin3 /  osteoclasts were incapable of 
doing so (Fig. 1 J and not depicted). Morphometric image analy-
sis of the resorbed areas revealed that resorption by kindlin-3 /   
osteoclasts was >20-fold lower than wild-type cells (Fig. 1 K). 
The profound resorption defects were not accompanied by dimin-
ished secretion of proteolytic enzymes, as secretion of matrix 
metalloproteinase 2 (MMP2) and -9 and cathepsin K activities 
were indistinguishable between control and kindlin-3 /  osteo-
clasts (Fig. 1, L and M).
Altogether, these "ndings indicate that osteopetrosis in 
kindlin-3 /  mice is caused by a dysfunction of osteoclasts 
rather than osteoblasts.
Kindlin-3 is not required for  
osteoclast differentiation
Osteoclasts originate from monocytic precursors in response to the 
actions of macrophage-colony stimulating factor (M-CSF) and re-
ceptor activator of nuclear factor B ligand (RANKL; Teitelbaum 
and Ross, 2003). Although the serum levels of M-CSF were similar 
(unpublished data), circulating levels of RANKL were increased 
eightfold in kindlin-3 /  mice (Fig. 2 A). Serum concentrations of 
Figure 1. Kindlin-3 /  mice develop severe osteopetrosis. (A and B) Histology of tibiae of P4 wild-type and kindlin-3 /  mice stained with hematoxylin 
and eosin (A) and van Kossa (B). (C and D) Quantitative peripheral computer tomography measurements determining bone mineral density (C) and histo-
morphometric analysis to determine bone surface from bones of P4 wild-type and kindlin-3 /  mice (D); n = 3. (E) Histology of tibiae of P4 wild-type and 
kindlin-3 /  mice stained for TRAP activity. (F and G) Histomorphometric analyses determining the number of osteoclasts (F) and surface covered by osteo-
clasts (G) of wild-type and kindlin-3 /  mice; n = 3. (H) Ca2+ levels in serum of P4 wild-type and kindlin-3 /  mice; n = 8. (I) PTH levels in plasma of P3 
wild-type and kindlin-3 /  mice; n = 10. (J and K) Resorption pits (J) and their quantification (K) of wild-type and kindlin-3 /  osteoclasts cultured on calcium 
apatite coated slides; n = 7. (L) Zymography of cell culture supernatants from primary wild-type and kindlin-3 /  osteoclasts. (M) Cathepsin K activity from 
lysates of primary wild-type and kindlin-3 /  osteoclasts; n = 11. Data are presented as mean ± SD (error bars). P-values indicate significant differences 
from wild-type (Student’s t test). n.s., not significant. Bars: (A and B) 250 µm; (E, top) 250 µm; (E, bottom) 25 µm; (J) 100 µm.
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decreases during osteoclast maturation, and 4 1, 5 1, 
and L 2 were similar in wild-type and kindlin-3 /  cells; 
however, M 2 was reduced to 80% in kindlin-3 /  cells. 
(Fig. 3 B and Fig. S4 C). Next, we addressed the af"nity states 
of integrins by determining the binding of the 9EG7 antibody, 
which recognizes activated mouse 1 integrins, and the binding 
of a $uorescently labeled FN fragment (FNIII7-10), which is 
bound by active v ( v 3 and v 5) and 5 1 integrins. Rest-
ing kindlin-3 /  macrophages failed to bind 9EG7 and showed 
considerably reduced FNIII7-10 binding, whereas MnCl2 treat-
ment, which can bypass inside-out–mediated integrin activa-
tion, markedly increased 9EG7 and FNIII7-10 binding (Fig. 3, 
C and D). Furthermore, adhesion to ICAM-1, a ligand for 2 
integrins, was strongly diminished in kindlin-3 /  macrophages 
compared with control cells (Fig. 3 E). Manganese treatment 
only partially rescued the adhesion defect of kindlin-3 /  cells, 
which suggests that kindlin-3 also operates in integrin outside-
in signaling.
Collectively, these data indicate that loss of kindlin-3 re-
sults in a severe adhesion defect caused by impaired activation 
and outside-in signaling of 1, 2, and v integrins.
Osteoclasts require kindlin-3 for integrin 
and growth factor signaling
Biochemical signaling events triggered by integrins and growth 
factor receptors control osteoclast adhesion, spreading, fusion, 
and differentiation (Ross and Teitelbaum, 2005). Wild-type 
osteoclasts generated from fetal liver cells differentiated into 
well-spread, multinucleated osteoclasts within 4–6 d of culture 
(Fig. 4 A). In contrast, kindlin-3 /  fetal liver cells, which also 
Altogether, these data suggest that although osteoclast 
differentiation is slightly delayed in the absence of kindlin-3 
in vitro, it occurs ef"ciently in kindlin-3 /  mice.
Kindlin-3 promotes osteoclast adhesion by 
regulating integrin activation
Kindlin-3 is required for the activation of integrins and integrin-
mediated adhesion (Moser et al., 2008, 2009a). To evalu-
ate osteoclast adhesion, we seeded wild-type and kindlin-3 /  
osteoclasts on osteopontin, a natural ligand for osteoclasts. 
Although wild-type osteoclasts adhered readily to osteopontin, 
kindlin-3 /  osteoclasts showed signi"cantly reduced adhesion 
(Fig. 3 A). Interestingly, kindlin-3 /  osteoclasts adhered to 
both glass and cell culture plastic, particularly when cultured 
over several days. Because the transmembrane proteoglycan 
CD44 has also been shown to support osteoclast adhesion to 
osteopontin, "bronectin, collagen, and laminin (Goodison et al., 
1999; Ponta et al., 2003), we hypothesized that CD44 might 
mediate the remaining osteoclast adhesion in the absence of 
kindlin-3. To test this hypothesis, we incubated pre-osteoclasts 
with a blocking anti-CD44 antibody and observed that the 
adhesion of kindlin-3 /  cells to "bronectin was further re-
duced, which indeed indicates that CD44 contributes to osteoclast 
adhesion (Fig. S4, A and B).
To determine integrin expression, we measured their 
levels on macrophages, as the large size and strong adhesive 
properties of mature osteoclasts prevented their analysis by $ow 
cytometry. Indeed, kindlin-3 /  macrophages express 76% 
and 63% of 1 and 3 integrins, respectively, when compared 
with wild-type macrophages. The expression of v 5, which 
Figure 2. Differentiation of kindlin-3 /  osteoclasts. (A) RANKL/OPG ratio in plasma of P3 wild-type and kindlin-3 /  mice; n = 11. (B) RT-PCR of osteo-
clastogenic markers upon M-CSF and RANKL treatment of wild-type and kindlin-3 /  fetal liver cells. (C) RT-PCR of kindlin-1 and -2 expression during 
in vitro osteoclast differentiation. RNA from keratinocytes served as positive control. (D) Number of nuclei per osteoclast 5 d after induction of differentiation; 
1,004 cells of each genotype obtained from five independent experiments were analyzed. (E) Osteoclast nuclear numbers determined from histological 
sections of P4 tibiae. 63 and 252 osteoclasts from wild-type and kindlin-3 /  bone sections were analyzed, respectively. Data are presented as mean ± SD 
(error bars). P-values indicate significant differences from wild-type (Student’s t test).
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osteoclasts. Notably, expression of integrin-binding mutant 
EGFP–kindlin-3 (EGFP–kindlin-3–QA; Moser et al., 2008) did 
not rescue osteoclast spreading, whereas fusion signi"cantly 
improved compared with cells infected with a control virus 
(Fig. S5, A and B).
Next, we analyzed whether integrin-mediated adhesion 
signaling can still occur in the absence of kindlin-3. Adhesion 
on vitronectin triggered phosphorylation of c-Src and focal ad-
hesion kinase (FAK) in wild-type pre-osteoclasts, but induced 
only a weak phosphorylation in kindlin-3 /  pre-osteoclasts 
produced multinucleated TRAP-positive cells, failed to spread 
(Fig. 4 A). Phalloidin staining showed an actin belt beneath the 
plasma membrane of control osteoclasts, whereas kindlin-3 /  
osteoclasts displayed randomly distributed actin patches in their 
cytoplasm (Fig. 4 B). Mn2+-mediated activation of integrins 
was unable to improve the spreading defect, suggesting that 
kindlin-3 is also required for integrin outside-in signaling, 
which is central in organizing the osteoclast cytoskeleton (un-
published data). Retroviral expression of EGFP–kindlin-3 into 
kindlin-3 /  fetal liver cells rescued the formation of well-spread 
Figure 3. Integrin defects in kindlin-3 /  osteoclasts. (A) Adhesion of primary wild-type and kindlin-3 /  osteoclasts to osteopontin. Number of adherent 
cells per field of view (FOV) is shown. (B) Surface expression of 1, 3, 5, and V integrins on wild-type (green) and kindlin-3 /  (red) macrophages. Iso-
type control staining is shown in dark blue. Numbers above graphs indicate integrin expression on kindlin-3 /  cells (mean ± SD) relative to wild-type cells 
(n = 6). (C) 9EG7 binding on wild-type and kindlin-3 /  macrophages in the presence or absence of 2 mM MnCl2. (D) Binding of Alexa Fluor 647–labeled 
FNIII7-10 by wild-type and kindlin-3 /  macrophages in the presence or absence of 3 mM MnCl2. Data show mean ± SD of four independent experiments 
and were subtracted by background binding of the isotype and EDTA control, respectively. (E) Wild-type and kindlin-3 /  macrophages plated on ICAM-1 
in the presence or absence of 1 mM MnCl2. P-values indicate significant differences from wild-type (Student’s t test).
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on glass or bone matrix. Wild-type pre-osteoclasts were able to 
form typical podosomes consisting of a central actin core sur-
rounded by a ring of adhesion molecules including v( 3) and 
1 integrins, vinculin, paxillin, and talin (Fig. 6, A, C, and D; and 
not depicted). Kindlin-3 /  cells formed small, actin core–like 
structures surrounded by a diffuse actin cloud. Vinculin, talin, 
and paxillin colocalized with the actin cloud, whereas v and 
1 integrins were diffusely distributed throughout the plasma 
membrane (Fig. 6, A, C, and D; and not depicted). Fluorescence 
intensity pro"ling through actin-core units revealed that actin 
cores alternate with vinculin rings in wild-type podosomes, 
whereas this alternating pattern of actin and vinculin staining 
was lost in kindlin-3 /  cells (Fig. 6 B). Approximately half 
(59.9% ± 11.1%) of the actin dots from kindlin-3 /  cells were 
depleted of vinculin and considered to be podosome structures 
even though a discrete vinculin ring was rarely observed. 
Re-expression of GFP–kindlin-3 into kindlin-3 /  pre-osteoclasts 
restored the size of the F-actin dots and the ringlike distribu-
tion of vinculin around the F-actin cores (Fig. S5 C). On the 
contrary, the integrin-binding mutant EGFP–kindlin-3–QA did 
not rescue podosome formation in kindlin-3 /  pre-osteoclasts 
and showed a diffuse distribution throughout the cell membrane 
when expressed in control pre-osteoclasts (Fig. S5 C). The 
percentage of cells that form normal podosomes was similar 
in EGFP–kindlin-3–expressing control and kindlin-3 /  cells, 
whereas re-expression of the EGFP–kindlin-3–QA resulted in 
signi"cantly fewer podosome-forming cells (Fig. S5 D). Re- 
expression of the integrin-binding mutant kindlin-3 did just 
partially improve the diffuse vinculin and F-actin localization in 
kindlin-3 /  cells (Fig. S5 C). In line with the normal podosome 
formation in EGFP–kindlin-3–expressing kindlin-3 /  cells, 
v integrins colocalized with vinculin to podosome rings, 
whereas v integrins were diffusively distributed in the mem-
brane of kindlin-3 /  cells expressing an EGFP–kindlin-3–QA 
construct (Fig. S5 E). Finally, the resorptive activity of kindlin-3 /  
osteoclasts expressing an EGFP–kindlin-3–QA was "ve times 
less compared with kindlin-3–de"cient osteoclasts expressing 
wild-type EGFP–kindlin-3 (Fig. S5 F).
High-resolution scanning electron microscopy con"rmed 
that kindlin-3 /  osteoclasts were able to form small actin 
patches, which were surrounded by a loose network of radial 
actin "bers (Fig. 7 A). In sharp contrast, control osteoclasts 
formed large actin cores within podosome clusters, which were 
extensively interconnected by thick actin bundles (Fig. 7 A). 
Despite their smaller size, the actin cores of kindlin-3 /  cells 
colocalized with cortactin, Arp2/3, and Wiskott-Aldrich syn-
drome protein (WASp), which are known core components of 
podosomes (Linder and Aepfelbacher, 2003), indicating that 
podosomal actin core formation occurs in the absence of 
kindlin-3 and activated integrins (Fig. 7, B–D).
Mature osteoclasts arrange their podosomes into differ-
ent higher ordered structures. On glass, they form a ring at 
the periphery of the cell called the podosomal belt (Fig. 8 A); 
whereas on mineralized matrices, they form several smaller 
ringlike adhesion structures called sealing zones (Fig. 8 B; 
Jurdic et al., 2006). Kindlin-3 /  osteoclasts were not able to 
form podosomal rings on glass surfaces or on sealing zones 
(Fig. 5 A), further corroborating the "nding that integrin- 
mediated signaling is severely compromised in the absence of 
kindlin-3. This weak activation is either triggered by integrin-
independent signaling processes or by some residual integrin 
activity that exists even in the absence of kindlin-3.
A previous study demonstrated that loss of v 3 integrin 
function in osteoclasts can be compensated by high concentra-
tions of M-CSF (Faccio et al., 2003b). To test whether kindlin-3 
loss can also be overcome by high levels of cytokines, we treated 
wild-type and mutant fetal liver cells with RANKL and different 
concentrations of M-CSF. Wild-type fetal liver cells differenti-
ated within 4 d into large, multinucleated osteoclasts when cul-
tured at low M-CSF levels (20 ng/ml), whereas kindlin-3 /  fetal 
liver cells rarely fused into polykaryons. High levels of M-CSF 
(100 ng/ml) rescued polykaryon formation but not the spreading 
defect of kindlin-3 /  cells (Fig. 5 B). Moreover, although low 
levels of M-CSF failed to induce normal phosphorylation of Erk, 
Akt, and Syk in kindlin-3 /  osteoclasts, high levels were able 
to induce normal phosphorylation of these signaling proteins 
(Fig. 5 C), which suggests normal differentiation of kindlin-3 /  
osteoclasts in the presence of high M-CSF levels.
Altogether, these "ndings show that kindlin-3 recruitment 
to integrins is required for their activation, actin reorganization, 
and cell spreading, as well as ampli"cation of growth factor sig-
naling in osteoclasts.
Kindlin-3 is required for the formation and 
arrangement of podosomes
Osteoclast adhesion is mediated by the formation of specialized 
adhesion structures called podosomes when they are cultured 
Figure 4. Defective spreading of kindlin-3 /  osteoclasts. (A) Wild-type 
and kindlin-3 /  osteoclasts grown on glass coverslips and stained for 
TRAP. (B) F-actin (stained with phalloidin, green) and nuclei (DAPI, blue) in 
wild-type and kindlin-3 /  osteoclasts. Bars, 100 µm.
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led us to hypothesize that additional integrins contribute to the 
kindlin-3 /  osteoclast defect. To test this, we established os-
teoclast cultures from mice lacking the 1, 2, or v integrin 
genes, respectively, and from mice lacking a combination of 
two or all three integrin genes. In addition, we generated osteo-
clasts from 3 integrin–de"cient mice to test whether other 
v integrins in addition to v 3 play a signi"cant role in osteo-
clast biology. Bone marrow cells with a single or v/ 1 or 
1/ 2 double integrin-null mutation differentiated into multi-
nucleated, spread, and TRAP-positive osteoclasts. Osteoclasts 
lacking both v and 2 integrins formed polykaryons but 
were less ef"cient in spreading and localizing their nuclei to 
the cell periphery (Fig. 9 A). Bone marrow cells lacking 
1/ 2/ v integrins were only able to form a few mono- and 
binucleated cells with TRAP activity, which suggests that loss 
of all integrin classes severely impairs osteoclastogenesis in vitro 
(Fig. 9 A). Notably, although these cells did not spread, they 
weakly adhered on glass.
Individual podosomes, podosome clusters, and podo-
some belts of 1, 2, and 1/ 2 double integrin-null cells 
were indistinguishable from wild-type cells. v- and 3-de"cient 
cells showed smaller podosome clusters with irregular distrib-
uted podosome units (Fig. 9 B). Deletion of v together with 
1 or 2 integrins abolished cluster formation completely, and 
typical podosomes with a discrete vinculin ring were rarely 
on bone matrices. F-actin and vinculin often colocalized in 
patches and were usually localized to the cell periphery (Fig. 8, 
A and B). The formation of podosomal belts and sealing zones 
requires an intact microtubule network (Destaing et al., 2003, 
2005). We therefore analyzed microtubule organization and 
acetylation by immuno$uorescence microscopy and Western 
blot analysis. Both the total and acetylated microtubule pools 
were similar between kindlin-3 /  and wild-type osteoclasts 
(Fig. 8, C and D). Furthermore, phosphorylation and the total 
amount of Pyk2, which is required for microtubule stability 
and acetylation in osteoclasts (Gil-Henn et al., 2007), were 
not altered in kindlin-3 /  cells (Fig. 5 A), an observation that 
was also made in 3 integrin–de"cient osteoclasts (Faccio 
et al., 2003a).
These data indicate that kindlin-3 is not required for initial 
actin core formation. However, actin core maturation and inter-
connection, podosome formation, and their subsequent assem-
bly into belts and sealing zones depend on kindlin-3.
1, 2, and v integrin classes are required 
for normal osteoclast function
v 3 integrin is considered the major functional integrin on 
osteoclasts. In contrast to the severe osteopetrotic phenotype of 
kindlin-3–de"cient mice, however, loss of v 3 leads to a mild 
and protracted osteopetrosis in mice and humans. This discrepancy 
Figure 5. Impaired adhesion and M-CSF sig-
naling in kindlin-3 /  pre-osteoclasts. (A) Wild- 
type and kindlin-3 /  pre-osteoclasts either 
maintained in suspension (S) or replated on 
vitronectin (A). Western blotting for kindlin-3, 
p-FAK, FAK, p-src, Src, p-Pyk2, and Pyk2. 
GAPDH and actin served as loading controls. 
(B) TRAP staining of wild-type and kindlin-3 /  
osteoclasts treated with 40 ng/ml RANKL 
together with either 20 ng/ml or 100 ng/ml 
M-CSF. Bar, 250 µm. (C) Starved wild-type 
and kindlin-3 /  osteoclasts treated with either 
10 ng/ml or 100 ng/ml M-CSF. Western 
blotting for activated Erk and Akt. Activated 
Syk was determined by immunoprecipitation 
followed by immunoblotting with anti-phospho-
tyrosine (4G10) antibody.
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observed (Fig. 9 B). Similar to loss of kindlin-3, cells lack-
ing 1/ 2/ v integrins formed small actin dots lacking an 
adhesion ring (Figs. 9 B and 6 A). In agreement with these 
observations, we found that the diameter of the actin core 
was signi"cantly smaller ( 650 nm) in podosomes from 
kindlin-3 / , 1/ 2/ v triple-null, and v/ 1 and v/ 2 double- 
null pre-osteoclasts when compared with wild-type cells 
( 800 nm) or cells with a single integrin or a double 1/ 2 
integrin gene ablation (Fig. 9 C). Podosome belts of v- 
de"cient cells often failed to surround the entire cell and were 
signi"cantly thinner than belts from 3-de"cient cells, which 
showed a belt size that was intermediate between control 
and v-de"cient osteoclasts (Fig. 9, D and E). v/ 1 as well 
as v/ 2 integrin–de"cient osteoclasts showed even thinner 
Figure 6. Impaired podosome formation 
in kindlin-3 /  osteoclasts. (A) Vinculin (red) 
and F-actin staining (phalloidin, green) 
of pre-osteoclasts plated on glass cover-
slips and observed by confocal microscopy. 
(B) Fluorescence intensity profile through 
three actin-core units (indicated by the white 
lines in A) of wild-type and kindlin-3 /  pre-
osteoclasts. (C and D) vinculin (red) and F-actin 
staining (phalloidin, blue) together with v 
integrin (green; C) or 1 integrin (green; D). 
Bars (A and C) 5 µm; (D) 10 µm.
actin belts, which contained fewer and irregularly localized 
actin dots (Fig. 9, D and E).
Finally, we differentiated bone marrow–derived cells on 
a calci"ed matrix and evaluated their sealing zones and their 
capability to resorb matrix. The absence of a single integrin or 
the simultaneous loss of 1 and 2 still allowed sealing zone 
formation (Fig. 10 A), whereas the absence of v together with 
either 1 or 2 integrins abolished the formation of a distinct ring 
(Fig. 10 A). The resorptive activity of v/ 1- and v/ 2-de"cient 
osteoclasts was reduced to 30% of the wild-type level. Despite 
the presence of sealing zones in single integrin-null osteoclasts, 
their resorptive activity was diminished by 50%, indicating that 
each individual integrin family member contributes to functional 
sealing zone formation and bone degradation (Fig. 10 B).
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detect was a signi"cantly elevated RANKL/OPG ratio in the 
serum of kindlin-3 /  mice. RANKL secretion by osteoblasts is 
triggered in response to PTH, which is released by the parathy-
roid gland when serum Ca2+ levels decrease because of dimin-
ished bone resorption (Grant et al., 1990; Suda et al., 1999). An 
immediate consequence of high RANKL levels is enhanced dif-
ferentiation of osteoclasts, which derive from the monocytic 
lineage and express high levels of kindlin-3. Indeed, we found 
reduced levels of Ca2+ and markedly increased levels of PTH in 
the blood of kindlin-3 /  mice. Consistent with the high circu-
lating RANKL levels, we found a dramatic increase in the num-
ber of multinucleated osteoclasts in bones of kindlin-3 /  mice. 
These osteoclasts, however, completely failed to degrade bone 
matrix in vitro. In search for a mechanistic explanation for the 
dysfunction of kindlin-3 /  osteoclasts, we identi"ed several 
cellular defects that could be ascribed to kindlin-3’s principal 
task to activate several classes of integrins and subsequently 
mediate their outside-in signaling properties.
Our "ndings show that differentiation of kindlin-3 /   
osteoclasts is slightly delayed and that fusion into multinu-
cleated polykaryons is less ef"cient under in vitro conditions. 
However, the number of large polykaryons is signi"cantly 
higher in kindlin-3 /  bones. This is most likely caused by in-
creased RANKL-induced osteoclastogenesis that compensates 
Discussion
Several LAD-III patients have displayed increased bone min-
eral density (Kilic and Etzioni, 2009; Malinin et al., 2009; 
McDowall et al., 2010; Sabnis et al., 2010), which points to the 
possibility that kindlin-3 plays a role in bone homeostasis. 
In search for an explanation of this observation, Malinin et al. 
(2009) reported that mesenchymal stem cells isolated from 
LAD-III patients produced signi"cantly higher amounts of car-
tilage and bone in transplantation experiments, and concluded 
that the increased bone mass was caused by increased matrix de-
position by hyperactive osteoblasts. Although kindlin-3 is highly 
and exclusively expressed in hematopoietic cells, osteoblasts ex-
press kindlin-2 but lack kindlin-3 expression, which suggests that 
the increased bone mass in LAD-III patients either developed 
independently of kindlin-3 or was caused by a dysfunction of a 
cell type other than osteoblasts. In this paper, we tested this hy-
pothesis by analyzing bone formation in mice lacking kindlin-3.
Kindlin-3 /  mice develop a severe osteopetrosis that is 
already apparent at birth. When we "rst analyzed the osteoblasts 
of kindlin-3–de"cient mice in vivo and in vitro, we found that 
they appeared normal in terms of their numbers, morphological 
appearance, localization to the bone, expression of marker 
genes, and matrix production. The only abnormality we could 
Figure 7. Podosomal actin core formation is not abolished in kindlin-3 /  cells. (A) Scanning electron microscopy of basal membrane preparations of 
wild-type and kindlin-3 /  osteoclasts. (B–D) Colocalization of cortactin (red) and F-actin (phalloidin, green; B), F-actin (red) and Arp2/3 (green; C), and 
WASp (red) and F-actin (green; D) in podosome clusters of wild-type and kindlin-3 /  pre-osteoclasts analyzed by confocal microscopy. Bars: (A, left) 1 µm; 
(A, right) 500 nm; (B–D) 10 µm.
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platelet integrins and that binding to 2 tails is required to 
activate leukocyte integrins (Moser et al., 2008, 2009a). Our 
"ndings here demonstrate that this essential function of kindlin-3 
is also conserved in osteoclasts. Osteoclasts require kindlin-3 
to mediate 1 and v integrin binding to "bronectin and osteo-
pontin and 2 integrin binding to ICAM-1. This suggests that 
v 3 integrins, considered the most important integrin class 
the fusion defects in vivo. Although TRAP-positive, multinucle-
ated kindlin-3 /  osteoclasts are present at very high numbers 
in kindlin-3 /  mice, their shape and ability to adhere to bone 
surfaces is severely impaired. Similarly, adhesion to and binding 
of several extracellular matrix proteins and to ICAM-1 is also 
almost completely abrogated. We have previously shown that 
kindlin-3 interaction with 1 and 3 tails is required to activate 
Figure 8. Abnormal F-actin distribution but normal microtubule organization and acetylation in kindlin-3 /  osteoclasts. (A) Vinculin (red) and F-actin 
staining (phalloidin, green) of wild-type and kindlin-3 /  osteoclasts plated on glass coverslips. (B) Vinculin (red) and F-actin staining (phalloidin, green) 
of wild-type and kindlin-3 /  osteoclasts plated on mineral surface of osteologic slides. DAPI (blue) shows nuclei (A and B). (C) Wild-type and kindlin-3 /  
osteoclasts were labeled with phalloidin (blue), anti-acetylated tubulin (green), and anti-tubulin antibodies. (D) Cell lysates from wild-type and kindlin-3 /  
osteoclasts were immunoblotted with antibodies against kindlin-3, acetylated tubulin, and tubulin. Antibodies against actin and GAPDH were used as load-
ing controls. Bars: (A) 25 µm; (B) 100 µm; (C) 10 µm.
Figure 9. Podosomes and actin belts in integrin-deficient osteoclasts. (A) Wild-type and single, double, and triple integrin-deficient osteoclasts stained for 
TRAP. (B) Vinculin (red) and F-actin staining (phalloidin, green) of wild-type and integrin-deficient pre-osteoclasts plated on glass. (C) Diameters of actin dots 
in pre-osteoclasts with indicated genotypes measured using MetaMorph software; n = 6/5/5/8/9/6/6/6/8/9 different cells from each genotype taken 
to measure the actin core size. (D) Vinculin (red) and F-actin staining (phalloidin, green) of wild-type and integrin-deficient osteoclasts plated on glass. DAPI 
(blue) shows nuclei. (E) Diameter of podosomal belts of wild-type and integrin-deficient osteoclasts plated on glass. Data are presented as mean ± SD (error bars). 
P-values indicate significant differences from wild-type (Student’s t test). Bars: (A) 100 µm; (B) 2 µm; (D, top) 25 µm; (D, bottom) 5 µm.
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to assume that loss of all three integrin classes leads to a fur-
ther impairment. These "ndings provide an explanation for the 
much more severe osteopetrotic phenotype of kindlin-3 /  mice 
compared with 3 integrin mutants. Interestingly, in contrast to 
the failure of osteoclast differentiation in the absence of 1, 2, 
and v integrins, kindlin-3 de"ciency does not impair osteo-
clast differentiation both in vivo and in vitro. The reason for this 
observation is not clear. Because kindlins and talins shift the 
equilibrium of integrins toward their activation state, it is pos-
sible that certain processes such as cell fusion can proceed with 
just a few activated integrins and thus do not require the kindlin-
3–mediated equilibrium shift, whereas other processes such 
as adhesion and podosome formation require a larger number 
of activated integrins. These questions can be addressed with 
osteoclasts of engineered mice carrying hypomorphic alleles 
for 1, 2, and v integrins. If true, very low levels of integrins 
Figure 10. Sealing zones of integrin- 
deficient osteoclasts. (A) Vinculin (red) and 
F-actin staining (phalloidin, green) of wild-
type and integrin-deficient osteoclasts plated 
on a mineral surface. DAPI staining (blue) 
shows nuclei. Bar, 25 µm. (B) Resorption 
activity of wild-type and integrin-deficient 
osteoclasts plated on calcium apatite-coated 
slides quantified with MetaMorph. Number 
of analyzed slides per genotype: n = 26/6/ 
6/6/6/3/3/3/8. Data are presented as 
mean ± SD (error bars). P-values indicate 
significant differences from wild-type (Stu-
dent’s t test).
of osteoclasts, are just one of several integrin players during 
osteoclast-mediated bone resorption. This "nding was corrobo-
rated by a series of genetic experiments in which we ablated 
several integrin genes either individually or in combination 
in osteoclasts. The experiments revealed an already strongly 
reduced resorptive activity of osteoclasts when the 1, 2, or 
v integrin genes were individually ablated, and a further func-
tional decline when two integrin classes were absent from 
osteoclasts. The "nding that v-de"cient osteoclasts show a sig-
ni"cantly more pronounced defect in matrix degradation com-
pared with 3-de"cient osteoclasts corroborates our hypothesis 
that other integrins beside v 3 also play an important role in 
osteoclast function. The ablation of all three integrin classes 
does not permit osteoclast development in vitro. This made it 
impossible to test their resorptive activity. In light of the severe 
defects in osteoclasts lacking two classes of integrins, it is fair 
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Mice
Kindlin-3 /  and integrin 3 /  mice have been described previously 
(Hodivala-Dilke et al., 1999; Moser et al., 2008). Multiple integrins were 
deleted by intercrossing mice carrying conditional null mutations in the v 
( vflox/flox) and 1 ( 1flox/flox) genes (Potocnik et al., 2000), a constitutive 
null mutation in the 2 ( 2 / ) gene (Scharffetter-Kochanek et al., 1998), 
and the Mx1Cre transgene (Kühn et al., 1995). All mice were from a 
mixed 129/SvJxC57BL/6 background. Cre expression in the hematopoi-
etic system was induced by a single intraperitoneal injection of 250 mg 
polyI/C (GE Healthcare). 7 d after polyI/C treatment, bone marrow cells 
were isolated and checked for integrin surface expression via FACS. All 
animals were kept under specific pathogen-free conditions at the animal 
facility of the Max Planck Institute of Biochemistry.
Antibodies
The following antibodies were used for immunostaining of cells: mouse anti-
vinculin antibody, mouse anti-talin, mouse anti-cortactin, rabbit anti-actin, and 
mouse anti-acetylated tubulin (all from Sigma-Aldrich); rat anti-tubulin, rat 
anti-integrin 1, and rat anti-integrin v (all from Millipore); mouse anti– 
p-Tyrosine (clone pY99) and mouse anti-WASp (both from Santa Cruz Bio-
technology, Inc.); rabbit anti-p16 subunit of Arp2/3 complex (Abcam); and 
FITC and Cy3-labeled secondary antibodies (Jackson ImmunoResearch 
Laboratories, Inc.). Phalloidin dyes were obtained from Invitrogen.
The following antibodies were used for flow cytometry: hamster IgG 
anti-integrin 1, isotype control hamster IgG, and isotype control mouse 
IgG1 (all from Biolegend); rat IgG2a anti-integrin 2, rat IgG2a anti- 
integrin 7, rat IgG2a anti-integrin 4, rat IgG2a anti-integrin 5, rat 
IgG2a anti-integrin L, rat IgG1 anti-integrin v, isotype control rat IgG1, 
isotype control rat IgG2a, and rat anti-integrin 1 clone 9EG7 (all from 
BD); and hamster IgG anti-integrin 3, mouse IgG1 anti-integrin 5, and rat 
IgG2b anti-integrin M, isotype control rat IgG2b (all from eBioscience).
The following antibodies were used for Western blotting: mouse 
anti–glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH; Merck); 
rabbit anti-actin and mouse anti-talin (both from Sigma-Aldrich); rabbit 
anti-JNK, rabbit anti-pJNK Thr183/Tyr185, rabbit anti-p38, rabbit anti-
pp38 Thr180/Tyr182, rabbit anti-pSrc Tyr418, rabbit anti-Pyk2, rabbit 
anti-pPyk2 Tyr402, rabbit anti-P42/44 MAPK, rabbit anti-pP42/44 MAPK 
Thr202/Tyr204, rabbit anti-Akt, and rabbit anti-pAkt Ser473 (all from Cell 
Signaling Technology); rabbit anti-FAK and rat anti-tubulin (both from Milli-
pore); rabbit anti-pFAK Tyr397 and rabbit anti-src (both from Invitrogen); 
and mouse anti-Syk (Abcam).
Histology
Long bones were dissected, freed from soft tissue, and either embedded in 
plastic (Osteo-Bed Bone Embedding kit, Polysciences Inc.) or decalcified in 
10% EDTA/PBS and embedded in paraffin. Paraffin sections were stained 
with hematoxylin and eosin and for TRAP activity using a commercial kit 
(Sigma-Aldrich). AP and van Kossa staining were performed according to 
standard protocols. The number of nuclei in osteoclasts was determined in 
plastic embedded bone sections from three different 4-d-old animals.
Pictures were taken by bright field microscopy with a microscope 
(Axioskop; Carl Zeiss, Inc.) equipped with a camera (DC500; Leica), 10× 
NA 0.3, 20× NA 0.50, and 40× NQ 0.75 objectives, and IM50 soft-
ware. Pictures were edited with Photoshop (Adobe).
Measurement of RANKL, OPG, and PTH concentrations
Blood was collected from P2–P5 mice after decapitation using a microvette 
(CB 300 LH; Sarstedt); samples were then centrifuged for 3 min at 7,000 g 
and the plasma was harvested. The concentrations of RANKL and OPG 
were determined with ELISA kits from R&D Systems, and the intact PTH con-
centration was determined with an ELISA kit from Immutopics International.
Osteoclast culture
Osteoclasts were differentiated in vitro either from fetal liver cells or from 
bone marrow. E14.5 wild-type and kindlin-3 /  fetal liver cells were ob-
tained by pushing the fetal liver through a 70-µm cell strainer (BD). The 
cells were kept in -MEM supplemented with 20 ng/ml M-CSF overnight 
(ON). Nonadherent cells were collected after 24 h. Leukocytes were 
isolated from the interface after centrifugation at 1,000 g for 20 min in 
leukocyte separation medium (Laboratoires Eurobio), then washed with 
-MEM medium and seeded at a concentration of 2,000 cells/mm2 in osteo-
clast differentiation medium ( -MEM containing 10% heat inactivated 
FCS, 100 U/ml penicillin, and 100 µg/ml streptomycin with 50 ng/ml 
M-CSF and 40 ng/ml RANKL). Cells were cultured at 37°C in 5% CO2 for 
5–8 d, and medium was changed every second day. Staining for TRAP 
should allow cell fusion but not bone resorption to proceed. An 
alternative scenario could be that cells that are plated for several 
days in the presence of serum and integrin ligands can activate 
integrins from outside and trigger integrin signaling even with-
out ef"cient inside-out signaling. This is obviously not possible 
in the absence of all integrin classes.
Loss of kindlin-3 expression or a triple knockout of the 
1, 2, and v integrin genes is also accompanied by impaired 
podosome formation. Podosomes consist of an integrin ring 
and a central actin core. Interestingly, small actin cores con-
taining core proteins such as cortactin, Arp2/3, and WASp form 
in kindlin-3–de"cient osteoclasts. Similarly, 1/ 2/ v-integrin 
de"cient macrophages also form actin cores with a reduced 
diameter, indicating that the induction of actin polymerization 
occurs independently of integrin action, whereas their matu-
ration requires an integrin signaling program. This observation 
is in agreement with previous studies showing that actin core 
formation and osteoclast adhesion to the substratum can also 
be mediated by the transmembrane proteoglycan CD44 in an 
integrin-independent manner (Chabadel et al., 2007). Actin 
cores lacking an adhesion ring are also found in c-src–de"cient 
osteoclasts, which suggests that c-src activity is central for their 
maturation and acts as an upstream signaling molecule required 
for the assembly of integrins and cytoplasmic adhesion proteins 
(Destaing et al., 2008; Saltel et al., 2008).
Treatment of kindlin-3 /  osteoclasts with Mn2+ signi"cantly 
improved integrin-mediated adhesion but restored neither the de-
fective F-actin reorganization nor podosome organization and 
assembly. This "nding is in agreement with several reports demon-
strating that kindlins mediate both inside-out as well as outside-in 
integrin signaling (Larjava et al., 2008; Moser et al., 2009b; Plow 
et al., 2009). Moreover, this interesting observation also indicates 
that integrin arrangement around F-actin cores cannot be accom-
plished solely by an active integrin; kindlin-3 and/or kindlin-3–
associated proteins are required in addition. Another consequence 
of the abrogated integrin outside-in signaling in kindlin-3 /  osteo-
clasts includes diminished FAK and Syk activation upon adhesion 
to extracellular matrix and impaired Erk and Akt phosphorylation 
that is seen only upon treatment with low concentrations of 
M-CSF, whereas high M-CSF levels are associated with normal 
Erk and Akt phosphorylation, indicating that integrin outside-in sig-
nals represent an ampli"er of M-CSF–induced c-Fms signaling.
This study shows for the "rst time that osteoclast- 
mediated bone resorption depends on multiple integrin classes, 
which are under control of kindlin-3. Further work will be 
required to elucidate the individual contributions of each inte-
grin subclass during podosome maturation and assembly, and 
whether certain signaling pathways that control the organiza-
tion of the cytoskeleton and the formation of sealing zones are 
directed by speci"c integrins in osteoclasts.
Materials and methods
Reagents
Recombinant murine M-CSF and receptor activator of NF- B ligand 
(RANKL) were obtained from R&D Systems and PeproTech, respectively. 
Osteopontin was purified from bovine plasma (provided by D. Heinegard, 
University of Lund, Lund, Sweden; Franzén and Heinegård, 1985).
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legs of newborn wild-type and kindlin-3 /  mice were minced and rotated 
for 1 h at 37°C in -MEM containing 10% FCS. Afterward, the freed cells 
were seeded onto the coated-glass slides for 1 h and the slides were care-
fully washed with medium to remove nonadherent cells. The adherent cells 
were allowed to spread ON and were then TRAP-stained.
Macrophage adhesion on ICAM-1 was performed as described 
previously (Chavakis et al., 2008). In brief, 96-well plates were coated 
with 4 µg/ml recombinant human ICAM-1 (R&D Systems) in coating buffer 
(150 mM NaCl, 20 mM Tris-HCl, and 2 mM MgCl2, pH 9) ON at 4°C, 
blocked with 3% BSA in PBS for 1 h at RT, then incubated with 50,000 
macrophages for 30 min in a tissue culture incubator in the presence or 
absence of 1 mM MnCl2. Each condition was assayed in quadruplet. After 
washing with PBS containing 1% BSA, adherent cells were fixed in 4% 
PFA for 10 min and stained with 5 mg/ml crystal violet in 2% ethanol for 
30 min. After washing, the remaining dye was dissolved in 2% SDS. Stain-
ing intensity was measured in an ELISA plate reader at 550 nm.
Resorption assay
Osteoclasts isolated from bones of P2–P4 wild-type and kindlin-3 /  mice 
or in vitro differentiated from fetal liver cells or bone marrow were plated 
in osteoclast differentiation medium on osteologic slides (BD) for 1 wk. 
To quantify matrix resorption, cells were removed from the slides by treat-
ing them with 1% Triton X-100 and mechanical agitation, pictures were 
obtained with a microscope (Axioskop; 20× NA 0.50 objective, see His-
tology), and the resorbed area was measured using MetaMorph software. 
Alternatively, cells were cultured on dentin discs (Immunodiagnostic Sys-
tems) and resorption pits were visualized by staining with 1% toluidine 
blue in 0.5% sodium tetraborate for 3 min.
Immunofluorescence
Cells were plated on 12-mm coverslips coated with FCS for 1 h at 37°C, 
fixed with 4% PFA in PBS for 10 min or with 4% PFA for 1 min followed by 
a methanol fixation for 10 min at 20°C, and permeabilized with 0.25% 
Triton X-100 in PBS for 20 min. Blocking was performed for 1 h with 3% 
BSA in PBS. Cells were then incubated with the primary antibody in block-
ing solution for 3 h at RT or at 4°C ON. F-actin was visualized with Alexa 
Fluor 488–Phalloidin or Alexa Fluor 647–Phalloidin. Cells were imaged at 
RT with a SP2 confocal microscope (DMIRE2; Leica) using Leica Confocal 
Software (version 2.5 Build 1227) with 40× NA 1.25 and 100× NA 1.40 
oil objective lenses. Single channels were imaged sequentially. All pictures 
were processed with Photoshop (Adobe).
Actin core size was measured in the actin channel by using Meta-
Morph software from at least six cells of each genotype. 50 actin dots were 
measured from each individual cell. The podosome belt size was obtained 
by measuring the thickness of the vinculin ring of at least 20 belts from 
osteoclasts that were differentiated in three or more independent prepara-
tions. Actin cores from at least 10 different pre-osteoclasts were analyzed. 
From each cell, 25 actin cores were analyzed.
Retroviral infections
EGFP–kindlin-3 and EGFP–kindlin-3–QA constructs (Moser et al., 2008) 
were amplified and directionally cloned using the EcoRI and BamHI 
sites of the pCLMFG retroviral vector (Naviaux et al., 1996). Vesicu-
lar stomatitis virus G–pseudotyped retroviral vectors were produced by 
transient transfection of 293T (human embryonic kidney) cells. Viral 
particles were concentrated from cell culture supernatant as described 
previously (Pfeifer et al., 2000) and used for infection of fetal liver cells. 
Fetal liver cells were prepared for differentiation into osteoclasts as de-
scribed. Cells were cultured in medium containing 10 ng/ml M-CSF 
and 40 ng/ml RANKL for 5 d, and were used for TRAP and immuno-
fluorescence staining and matrix degradation assays, or were lysed for 
Western blotting.
Gelatin zymography
Osteoclasts were isolated from bones of P2–P4 wild-type and kindlin-3 /  
mice, plated in osteoclast differentiation medium in a single 24 well for 
about 1 wk, and washed and incubated with serum-free -MEM for 24 h. 
The conditioned medium was harvested, concentrated in Centricon filter 
units (10 kD cut-off; Millipore), mixed with nonreducing SDS sample buffer, 
and run on an SDS gel with a 4% stacking gel and a 12% running gel con-
taining 0.2% gelatin. Gels were incubated twice for 15 min at RT in 
0.2% Triton X-100 in ddH2O and then for several days at 37°C in MMP re-
action buffer (50 mM Tris-HCl, pH 7.5, 0.2 M NaCl, 5 mM CaCl2, and 
0.02% NaN3). The bands of gelatinolytic activity were revealed after stain-
ing with Coomassie blue.
activity was performed after 5 d in culture. Pictures were taken with a 
microscope (Axioskop) using a 20× NA 0.50 objective (see Histology).
For pre-osteoclast generation, 5 × 106 interface cells were plated 
on a 10-cm dish and cultured in osteoclast differentiation medium for 2 d. 
Cells were washed with PBS and lifted with 10 mM EDTA in PBS. Adherent 
cells that were treated with osteoclast differentiation medium for at least 2 d 
but had yet not fused into polykaryons were defined as pre-osteoclasts.
Isolation and functional assays with primary osteoblasts
Mouse calvarial osteoblasts were isolated from newborn mice as described 
previously (Wu et al., 1992). 8 × 104 primary osteoblasts were cultured 
in -MEM in a 12-well plate until confluence. Osteoblastogenic medium 
( -MEM, 10% FCS, 5 mM -glycerophosphate, and 10 mg/ml ascorbic 
acid) was added to induce osteoblast differentiation. Osteoblast identity 
was confirmed at day 4 of differentiation by RT-PCR for AP, osteocalcin, 
and collagen I expression.
AP staining was performed on osteoblasts fixed in 4% PFA for 15 min 
and stained with DIG III solution (0.4% nitro-blue tetrazolium chloride 
[NBT]/5-bromo-4-chloro-3 -indolyphosphate p-toluidine salt [BCIP], 0.4 M 
Tris-HCl, pH 9.5, 0.4 M NaCl, and 0.2 M MgCl2). To determine AP activ-
ity, osteoblasts from 12-well plates were collected in 500 µl lysis buffer 
(10 mM Tris-HCl, pH 7.5, 0.5 mM MgCl2, 0.1% Triton X-100, and 1× 
protease inhibitors) and homogenized by sonication for 20 s followed by 
centrifugation. 50 µl of the supernatant was mixed with 50 µl of 10 mM 
p-nitrophenylphosphate (Sigma-Aldrich) in 0.1 M glycine, 1 mM MgCl2, 
and 1 mM ZnCl2, pH 10.4, and incubated for 30 min at 37°C. 50 µl 
1 M NaOH was added to stop the reaction, and absorption at 405 nm 
was measured. Assays were performed in triplicate and the AP activity was 
normalized to the initial protein content.
Alizarin red S (ARS) staining and quantification of in vitro mineral-
ization of osteoblasts was performed at day 21 after induction of osteoblast 
differentiation as described previously (Gregory et al., 2004). In brief, 
cells were fixed in 4% PFA for 15 min at RT, washed twice with ddH2O, 
and incubated with 2% ARS, pH 4.2 (adjusted with NH4OH) for 20 min 
while shaking. Cells were washed five times with ddH2O for 5 min each 
and pictured. Bound ARS was dissolved in 10% acetic acid for 30 min 
at RT. The cell layer was scraped from the plate, transferred to a reaction 
tube, and vigorously shaken for 30 s. The suspension was overlayed with 
mineral oil, heated to exactly 85°C for 10 min, and kept on ice for 5 min. 
After centrifugation at 20,000 g for 15 min, two equivalents of 10% 
NH4OH were added to five equivalents of ARS solution to get a pH of 
4.1–4.5. This solution was measured at 405 nm in triplicate.
Pictures were obtained using a stereomicroscope (MZ FLIII; Leica) 
equipped with a Plan-Apochromat 1.0× objective, a ProgRes C14 camera, 
and Photoshop (Adobe) software.
RT-PCR
RT-PCR was used to examine the expression levels of osteoclast and osteo-
blast marker genes. Osteoclasts were obtained as described; cells at time 
point day 0 were taken immediately after performing the gradient centrifu-
gation, cells at time point day 1 were cultured for 24 h in differentiation 
medium containing RANKL and M-CSF, and so on.
Total RNA was isolated using an RNeasy kit (QIAGEN). cDNA was 
obtained using the SuperScriptTM III Reverse transcription kit (Invitrogen). 
The following primers were used: calcitonin receptor 1b forward, 5 -TTTACC-
GACGAGCAACGCCTACGC-3 , and reverse, 5 -CATGTAGGACTCG-
GCCTCGTGGG-3 ; cathepsin K forward, 5 -GCTATATGACCACTGCTTTC-
CAATACG-3 , and reverse, 5 -ACTGCATGGTTCACATTATCACGGTC-3 ; 
GAPDH forward, 5 -TCGTGGATCTGACGTGCCGCCTG-3 , and reverse, 
5 -CACCACCCTGTTGCTGTAGCCGT-3 ; collagenI forward, 5 -AAGAG-
GCGAGAGAGGTTTCC-3 , and reverse, 5 -ATCACCAGGTTCACCTTTCG-3 ; 
kindlin-3 forward, 5 -AGCTGTCTCTGCTGCGTGCTC-3 , and reverse, 
5 -ATACCTTGCTGCATGAGGCAC-3 ; MMP9 forward, 5 -CGAGTGGAC-
GCGACCGTAGTTGG-3 , and reverse, 5 -CAGGCTTAGAGCCACGACCAT-
ACAG-3 ; kindlin-1 forward, 5 -CTACACCTTCTTTGACTTG-3 , and reverse, 
5 -AGGGATGTCAGTTATGTC-3 ; kindlin-2 forward, 5 -GTACCGAAGTAG-
ACTGCAAGG-3 , and reverse, 5 -CATACGGCATATCAAGTAGGC-3 ; AP 
forward, 5 -CCTTTGTGGCTCTCTCCAAG-3 , and reverse, 5 -CTGGCCTTCT-
CATCCAGTTC-3 ; and osteocalcin forward, 5 -AAGCAGGAGGGCAATA-
AGGT-3 , and reverse, 5 -AGCTGCTGTGACATCCATAC-3 .
Adhesion assays
12-mm glass slides were coated for 6 h at RT with 5 µg/ml bovine osteo-
pontin in PBS or with 3% BSA. The adhesion assay was performed with 
osteoclasts, which were directly isolated from long bones as described 
previously (Flores et al., 1992; Ek-Rylander et al., 1994). In brief, all four 
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ON at 4°C on a rotator, then protein G–Sepharose beads (Sigma-Aldrich) 
were added to the lysates, incubated for 3 h at 4°C on a rotator, washed 
three times in lysis buffer, and boiled in 3× SDS sample buffer for 5 min. 
After centrifugation, proteins were separated by 10% SDS-PAGE, Western 
blotted, and probed using an HRP-labelled 4G10 antibody (Millipore).
Electron microscopy
Primary osteoclasts were cultured on glass coverslips and then “unroofed” 
as described previously (Heuser, 2000; Luxenburg et al., 2007). In brief, 
cells were exposed to hypotonic buffer (20% PHEM, 6 mM Pipes, 5 mM 
Hepes, 0.4 mM Mg2SO4, and 2 mM EGTA) and broken by brief sonication 
for 2 s. The resulting ventral membrane preparations were fixed with 2.5% 
(vol/vol) glutaraldehyde in 0.1 M phosphate buffer (pH 7.4, 1 h at RT), 
postfixed with 1% (wt/vol) aqueous OsO4, dehydrated, critical-point dried, 
and sputter-coated with 10 nm Au-Pd. Samples were viewed at 5 kV with 
a scanning electron microscope (DSM 982-Gemini; Carl Zeiss, Inc.).
Statistical analysis
A Student’s t test was used to analyze histomorphometric data, osteoblast 
data, ELISA assays, 1 integrin activation, osteoclast fusion, belt thickness, 
resorption, and adhesion. P < 0.05 was considered to be statistically sig-
nificant. All graphs include standard deviation error bars.
Online supplemental material
Fig. S1 shows histological sections of control and kindlin-3 /  long bones 
from different developmental stages indicating progressive ossification in 
kindlin-3 /  mice. Fig. S2 shows normal biological activity of kindlin-3 /  
osteoblasts. Fig. S3 shows normal p38 and JNK phosphorylation of 
kindlin-3 /  osteoclasts upon RANKL treatment in vitro. Fig. S4 shows that 
CD44 contributes to the residual adhesion of kindlin-3 /  pre-osteoclasts 
and integrin surface expression levels on control and kindlin-3 /  macro-
phages. Fig. S5 shows that retroviral-expressed EGFP–kindlin-3 rescues cell 
spreading, podosome formation, and matrix degradation in kindlin-3 /   
osteoclasts, whereas expression of an integrin-binding mutant EGFP–kindlin-3 
construct fails to do so.
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Cathepsin K activity measurement
Functional cathepsin K concentration was measured in protein lysates of 
cultured osteoclasts using a Cathepsin K Activity Assay kit (BioVision, Inc.). 
The assay was performed according to the manufacturer’s instructions 
using 50 µg protein lysate per measurement.
Bone mineral density and histomorphometric measurements
pQCT of the distal femur was performed with XCT Research SA+ (StraTec 
Medizintechnik). Bone density was measured exactly in the middle of the 
bone length using peel mode 2 with the threshold set at 100. Calcein 
labeling was performed as follows: 50 µl of 5 mg/ml calcein (Sigma- 
Aldrich) in 0.9% NaCl and 50 mM NaHCO3 was injected at P0 and 
exactly 24 h later intraperitoneally. Mice were sacrificed 15 h after the 
second injection and long bones were dissected, fixed in 70% ethanol, 
and embedded in polymethylmethacrylate. 3-µm sections of the distal 
femur were deplasticized and stained for Masson-Goldner with hema-
toxylin (Gill II; Carl Roth), acid fuchsin-ponceau xylidine, and phospho-
molybdic acid-orange G for visualizing cells, and osteoid and light green 
for visualizing mineralized matrix. Cancellous bone was examined in the 
1-mm band below the growth plate, whereas primary cancellous bone 
was examined in the first 200 µm and secondary cancellous bone in 
the remaining 800 µm. Data presented were combined for both types. 
Histomorphometric analysis was performed according to the standards 
set forth by the American Society for Bone and Mineral Research (Parfitt 
et al., 1987). The following parameters were examined: osteoid surface 
(OS), bone surface (BS), osteoblast number (Ob.N), osteoclast number 
(Oc.N), and osteoclast surface (Oc.S). Measurements were performed by 
a person blinded to the genotype of the mice.
Flow cytometry
Fetal liver cell–derived macrophages and pre-osteoclasts were incubated 
with Fc receptor–blocking antibody (Millipore) and then with the appropri-
ate fluorophore-conjugated monoclonal antibodies for 30 min on ice. 
Analysis was performed with a FACSCalibur (BD). 1 integrin activation 
was induced with 2 mM Mn2+ and analyzed with the 9EG7 antibody and 
a fluorophore-conjugated anti–rat antibody. 9EG7 binding was normal-
ized to 1 integrin surface levels.
FNIII7-10 binding assay
Human FNIII7-10 fragment was subcloned into pET15b plasmid (Invitro-
gen), expressed in bacteria, and subsequently labeled with Alexa Fluor 
647 carboxylic acid via a succinimidyl ester (Invitrogen) as described pre-
viously (Czuchra et al., 2006). To assess ligand-binding properties, fetal 
liver–derived macrophages were harvested and incubated with Alexa Fluor 
647–coupled FNIII7-10 fragment in TBS in the presence or absence of 
10 mM EDTA or 2 mM MnCl2, respectively, and then subjected to flow 
cytometry analysis. Mean fluorescence of EDTA-treated cells was consid-
ered unspecific signal and was subtracted from all values.
Blocking of CD44-mediated adhesion
Osteoclast precursors were lifted using 10 mM EDTA in PBS and were first 
incubated for 15 min with an Fc receptor–blocking antibody followed by a 
15 min incubation with either an anti-CD44–blocking antibody (BD) or rat 
IgG2b (eBioscience) before seeding on a fibronectin-coated surface. After 
adhesion for 30 min, cells were carefully rinsed with PBS and fixed with 
4% PFA. Pictures were obtained using a microscope (Axiovert 40C; Carl 
Zeiss, Inc.) with a camera (Prosilica), a 10× objective lens, and FireWire 
Recorder software.
RANKL- and M-CSF-signaling
Mature osteoclasts were serum starved in -MEM for 3–4 h and treated with 
either recombinant M-CSF (100 ng/ml or 10 ng/ml) or recombinant RANKL 
(100 ng/ml) for the times indicated. Cells were washed in cold PBS, lysed on 
ice with modified RIPA lysis buffer (50 mM Tris-HCl, pH7.3, 150 mM NaCl, 
2 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 1× protease in-
hibitor mixture [Roche], and 1× phosphatase inhibitor cocktail 1+2 [Sigma-
Aldrich]) and incubated on ice for 10 min. Cell lysates were cleared by 
centrifugation at 14,000 rpm for 10 min at 4°C, and 40 µg of total lysates 
was subjected to 10% SDS-PAGE, transferred onto polyvinylidene fluoride 
membranes, blocked for 1 h in 5% BSA in TBS-T for detecting phosphory-
lated proteins or in 5% skim milk in TBS-T for detecting other proteins, then in-
cubated with primary antibodies at 4°C ON followed by probing with 
HRP-labeled secondary antibodies (Jackson ImmunoResearch Laboratories).
For detection of Syk phosphorylation, 500 µg of lysate was used for 
immunoprecipitation. Lysate was incubated with 3 µg of primary antibody 
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Figure S1. Fetal development of osteopetrosis. (A) Histology of femora from wild-type and kindlin-3 /  embryos at E14, E16, and P1. Consecutive sec-
tions stained with hematoxylin and eosin (H&E), van Kossa, TRAP, and AP activity. Bar, 200 µm. (B) Number of TRAP-positive osteoclasts in histological 
sections from wild-type and kindlin-3 /  femora at P1. n.s., not significant.
JCB S2 
Figure S2. Osteoblasts are normal in kindlin-3 /  mice. (A) Histomorphometric measurement of osteoblast number per bone surface in tibiae of P2 
wild-type and kindlin-3 /  mice; n = 4. (B) RT-PCR of osteoblast markers and kindlin-3 in primary wild-type and kindlin-3 /  osteoblasts and wild-type 
osteoclasts. (C) RT-PCR of kindlin-1 and -2 in wild-type and kindlin-3 /  osteoblasts and control osteoclasts. RNA from keratinocytes was used as a 
control. (D) Primary calvarial osteoblasts from wild-type and kindlin-3 /  newborn mice stained for AP. Bar, 3 mm. (E) Relative AP activity in lysates from 
primary wild-type and kindlin-3 /  osteoblasts was measured photometrically at 405 nm; n = 10/4. (F) Bone nodule formation by cultured wild-type 
and kindlin-3 /  osteoblasts visualized by Alizarin red S staining. Bar, 3 mm. (G) Quantification of mineralization after Alizarin red S dye extraction 
and photometric measurement at 405 nm; n = 6/4. (H) Bone formation rate corrected to bone surface measured by histomorphometry; n = 4. Data are 
presented as mean ± SD (error bars).
Figure S3. Normal RANKL signaling in kindlin-3 /  osteoclasts. Starved wild-type and kindlin-3 /  osteoclasts treated with 100 ng/ml RANKL for the 
indicated time periods. Western blot analyses for p-p38 and p-JNK are shown.
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Figure S4. CD44-mediated adhesion of kindlin-3 /  pre-osteoclasts and integrin expression levels on kindlin-3 /  macrophages. (A and B) Wild-type 
and kindlin-3 /  pre-osteoclasts were treated with either an isotope control or an -CD44 antibody and plated on fibronectin. Cells were imaged (A) and 
quantified (B) after gentle washing and fixation; n = 4. Bar, 100 µm. (C) 4, 5, L, M, 2, and 7 integrin surface expression of wild-type (green) 
and kindlin-3 /  (red) macrophages. Isotype control staining is shown in dark blue. Data are presented as mean ± SD (error bars). P-values indicate sig-
nificant differences from wild-type (Student’s t test).
JCB S4 
Figure S5. Re-expression of wild-type and an integrin-binding mutant kindlin-3 in kindlin-3 /  osteoclasts. (A) TRAP staining of wild-type and kindlin-3 /  
osteoclasts transduced with either control virus (pCLMFG), or viruses expressing EGFP–kindlin-3 or an integrin-binding mutant EGFP–kindlin-3–QA. 
Bar, 100 µm. (B) Western blotting for GFP and kindlin-3 indicates relative expression levels of endogenous and retroviral-induced wild-type and mutant 
kindlin-3 expression in osteoclasts. GAPDH and actin served as loading controls. (C) Vinculin (red) and F-actin staining (phalloidin, blue) of wild-type and 
kindlin-3 /  osteoclasts transduced with an EGFP–kindlin-3 or an EGFP–kindlin-3 binding mutant EGFP–kindlin-3–QA (green). Bar, 5 µm. (D) The percent-
age of infected fetal liver cells that formed podosomes was quantified in four independent experiments. (E) Vinculin (blue) and integrin v (red) staining 
of kindlin-3 /  osteoclasts transduced with viruses expressing EGFP–kindlin-3 or mutant EGFP–kindlin-3–QA (green). Bar, 5 µm. (F) Resorption activity of 
kindlin-3 /  osteoclasts transduced with an EGFP–kindlin-3 or mutant EGFP–kindlin-3–QA–expressing virus on calcium apatite-coated slides quantified with 
MetaMorph; n = 3. Data are presented as mean ± SD (error bars). P-values indicate significant differences from wild-type (Student’s t test).
